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In the past decade, allergy research has been greatly influenced by the proposed “hygiene 
hypothesis”, that the microbial environment interfaces with the innate immune system 
and modulates antigen specific adaptive immune responses. The environmental microbial 
products such as lipopolysaccharide (LPS) can stimulate immune responses to confer 
protection or enhancement of allergies. Moreover, although it is well established that 
environmental allergen exposure is a major triggering factor associated with the 
development and persistence of Th2-mediated allergic diseases, the mechanisms for the 
initiation and development of such Th2 responses remain ambiguous. It is important to 
elucidate the direct effects of environmental factors such as LPS and mite allergens on 
individual immune-cell populations, particularly antigen presenting cells such as 
dendritic cells (DCs), macrophages and B cells. Most previous studies focused on DCs. 
The main objective of this study is to address the question from the B cell perspective.  
 
The first part of the study focused on the investigation of the immunomodulatory effects 
of LPS alone on the murine splenic B cells. Results indicated that LPS dose-dependently 
up-regulated IgM, CD86, CD40 and MHC II molecules as well as down-regulated 
CXCR4 molecule in B cells. B cells stimulated with high doses (1-10µg/mL) of LPS 
produced significant levels of IL-10, but the low doses (0.1-100ng/mL) of LPS stimulated 
B cells failed to produce IL-10. Functional assays revealed that low doses of LPS-
stimulated B cells were capable of driving Th2 polarization, whereas high doses of LPS-
stimulated B cells polarized T cells into the Tr1 phenotype. Therefore, LPS-activated B 
 xiii
 xiv
cells acquire differential modulatory effects on the polarization of antigen specific T 
cells, which is dependent on the stimulation of LPS in a dose-dependent manner. 
 
The second part of the study aimed to investigate the effects of house dust mite allergens 
on LPS-stimulated murine B cells. Results showed that Der p 1 and Der p 2 could work 
cooperatively with LPS to enhance B cells proliferation. B cells co-cultured with low 
dose of LPS containing Der p 1 were capable of priming Der p 1-specific T cell responses 
in BALB/c mice. Further functional assays indicated that B cells co-stimulated with very 
low doses of LPS (1ng/mL) and Der p 2 (100ng/mL) could also drive Th2 polarization. 
Addition of high (30µg/mL) or low dose (100ng/mL) of Der p 2 allergen had no 
significant impact on low doses of LPS activated B cell-conferred Th2 polarization. 
 
In summary, this study has contributed some new and useful information in the 
understanding of the mechanistic pathways by which LPS stimulated B cells impact on T 
cells polarization and allergen sensitization. It may offer a possible mechanistic 
explanation for the opposing influences of low and high levels of environmental LPS on 
the development of allergic diseases; therefore providing an immunological basis for the 
hygiene hypothesis from the B cell perspective. This information may be exploited for 
formulating novel strategies that are targeted at B cell antigen presenting pathways for 
the prevention and treatment of allergic diseases. 
 
Chapter 1  
Introduction 
 
1.1 Innate immunity  
 
The immune system has evolved to sense and to respond to invasions by microorganisms 
as well as to recognize altered self. There are two arms to this response—innate arm and 
adaptive arm. The innate arm provides first detection of foreign invasion by recognizing 
common microbial components in a non-specific fashion. Recognition by the innate arm 
of the immune system leads to the release of cytokines, resulting in a state of 
inflammation. For most infections, the innate immune system is sufficient to clear the 
infection; however, when an infection escapes the innate response, the second arm, the 
adaptive immune response, takes the helm. Unlike the innate arm, the adaptive arm, 
composed of B and T cells, recognizes foreign molecules via antigen-specific 
extracellular receptors (Janeway CA et al., 2001). 
 
Two important properties are identified with these two arms of immune response: (1) the 
two arms rely on distinct mechanisms for self and non-self recognition. Innate immunity 
uses a limited number of germline-encoded pattern recognition receptors (PRRs), the 
specificity of which has been ‘polished’ during evolution, to recognize microbial 
structures. Adaptive immunity relies on B cell receptor (BCR) and T cell receptor (TCR) 
repertoires for antigen recognition, which recognize both self and non-self antigens. The 
specificities of BCRs and TCRs are controlled by multiple overlapping mechanisms 
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through positive and negative clonal selection and the surveillance of regulatory T cells 
(Takeda K et al., 2003). (2) The activation of adaptive immunity is essentially dependent 
on innate immunity—naïve T cells are only activated by antigens that have been 
processed by antigen presenting cells (APCs) to prime adaptive immunity. Besides the 
well recognized APC—Dendritic cells (DCs), B cells, monocytes and macrophages can 
also serve as potent APCs (Unanue ER. 1984; Lanzavecchia A. 1990; Parker DC et al., 
1991; Banchereau  J et al., 2000). The activation and maturation of these APCs play a 
central regulatory role in priming and activation of T cells.  
 
1.1.1 Dendritic cells (DCs), Toll-like receptors (TLRs) and pathogen-associated 
molecular patterns (PAMPs) 
 
Dendritic cell (DC) is one of the professional APCs and the most potent APC that plays 
an essential role not only in T cell priming but also in T cell differentiation (Eisenbarth 
SC et al., 2003).  The unique theory that DCs are central players in bridging innate 
immunity and adaptive immunity was first proposed by Janeway in 1989.  The main 
theme in his proposal was that in host, “pattern-recognition receptors” (PRRs), germline-
encoded proteins evolutionarily selected to recognize “pathogen-associated molecular 
patterns” (PAMPs) carried by potential invaders (Janeway CA. 1989). It is well known 
that PAMPs are common maturation factors for APCs. These highly conserved microbial 
structures constitute a principal group of DCs maturation factors (Medzhitov R et al., 
2000). The recognition of PAMPs by APCs occurs via PPRs, of which Toll-like receptors 
(TLRs) are the best characterized in mammalian species.   Here, the central role of 
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activated DCs in bridging innate and adaptive immunity lies in the fact that maturation 
process of DCs initiating mainly by PAMPs represents a key regulatory step from innate 
recognition to adaptive T cell activation and T cell effector function. In another way of 
interpretation, recognition of PAMPs common in bacterial products such as endotoxin 
(Braun-Fahrlander C et al., 2002) and muramic acid, a component of peptidoglycan that 
is part of the cell wall of most bacteria (van Strien RT et al., 2004), takes place through 
PRRs including TLRs expressed on DCs.  Therefore, the recognition process represents a 
link between the innate and adaptive immune systems (Akira S 2003). Of the panel of 
PAMPs, Lipopolysaccharide (LPS) is the most studied and well-characterized PAMPs. 
 




Endotoxin was discovered by Richard Pfeiffer during the process of examination of the 
nature of the toxins involved in cholera pathogenesis. Pfeiffer showed that cholera 
bacteria that had been killed by heat retained their toxic potential, which proved that the 
poison was not a classical protein toxin. His experiments led him to formulate the 
concept that V. cholerae harbored a heat-stable toxic substance that was associated with 
the insoluble part of the bacterial cell. He called this substance endotoxin, which was 
from the Greek ‘endo’ meaning ‘within’. Pfeiffer proposed that endotoxins were 
constituents of both Gram-negative and Gram-positive bacteria; i.e nearly all groups of 
bacteria consisted of this kind of substance. He subsequently identified them in 
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Salmonella typhi and Haemophilus influenza. The molecular mechanisms of microbial 
pathogenesis of endotoxin then became the focus of a vast inquiry. Eugenio Centanni, the 
Italian pathologist, who was conversant with microbes and with Pfeiffer’s work, 
summarized Pfeiffer’s work:  the whole family of bacteria possessed essentially the same 
toxin, which depended on the typical feature of the general disturbances caused by 
bacterial infections. This tentative connection between microbial toxins and the system 
for innate immune recognition formed a solid conceptual link in the 1970s (Brade H et 
al., 1999; Rietschel ET et al., 2002; Beutler B et al., 2003). 
 
1.1.2.2 Definition, components/structure and recognition 
 
As endotoxin presents polysaccharide and lipid components, Lüderitz and Westphal 
designated their largely protein-free product as lipopolysaccharide (LPS) (Shear MJ et 
al., 1943). Mainly through the work of Mary Jane Osborn and Hiroshi Nikaido, it is now 
clear that endotoxin is an important structural component of the outer membrane of 
Gram-negative bacteria, containing the O-antigenic polysaccharide determinants that 
were discovered from serology (Brade H et al., 1999; Beutler B et al., 2003). 
 
The composition of LPS changes according to the origin of the bacteria. LPS from 
Escherichia coli is composed of three covalently linked regions: lipid A or endotoxin, a 
core oligosaccharide and an O antigen (Figure 1.1). The inner most layer, lipid A, which 
is responsible for LPS toxicity, consists of six fatty acyl chains linked in various ways to 
two glucosamine residues. The branched core oligosaccharide contains ten saccharide 
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residues. The outermost O antigen, which is highly variable among bacteria and 
determines the LPS antigenic specificity, is made up of many repeating units of a 
branched tetrasaccharide. When LPS remains in the membrane, activation of the innate 
immune system is poor (Kitchens RL et al., 1998; Miyake K. 2004).  
 
Recognition of LPS occurs largely by the mammalian LPS receptor — the TLR4–MD2–
CD14 complex (Figure 1.2), which is present on many cell types including DCs and 
macrophages (Wright SD 1990; Poltorak A et al., 1998; Hoshino K et al., 1999; Qureshi 
ST et al., 1999; Shimazu R et al., 1999).  
 
Recognition of LPS also requires accessory protein and molecules (Figure 1.3).  LPS-
binding protein (LBP) is a 60kDa serum glycoprotein that binds to the lipid A moiety of 
LPS (Schumann RR, et al., 1990). It is a lipid transferase that catalyzes the transfer of 
bacterial membrane LPS from the outer membrane to deliver to CD14. CD14 is a 
glycoprotein of about 50kDa, which is either expressed on the surface of 
myelomonocytic cells as a glycosyl phosphatidylinositol-anchored molecule (membrane 
CD14, mCD14) or is present in the circulation as a soluble form (sCD14) (Wright SD et 
al., 1990). CD14 concentrates LPS for binding to the TLR4–MD2 complex. How this 
complex recognizes lipid A and signals across the plasma membrane is still not 
completely understood. The importance of TLR4, CD14 and MD2 in LPS recognition is 
highlighted by the unresponsive phenotype of mice carrying knockout mutations in any 
of these genes and the fact that, in humans, polymorphisms in these genes reduce the 
magnitude of LPS responses. In addition, in mice, a lack of these components leads to 
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increased susceptibility to infection by the Gram-negative pathogen Salmonella enterica 
serovar Typhimurium, illustrating the general principle that functional innate immune 
recognition is important for protection against bacterial infections (Haziot A et al., 1995; 
Hoshino K et al., 1999; Nagai Y et al., 2002; Hamann L et al., 2004). 
 
1.1.2.3 TLR4, RP105 and accessory molecules 
 
Among the reported TLR family members, TLR4 and RP105 have unique structural 
characteristics in that they associate with accessory molecules MD-2 and MD-1, 
respectively (Figure 1.4, Kimoto M et al., 2003). 
 
MD-2 is a soluble protein associated with the extracellular domain of TLR4. The 
TLR4/MD-2 complex recognizes LPS. Binding of MD-2 to TLR4 is dependent on Cys95, 
Tyr102 and Cys105 in both mice and humans. Physical association of TLR4 with MD-2 is 
crucial for it to recognize LPS.  In vitro transfection experiments revealed that the 
expression of TLR4 alone did not transmit the LPS signal (Shimazu R et al., 1999). 
Stimulation of transfectant cell lines with TLR4/MD-2, but not TLR4 alone by LPS, 
results in the activation of the nuclear factor κB (NFκB) reporter gene. Furthermore, cells 
with TLR4 alone or TLR4 with the mutant MD-2 have been shown to be hyporesponsive 
to LPS (da Silva Correia J et al., 2001; Ohnishi T, et al., 2001; Schromm AB et al., 2001; 
Visintin A et al., 2001). 
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Exploration of MD-2-deficient mice further confirms the crucial function of MD-2 in 
LPS-induced cell activation. MD-2 knockout (MD-2-/-) mice do not respond to LPS:  B-
lymphocytes from MD-2-/- mice do not proliferate; and there are no induced CD86 
expressions in response to LPS. In the macrophages of MD-2-/- mice, LPS does not 
induce tumor necrosis factor-α (TNF-α) or interleukin-6 (IL-6). DCs from MD-2-/- mice 
are shown not to secrete IL-12 and cannot express CD86 by LPS stimulation. However, 
MD-2-/- mice are able to resist endotoxin shock but are susceptible to Salmonella 
typhimurium infection (Nagai Y et al., 2002; Akashi-Takamura S et al., 2008). These 
evidences reveal that MD-2 is an indispensable molecule for LPS responses.  
 
RP105, a short form of radioprotective 105, was originally discovered as a cell surface 
molecule on B cells that induce proliferation, up-regulation of B7.2 (CD86) and 
resistance against radiation-induced apoptosis upon ligation by an antibody (Miyake K et 
al., 1994). Like TLR4, RP105 is also a type I transmembrane protein with 22 leucine-rich 
repeats (LRRs) in its extracellular domain (Miyake K et al., 1995). It was the first LRR 
protein reported on the surface of B cells. However, in contrast to other TLR family 
molecules, it lacks a TIR domain in the cytoplasmic region and contains a short 
cytoplasmic tail that has only 6 to 11 amino acids. Signals through RP105 activate Lyn, 
Bruton type kinase (BTK), protein kinase C (PKC), mitogen activated protein kinase 
(MAPK)-β and NFκB (Miyake K et al., 1994; Chan VW 1998; Grumont RJ et al., 1998). 
RP105 is associated with MD-1, which has homology with MD-2. MD-1 is indispensable 
for cell-surface expression of RP105. Transfection experiments reveal that MD-1 is 
associated with RP105 (Miyake K et al., 1998). The RP105-/- mice B cells are defective 
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in response to TLR2 and TLR4 ligands, as demonstrated by poor proliferation and are 
severely impaired in hapten-specific antibody production in response to TLR2 and TLR4 
ligands (Nagai Y et al., 2002). 
 
To date, it is quite clear that the expression of RP105 is not limited to B cells. Like TLR4, 
the expression of RP105 on other antigen presenting cells such as DCs and macrophages 
has been reported (Divanovic S et al., 2005).  RP105/MD-1 is associated directly with 
TLR4/MD-2. They are expressed on the surface of B cells, macrophages and DCs. 
However, the role of RP105/MD-1 in TLR4/MD2 responses seems to vary between 
immune cells. In B cells, RP105/MD-1 is likely to positively regulate TLR4/MD2 
responses. It facilitates TLR4 signaling—both TLR4/MD-2 and RP105/MD-1 are 
required to the fully activation of B cells. Either RP105 -/-or MD-1-/- results in reduced B 
cell responses to LPS in mouse (Kimoto M et al., 2003).   By contrast, in macrophages 
and DCs, RP105 negatively regulates LPS induced responses—TLR4/MD-2 and 
RP105/MD-1 play a distinct role in mediating LPS initiated signaling (Divanovic S et al., 
2005).  Further study is necessary to elucidate the mechanisms of LPS recognition and 
signaling through RP105/MD-1. 
 
1.1.2.4 LPS receptors association/cluster 
 
Although the importance of TLR4 as the central component of the mammalian LPS 
“sensing machinery” is unequivocal, it is beginning to become evident that receptor 
associations are crucial for LPS recognition. LPS seems to induce clustering of multiple 
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receptors including CD14 and TLR4 during the activation process. As reviewed above, it 
has been demonstrated that LPS binds to MD-2, which in turn binds to TLR4 and induces 
aggregation and signal transduction (Visintin A et al., 2003). Other receptor components 
such as heat shock proteins 70 and 90, growth and differentiation factor 5, CD55 and 
CXC chemokine receptor 4 (CXCR4) have been suggested to be part of this activation 
cluster, possibly acting as additional LPS transfer molecules (Triantafilou M et al., 
2002a;  Triantafilou M et al., 2002b;  Figure 1.5). 
 
CXCR4 was identified by Triantafilou K et al., as a component of the “LPS-sensing 
apparatus” that is independent of CD14 (Triantafilou K et al., 2001). It is a chemokine 
receptor that belongs to the G-protein-coupled receptor (GPCR) family. CXCR4 is 
expressed not only on different leukocyte subpopulations, but also on non-haematopoietic 
cell types such as vascular endothelial cells (Murdoch C et al., 1999) and human 
astroglioma cells (Oh JW et al., 2001). It is reported that in macrophage and DCs, 
CXCR4 expression has been shown to increase after exposure to bacterial products, such 
as LPS (Moriuchi M et al., 1998; Mariani V et al., 2007). However, to the best of my 
knowledge, the profile of CXCR4 expression on B cells—another important type of 
APC—after exposure to LPS, has not been addressed previously. 
 
The most recent report addressing the important role of CXCR4 in LPS recognition 
(Triantafilou M et al., 2008), demonstrated that transfection of CXCR4 resulted in the 
responsiveness to LPS. Fluorescence correlation spectroscopy experiments further 
showed that LPS directly interacts with CXCR4, suggesting that CXCR4 was not only 
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involved in LPS binding but also responsible for triggering signaling, especially MAPK 
in response to LPS. The authors concluded that co-clustering of CXCR4 with other LPS 
receptors seemed to be crucial for LPS signaling, thus suggesting that CXCR4 is a 
functional part of the multimeric LPS “sensing apparatus”. 
 
Crosstalk between GPCR and TLR 
 
Emerging evidence documented that, in the scenario of macrophages, GPCR signaling 
components may play a novel role in crosstalk with GPCR-independent signaling 
pathway such as TLRs signaling pathway. As reviewed by Lattin J et al., recently, the 
authors proposed that GPCR signaling components such as G protein subunits, regulators 
of G-protein signaling (RGS), GPCR kinases (GRKs) and β-arrestin might regulate TLRs 
signaling. These components of GPCR signaling might interact with components of 
multiple pathways, which allowed them to mediate signaling crosstalk between GPCR 
and TLR. The potential crosstalk mechanisms included in response to the TLR agonist, 
such as LPS, transactivation of GPCR, such as CXCR4; mediation of downstream 
signaling of non-GPCRs, such as NF-κB, TRAF6, ERK1/2, JNK, and p38, by GPCR 
regulatory component. Crosstalk between GPCR and non-GPCR pathways enabled the 
coordination of precise and appropriate cellular responses (Lattin J et al., 2007, Figure 
1.6). To date, there is no report addressing on the scenario of B cells. Whether the 
observation and mechanisms can be applied to B cells, or whether there exists special 
crosstalk pathways, especially in the CXCR4 and TLR4 signaling remains to be further 
investigated and validated. 
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 1.1.2.5 TLR4 and LPS signaling pathway 
 
TLR4, the first mammalian homologue of Drosophila Toll being discovered, works 
downstream of CD14 and is responsible for delivering LPS signal. TLR4 is a type I 
transmembrane molecule, with leucine-rich repeat (LRR) motifs in the extracellular 
portion, and Toll IL-1 receptor (TIR) domain in the cytoplasmic region (Medzhitov R et 
al., 1997; Hoffmann JA et al., 1999). 
 
C3H/HeJ mouse, the substrain of C3H mouse, which has a spontaneous point mutation 
that resulted in an amino acid change of the cytoplasmic proline residue at position 712 to 
histidine in the signaling domain of the TLR4 protein, is the LPS-non responsive mouse 
strain that has abolished LPS responses effect (Poltorak A et al., 1998). C57BL10/ScCr 
mouse, which is another LPS-nonresponsive mutant mouse strain, lacks the entire 
genomic region for the TLR4 gene. These results are confirmed by targeting of the TLR4 
gene. It is clear that the proline residue lies in the TIR domain, is conserved among all 
TLRs and now well established as a signaling domain in the TLR signaling pathway 
(Hoshino K et al., 1999; O’Neill LA et al., 2000).  
 
In the signaling pathway downstream of the TIR domain, a TIR domain-containing 
adaptor, MyD88, is first characterized to play a crucial role. MyD88 consists of a TIR 
domain in the C-terminal portion, and a death domain in the N-terminal portion. MyD88 
associates with the TIR domain of TLRs. TIR domain-containing adaptor protein 
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(TIRAP) is another adaptor molecule that is required for a link between TLR4 and 
MyD88 (Yamamoto M et al., 2002). Upon stimulation by LPS, MyD88 recruits members 
of IL-1 receptor-associated kinase (IRAKs), IRAK1 and IRAK4 to TLRs through 
interaction of the death domains of these two types of molecules. IRAK is activated by 
phosphorylation and then associates with TRAF6 (TNF receptor-associated factor 6), 
which further leads to the activation of mitogen-activated protein kinases (MAPKs), such 
as p38s, ERKs (extracellular signal-regulated kinases) and JNK (c-JunN-terminal kinase). 
TRAF6 can also lead to the activation of the IκBα kinase complex (IKK), the 
phosphorylation and subsequent degradation of IκBα, and finally resulting in the 
activation of NF-κBs (Barton GM et al., 2003; Figure 1.7). 
 
Upon stimulation with LPS, TLR4 is also able to activate an alternative MyD88-
independent signaling pathway (Kaisho T et al., 2001; Figure 1.7). Two TIR-containing 
adaptor molecules, TIR domain-containing adaptor-inducing interferon (IFN)-β (TRIF, 
also known as TICAM-1) and TRIF-related adaptor molecule (TRAM), are demonstrated 
to work in concert to activate MyD88-independent activation pathway. LPS stimulation 
leads to the activation of the IFN regulatory factor 3 (IRF3), and thereby induces IFN- β. 
IFN- β, in turn, activates Stat1, leading to the induction of several IFN-inducible genes 
(Doyle SE et al., 2002;  Toshchakov V 2002;   Yamamoto M et al., 2002; Yamamoto M 
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1.1.3 Toll-like receptor (TLR) 
 
In contrast to clonally rearranged antigen-specific T or B cell receptors, TLRs are 
germline encoded.  To date, there are 10 functional TLRs that have been identified in 
human subjects. In mouse, 11 distinct TLRs have been described–TLR1–9, 11 and 13 
(TLR11 is also called TLR12 by Tabeta et al., (Tabeta K et al., 2004)). TLR1–9 are 
conserved between human and mouse. However, although TLR10 is presumably 
functional in human, the C-terminal half of the mouse Tlr10 gene is substituted by an 
unrelated and non-productive sequence, indicating that mouse TLR10 is non-functional. 
Similarly, mouse TLR11 is functional, but there is a stop codon in the human TLR11 
gene, which results in a lack of production of human TLR11 (Takeda K et al., 2005).  
 
TLRs are expressed on both lymphoid and nonlymphoid cells including monocytes, 
macrophages, DCs, B cells and endothelial cells or cardiac myocytes. TLRs are capable 
of sensing organisms ranging from bacteria to fungi, protozoa and viruses by recognizing 
conserved molecular patterns expressed by such organisms (so-called PAMPs). In 
addition to PAMPs, several endogenous ligands such as unmethylated CpG DNA, single-
stranded RNA as well as diverse products from dying cells have also recently been 
identified and these may be especially important for the development of autoimmunity 
(Takeda K et al., 2003; Uematsu S et al., 2006). 
 
Amongst the cells of the immune system, B cells exhibit a unique status as they express 
both germline encoded TLRs and a clonally rearranged, antigen specific receptor, the B 
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cell antigen receptor (BCR). Naïve human B cells do not express significant levels of 
TLRs unless they are pre-stimulated through the BCR.  In contrast, human memory B 
cells constitutively express TRL2, TLR6, TLR7, TLR9 and TLR10 (Bernasconi NL et 
al., 2003; Bourke E et al., 2003). Expression of TLRs on murine B cells has not been 
analyzed as systematically as in human. However, most TLRs seem to be expressed 
constitutively including TLR2, TLR3, TLR4, TLR7 and TLR9. As in human, TLRs are 
expressed differentially in B cell subsets in mice. In particular, marginal zone B cells 
express higher levels of TLRs compared to follicular mature B cells (Gunn KE et al., 
2006). A recent report from Barr TA et al., demonstrated that mouse B cells expressed 
mRNA for all TLRs. However, their responses to the triggering factors of these receptors 
were clearly distinct from those of DCs (Barr TA et al., 2007).  
 
TLRs, their ligands and TLR expression profiles on the human immune cells are 
summarized in Table 1.1. The interaction of TLRs with ligands initiates cellular signaling 
cascade, which not only ensues the engagement of TLRs launching innate host defense 
mechanisms (Brightbill HD et al., 2000; Birchler T et al.,  2001), but also provides 
signals required for initiating and modulating the adaptive immune response (Medzhitov 
R et al.,  1997; Takeda K et al., 2005). 
 
In the context of the development of allergic diseases, much research work has been 
focused on TLR4 with its ligand LPS from Gram-negative bacteria (Barton GM et al., 
2002) and TLR2, with one of the ligands peptidoglycan of Gram-positive bacteria (Vogel 
SN et al., 2003). Polymorphisms in the genes for TLR4 and TLR2 have further been 
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shown to interact with the environments, modulating the protective effect of allergy (Eder 
W et al., 2004b).  In the recent report, Barr TA and colleagues assayed the distinct 
cytokines profiles from TLR-mediated stimulation of two types of APCs: B cells and 
DCs. They highlighted the potentially unique nature of immune modulation when B cells 
acted as APCs (Barr TA, et al., 2007). 
 
Other TLRs such as TLR9, mediating responses to bacterial DNA through the 
recognition of cytosine-guanine pairs in the bacterial DNA (CpG motifs) (Hemmi H et al., 
2000) and TLR5, recognizing flagellin, a protein that forms the flagella in bacterial 
flagellum have also been investigated (Kaisho T et al., 2006). However, the nature of the 
interaction between innate and adaptive immunity with reference to non-pathogenic 
antigens such as environmental allergens still remains unclear.  
 
1.2 Allergy and allergic response 
 
Allergic disease such as allergic bronchial asthma, allergic rhinitis, and atopic dermatitis 
is reported worldwide and the prevalence is increasing (Asher MI et al., 2006). For 
example, asthma is one of the chronic airway inflammatory diseases, which is 
characterized by recurrent episodes of airway obstruction and wheezing. The pathological 
aspects of asthma are airway inflammation and eosinophil infiltration in the airways, 
which are well-known characteristics of this disease. Nowadays, however, it is quite 
certain that eosinophil is not the only cell type that plays a crucial role in asthma. Many 
other cell types such as lymphocytes, mononuclear cells, mast cells, and macrophages are 
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also variably increased in the airways of asthmatics compared with non-asthmatics (Cohn 
L et al., 2004). Although considerable progress has been made in the understanding of 
the mechanism underlying the pathogenesis of allergic diseases, the relative contribution 
of various cell types and their products to the initiation and maintenance of allergic 
responses, and to the allergic inflammation process remain unclear. Among the many cell 
types that are involved in allergic diseases, lymphocyte is one of them. The role of 
lymphocyte in the allergic disease especially the role in the induction/initiation of allergy 
is still not clearly understood.  
An allergy is a chronic disease characterized by an overreaction of the immune system to 
protein substances either inhaled, ingested, touched or injected, that normally do not 
cause an overreaction in non-allergic people (Glossary of Allergy Terms. Asthma and 
Allergy Foundation of America). How the host immune system senses and interacts with 
foreign substance is therefore critical in the initiation or induction of allergic reactions. 
The term was originally coined by the Viennese pediatrician Clemens von Pirquet in 
1906 after noting that some of his patients were hypersensitive to normally innocuous 
entities such as dust, pollen, or certain foods. Pirquet called this phenomenon "allergy", 
from the Greek words allos meaning "other" and ergon meaning "work"(Kaplan AP. 
1998; Lipkowitz MA et al., 2001). After Gell P and Coombs R designed a new 
classification scheme to reflect what were then redefined hypersensitivity reactions, the 
word "allergy" is restricted to type I hypersensitivities, which are caused by the classical 
IgE mechanism (Gell P. 1975). 
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1.2.1 Th1 cells, Th2 cells and Th17 cells 
 
T cells develop in the thymus. Matured circulating T cells that have not yet encountered 
their antigens are known as naїve T cells. When they encounter antigen, T cells are 
induced to proliferate and differentiate into cells capable of contributing to the removal of 
the antigen, which are termed as effector T cells. As all T cells can be distinguished by 
their display of two membrane glyocoproteins, CD4+ or CD8+, effector T cells thus fall 
into functional classes that detect peptide antigens derived from different types of 
pathogen. CD4+ T cells are generally T helper (Th) cells and are class II MHC molecule 
restricted; CD8+ T cells are generally T-cytotoxic (Tc) cells and are class I MHC 
restricted (Marrack P et al., 1986;  Grey HM et al., 1989). Traditionally, Th cells can 
further differentiate into two types of effectors T cells, named Th1 and Th2 cells, based 
on their functional capabilities and lymphokine profiles. Since the original findings of 
Th1/Th2 CD4+ T cells subsets by Mosmann TR et al., (Mosmann TR et al., 1986) the 
study of the Th1/Th2 CD4+ T cells dichotomy has become an active research field in 
itself. This step, at which naїve CD4+ T cells become either Th1 cells or Th2 cells, has a 
critical impact on the outcome of an adaptive immune response.  In general, Th1 cells are 
defined by their production of interferon (IFN)-γ , tumor necrosis factor (TNF)-β, 
interleukin-2 (IL-2) and lymphotoxin- β (LT- β), which mediate defense against infection 
with intracellular microbes (type 1 immunity) and isotype switching to immunoglobulin 
G2a (IgG2a).  Th2 cells secrete IL-4, IL-13, IL-5, IL-6, IL-10 and IL-9, which are 
necessary for inducing the humoral response to combat parasitic helminths (type 2 
immunity) and isotype switching to IgG1 and IgE. They also promote mast cell and 
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eosinophil growth, differentiation and activation, which involve in allergic response 
(Romagnani SJ, 1995; O’Garra A 1998). The balance between Th1/Th2 subsets 
determines the susceptibility to disease states. The improper development of Th2 cells 
can lead to allergy and asthma, while excessive Th1 response can lead to autoimmunity 
(Glimcher LH et al., 2000; Murphy KM et al., 2002).  
Another newly identified type of CD4+ T cell has been named the Th17 cell on the basis 
of secretion of IL‑17A and IL‑17F, which are associated with neutrophilic inflammation 
(Stockinger B 2007). Th17 cell is selectively activated by IL‑1β and IL‑6. The 
transcription factor RORγt (retinoic-acid-receptor-related orphan receptor‑γt) identifies it 
(Chen Z et al., 2007), with IL‑23 being responsible for the proliferation of type of cell. 
IL‑17A is over-expressed in asthmatic airways in association with neutrophil influx 
(Bullens DM et al., 2006) and it induces production of the neutrophil chemoattractant 
IL‑8 (CXCL8) by human airway smooth muscle cells (Dragon S et al., 2007). 
 
1.2.2 Regulatory T cells (Treg) 
 
Having been long debated, the notion of suppressor T cells — renamed regulatory T cells 
(Treg) — is back on the map, but many questions remain regarding the nature of these 
regulatory cells. It is now generally acceptable that Treg cells represent a unique 
population of lymphocytes capable of powerfully suppressing immune responses (Bach J 
F.  2003; Wing K et al., 2006). The cardinal feature of Treg is their dramatic ability to 
suppress both adaptive and innate immune responses (Sakaguchi S. 2004; Lim HW et al., 
2005; Maloy K J et al., 2005). Treg can be divided into two broad types, the so-called 
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‘naturally occurring’ regulatory T cells (nTreg) and ‘adaptive’ regulatory T cells (aTreg) 
(Bluestone JA., 2003). 
 
nTreg is generated during the early stages of fetal and neonatal T-cell development 
within the thymus and exit to the periphery with a stable and fully functional suppressive 
phenotype where they constitute about 5–10% of peripheral CD4+ T cells. nTreg 
constitutively expresses CD25 in normal naїve mice and healthy humans and indeed, to 
date, this has proved to be the most useful surface marker for nTreg (Sakaguchi S et al., 
1995; Baecher-Allan C et al.,  2001). A number of other cell-surface molecules have 
been used to identify nTreg, amongst which are the CTLA-4 (CD152), aEb7-integrin 
(CD103), GITR (glucorticoid-induced tumor necrosis factor family-related gene/protein) 
and neuropilin-1 (Takahashi T et al., 2000; Lehmann J et al., 2002; McHugh RS et al., 
2002; Shimizu J 2002; Bruder D et al., 2004). However, to date, there is no cell-surface 
molecule that has been found to be uniquely associated with Treg. In most cases, they are 
up-regulated by conventional T cells upon activation. The crucial role of nTreg is mainly 
to prevent immune responses against self-antigens, i.e maintaining self-tolerance 
(Belkaid Y et al., 2002; Ko K et al., 2005). 
.  
aTreg is generated from mature T-cell populations under certain conditions of antigenic 
stimulation, and it can be induced in vitro by culturing mature CD4+ T cell with antigen 
or polyclonal activators in the presence of immunosuppressive cytokines, notably IL-10 
(Barrat FJ et al., 2002). Similar to nTreg, aTreg originates from the thymus, but it might 
be derived from classical T-cell subsets or nTreg. The level of expression of CD25 by 
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aTreg is variable, depending on the disease setting and the site of regulatory activity. Of 
note, aTreg functions in vivo in a cytokine-dependent manner. So, it is proposed that 
aTreg is distinguished from nTreg not by their origin (the thymus), but rather by the 
requirement for further differentiation as a consequence of exposure to antigen in a 
distinct immunological context (Bluestone JA et al., 2003). 
 
Depending on the method and mode of generation, aTreg can be classified as either T 
regulatory type 1 (Tr1) or Th3 cells (Chen Y et al., 1994; Groux H et al., 1996). Tr1 cells 
can be generated by activation in the presence of the immunomodulating cytokine IL-10. 
Tr1 cells secrete a pattern of cytokines distinct from that of Th1 and Th2 effector cells. 
They are characterized by high levels of IL-10 and generally low levels of transforming 
growth factor (TGF)-β and IL-5. In addition, Tr1 cells are anergic, functionally 
suppressive in vitro and are able to prevent the development of experimentally induced 
Th1 autoimmune diseases such as colitis when transferred in vivo (Groux H et al., 1997). 
Th3 cells preferentially secrete TGF-β together with varying amounts of IL-4 and IL-10 
and are able to suppress the induction of experimental autoimmune encephalitis by TGF-
β-dependent mechanisms (Wing K et al., 2006). 
 
The main function of aTreg is to maintain homeostatic control over various adaptive 
immune responses, and it might or might not be a crucial participant in the maintenance 
of self-tolerance (Bluestone JA et al., 2003). 
 
Mechanisms of suppression 
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Many studies have indicated that natural and adaptive subsets of Treg cells differ in their 
mechanism of action. aTreg mediates the inhibitory activities by producing 
immunosuppressive cytokines such as TGF-β and IL-10. By contrast, nTreg, at least in 
vitro, functions by a cytokine-independent mechanism, which presumably involves direct 





1.2.3 Innate control of Th1/Th2 cell differentiation/polarization  
 
Factors that are responsible for the differentiation of naїve CD4+ T cells into a Th1 or 
Th2 polarization profile have been extensively investigated. Strong evidence suggests 
that Th1 and Th2 cells do not derive from distinct lineage, but rather from the same T 
helper cell precursor under the influence of both environmental and genetic factors acting 
at the level of antigen presentation (Abbas AK et al., 1996; Romagnani S. 1997).  Among 
the environmental factors, a role for the route of antigen entry, the physical form of 
immunogen, the type of adjuvant, and the dose of antigen have been suggested. The 
genetic mechanisms that control the type of T helper cell differentiation still remain 
elusive. The environmental and genetic factors mixed together can define the Th1/Th2 
differentiation mainly by modulating the interplay of three fundamental groups of ligand-
receptor interaction at cell surface. They are: (1) nature of interaction of the TCR with 
MHC-peptide complex, which can probably control features of differentiation, T cell 
activation, clonal expansion and survival. The antigen doses and whether a peptide is a 
potent agonist, mixed antagonist, or partial agonist influence the development of Th1 or 
Th2 cells in vivo (Constant SL, Bottomly K, 1997; Badou A et al., 2001). (2) Signals 
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from APCs through co-stimulatory molecules such as CD28 and inducible co-stimulator 
(ICOS) are also critical regulators (Cua DJ et al., 1996; Constant SL, Bottomly K, 1997; 
Maldonado-lopez R et al., 1999; Yoshinaga SK et al., 1999; Akiba H et al., 2000) and (3) 
Cytokines and transcription factors that exert potent influences on the efficiency of Th1 
and Th2 development (Le Gros G et al., 1990; Paul WE, Seder RA 1994; Glimcher LH, 
Singh H 1999).  
1.2.4 Differentiation of CD4+ T-cell subsets by cytokines 
 
Although the mechanisms that control the step in CD4+ T-cell differentiation are not yet 
fully defined, it is clear that cytokines present during the initial proliferative phase of T 
cell activation have profound influence. Naїve CD4+ T cells initially stimulated in the 
presence of IL-12 and IFN-γ tend to develop into Th1 cells, in part because IFN-γ inhibits 
the proliferation of Th2 cells (Maggi E et al. 1992; Hsieh CS et al., 1993). By contrast, 
CD4+ T cells activated in the presence of IL-4, especially when IL-6 is also present, tend 
to differentiate into Th2 cells. This is because IL-4 and IL-6 promote the differentiation 
of Th2 cells. IL-4 is the most dominant factor in determining the Th2 polarization in 
cultured cells (Maggi E et al., 1992).  IL-4 or IL-10, either alone or in combination, can 
also inhibit the generation of Th1 cells (Manetti R et al., 1994; Rincon M et al., 1997).  
 
The presence of IL-10 and IFN-α at T cell priming results in the differentiation of Tr1 
cells, which mainly produces IL-10 and TGF-β. Via the production of high levels of IL-
10 and TGF-β, Tr1 cells can down-regulate both Th1- and Th2-type responses. The 
production of high levels of certain cytokines defines specific CD4+ T cell subsets, and 
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determines their effector functions. The influence of cytokines in the differentiation of 
CD4+ T cell subsets and the effect of CD4+ T cell subsets with the emphasis on Tr1 cells 
are simplified and illustrated in Figure 1.8 (Grazia M et al., 2001). 
 
1.2.5 House dust mite allergens 
 
One of the most strongly allergenic materials found indoors is house dust, often heavily 
contaminated with the fecal pellets and cast skins of house dust mite. Dust mite may be a 
factor in 50 to 80 percent of asthmatics, as well as in countless cases of eczema, hay fever 
and other allergic ailments. House dust mites are complex organisms that produce 
thousands of different proteins and other macromolecules (Platts-Mills TAE et al., 1987; 
Arlian LG et al., 2001; Thomas WR et al., 2002). Most mite allergens are biochemical 
active molecules present in mite bodies, secreta and excreta. Mite bodies and fecal 
particles contained the greatest proportion of mite allergens (Tovey ER et al., 1982; 
Arlian LG et al., 1987). Two species of Dermatophagoides of house dust mites 
(Dermatophagoides pteronyssinus and Dermatophagoides farina. In short, Der p and Der 
f, respectively) are associated with allergic disease. Examination of house dust mite 
extracts has indicated that more than 30 proteins can induce IgE antibody in patients 
allergic to the house dust mite. To date, house dust mite allergens have been categorized 
into 19 groups on the basis of their biochemical composition, sequence homology, titers 
of human IgE reactivity and molecular weight. Among them, the group 1 and 2 allergens 
are identified as major allergens because they are not only present in high concentrations 
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in household dust (Platts-Mills TAE et al., 1987; Custovic A et al., 1996), but also give 
high reactivity with mite-sensitive patient sera of about 90% (Heymann PW et al., 1989). 
 
1.2.5.1 Group 1 allergens 
 
Group 1 allergens (Der p 1 and Der f 1) are the most clinically relevant allergen proteins 
because they exist in abundance in mite fecal pellets and account for more than 50% of 
IgE antibodies against total mite extracts. They belong to the papain-like cystein protease 
family (Chua KY et al., 1988; Dilworth RJ et al., 1991). Der p 1 is the first major 
allergen described from Dermatophagoides pteronyssinus (Chapman MD et al., 1980). 
cDNA sequences of the group 1 allergens reveal that they are 25-kDa MW proteins and 
comprise  a signal peptide of 18 amino acid residues, a 80 residue propeptides and 222 
residues mature portion for Der p 1 and 223 residues for Der f 1 (Chua KY et al., 1988; 
Dilworth RJ et al., 1991). Studies with Der p 1 and Der f 1 show a sequence identity of 
80% (Dilworth RJ et al., 1991).   
 
Several studies have suggested that the proteolytic or enzymatic activities of cysteine 
protease of Der p 1 involve in the pathogenesis of allergy. It is able to cleave both human 
(Schulz O et al., 1998;  Ghaemmaghami AM et al., 2001)  and mouse CD25 (Gough L et 
al., 1999), the 55 KDa α subunit of IL-2 receptor in T cells. As a result, these T cells 
show markedly diminished proliferation and IFN-γ production, and consequently bias to 
the Th2 subset development (Schulz O et al., 1998;  Ghaemmaghami AM et al., 2001). 
The in vitro work has been in line with the in vivo findings which shows that by 
                                                                                                                                 Chapter 1 Introduction 24
immunization of CBA mice with proteolytically active Der p 1 results in the 
enhancement of both total IgE and Der p 1-specific IgE production as compared with 
control mice immunized with Der p 1 that has been irreversibly blocked by cysteine 
protease inhibitor E64 (Gough L et al., 1999; Kikuchi Y 2006). Mechanistic study of 
upstream of Th2 development indicates that proteolytically active form of Der p 1, by 
stimulation through CD40, conditions DCs to produce less IL-12, which induces naïve 
CD4+ T cells to secrete more IL-4 and less IFN-γ (Ghaemmaghami AM et al.,  2002).  
Der p 1 can also directly promote IgE synthesis through cleavage of the low affinity IgE 
receptor CD23 on B cells (Schulz O et al., 1995; Pomes A. 2002). In addition, Der p 1 
has been proven to disrupt tight junction and to enhance the permeability of respiratory 
epithelium (Wan H et al., 2000), therefore it induces inflammatory cytokines release 
from epithelial cell cultures (King C et al., 1998).  
 
1.2.5.2 Group 2 allergens  
 
The group 2 allergens are first characterized as 14-18 KDa MW allergens with a high IgE 
binding activity, therefore, they are considered as major allergens (Lind P. 1985; Yasueda 
H et al., 1986; Heymann PW et al., 1989). The cDNA sequences of  Der p 2 (Chua KY et 
al., 1990a) and Der f 2 (Yuuki T et al., 1990; Trudinger M et al., 1991) show that the 
allergens have 129 residues, and they share 88% sequence identity with high IgE cross-
reactivity (Yasueda H et al., 1989). The precise biological functions of group 2 allergens 
in situ are unknown although they have been shown to be resistant to denaturation by 
proteases, heat and extremes of pH (Lombardero M et al., 1990). Sequence homology 
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searches suggest that the group 2 allergens are associated with the mite reproduction, 
although confocal microscopy indicates that they are present in the mite gut (Van Hage-
Hamsten M et al., 1995).  
 
Der p 2 is isolated and fully characterized by Chua KY et al., in 1990 (Chua KY et al., 
1990b). The tertiary structure of Der p 2 has been solved by NMR spectroscopy (Mueller 
GA et al., 1997; Mueller GA et al., 1998) and crystallography (Derewenda U et al., 
2002). The protein contains three disulfide bonds and two anti-parallel β- pleated sheets, 
which overlay each other at an angle of approximately 30°. The main difference between 
the NMR and crystal structure of Der p 2 is the distance between the two β- pleated 
sheets. In the crystal structure, the β sheets are significantly further apart, creating an 
internal cavity that is occupied by unidentified hydrophobic ligand. The crystal structure 
suggests that binding of non-polar molecules may be essential to the physiological 
function of the Der p 2 protein. It is also indicated that Der p 2 is a lipid-binding protein, 
like some of its distant mammalian homologues (Derewenda U et al., 2002). 
 
Der p 2 and its homologues are members of ML protein superfamily. ML stands for MD-
2-related lipid-recognition, is a novel domain identified in Der p 2, Der f 2, MD-1, MD-2 
and other multiple proteins of unknown function in plants, animals and fungi. The 
common feature of this type of protein is that, by interaction with specific lipids through 
their ML lipid domain, the protein is capable of mediating diverse biological functions 
(Inohara N et al., 2002). The sequence homologies of ML protein superfamily are 
illustrated by Gruber A et al., (Gruber A et al., 2004) and shown in Figure 1.9.   
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 Keber MM et al., prepared the tertiary structure model of the MD-2, based on the 
homology with Der p 2 to identify the similarity between Der p 2 and MD-2 and further 
elucidated whether Der p 2 possessed a similar role in insects as MD-2 does in 
vertebrates with respect to the recognition of LPS. Their data indicated that Der p 2 had 
the protein fold most compatible with the sequence of MD-2. Therefore, these two 
proteins share many common biochemical characteristics: they are both rich in β-
structure and are very stable. However, MD-2 binds LPS with high affinity; whereas Der 
p 2 only weakly binds to LPS. Comparison of electrostatic potentials of the structural 
model of MD-2 and Der p 2 indicates that there is a region of high positive potential on 
MD-2, which is absent in Der p 2. This may be the reason for the weak binding of LPS to 
Der p 2 (Keber MM, et al., 2005).  
 




During the past 100 years, some previously common childhood infections decline 
dramatically due to the development of vaccination and antibiotics. In contrast, the 
prevalence of asthma and atopic disease has increased, particularly during the past 30 
years. This increase is certainly not accounted for by a change in genetic risk factors, as 
genetically similar populations in the previous East and West Germany have very 
different incidence of asthma (von Mutius E et al., 1998). The explanation for the 
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‘allergy epidemics’ was initially proposed by Stranchan.  In 1989, Strachan published a 
paper observing the relationship of hay fever with hygiene and household size (Strachan 
DP. 1989). The results indicated that the prevalence of hay fever varied with family size. 
In this landmark study, which signals the initiation of Hygiene Hypothesis, Strachan 
proposed that improved hygiene that resulted in reducing exposure to infections in early 
childhood might be the factor for the increased risk in development of allergic diseases. 
 
The immunological basis of hygiene hypothesis is still controversial. The initial 
explanation is emphasized on the dominant Th1/Th2 dichotomy, formulating the theory 
of “missing immune deviation”. Infants are born with strong Th2 responses. But later on, 
under environmental influence, mainly that of common childhood infection or microbial 
burden, their Th1 responses mature in the first year or so of life (Warner JA. 
1999; Dealtry GB et al., 2000). Children born to atopic parents are slower to do this than 
those born to non-atopic parents (Prescott SL et al., 1999).  Exposure of a pregnant 
mother and ⁄or her son in the first year of life to microbial products released by farm 
animals, which is of typical rural lifestyle, exerts an important protective role against the 
development of allergy as a consequence of the chronic stimulation of the TLRs 
expressed by cells of the innate immunity (Braun-Fahrlander C et al., 2002). Viral and/or 
bacterial infections could inhibit the Th2 immune response associated with atopic 
reactions by stimulating a Th1 response involved in defence against bacterial infections 
and delayed-type hypersensitivity reactions. However, modern westernized lifestyles, 
which are of typical hygienic environments, deprive the immune system of stimuli 
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required to boost Th1 responses, leading to a surge in the prevalence of Th2-mediated 
allergic disease (Sheikh A et al., 2004). 
 
The underlining immunological mechanism focuses that reduced stimulation of TLRs on 
innate immune cells such as DCs and NK cells results in decreased production of 
cytokines, such as IL-12, IFN-α and IFN-γ, which not only promote the development of 
Th1 cells, but also antagonize the development of Th2 cells (Romagnani S et al., 1994;  
Abbas AK et al., 1996).  More recently, however, as it is evident that the Western world 
is witnessing an increase not only in Th2-skewed allergic diseases, but also the Th1-
mediated autoimmune disorders (Martinez FD. 2001), an alternative view emerged, 
indicating the importance of reduced activity of Treg cells (the “reduced immune 
suppression” theory).  Treg cells serve to fine-adjust both Th1 and Th2 immune 
responses (Wills-Karp M et al., 2001).  The innate immune system senses the 
environment and modulates the Treg cells accordingly, which subsequently maintain the 
balance between immune tolerance and responsiveness. The theory of “reduced immune 
suppression” proposes that decrease in the microbial burden jeopardizes the efficiency of 
the Treg cells, contributing to the prevalence of Th2-mediated allergy and asthma (Bach 
JF. 2002; Yazdanbakhah M et al., 2002; Vercelli D. 2003).   
 
 
1.3.2 Cellular and molecular mechanisms  
 
The core of hygiene hypothesis suggests that an early life (particularly in utero and/or 
during the first year of life) environmental condition rich in normal bacterial  flora 
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interacts with and modulates the innate immune system, priming it to the Th1 direction 
and maintaining the clinical balance of Th1 and Th2. However, a hygienic environment 
rather shapes the development of Th2 phenotypes. 
 
The current view of cellular and molecular mechanisms underlying these phenomena 
includes fine-balancing between innate immune mechanisms and Th1, Th2 and 
regulatory T cells. These novel immunoregulatory events may explain the hygiene 
hypothesis by an interaction of environmental factors with innate immune mechanisms 
and various subtypes of T cell responses. This core also needs to be integrated with the 
preeminent role of genetic variation in shaping immune responses to environmental 
stimuli. 
 
1.3.2.1 Dendritic cells (DCs) and Toll-like receptors (TLRs) 
 
Epidemiological evidences strongly support that traditional farming and less hygienic 
environments have protective effect against allergic sensitization and asthma (Riedler J et 
al., 2001; Braun-Fahrlander C et al., 2002).  Measurement of these environments also 
demonstrate that not only the concentrations of bacterial products, such as endotoxin 
from gram-negative bacteria and muramic acid from all bacteria, but also fungal levels 
are found higher in the mattresses of farm children compared with concentrations found 
in the mattresses of non-farm children (Braun-Fahrlander C et al., 2002; van Strien RT et 
al., 2004; Schram-Bijkerk D et al., 2005).  
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Endotoxin levels have also been measured in non-farming environments, and most 
studies have found an inverse association with atopic sensitization, supporting the 
findings from the farming environments (Eder W et al., 2004a). Hence, the molecular 
mechanism study for the hygiene hypothesis has mainly focused on the interactions 
between microbial products such as LPS and the well-characterized PRRs—TLRs, 
representing a link between the innate and adaptive immune systems. Many of the ligands 
for TLRs have been shown to have both a positive and a negative effect on allergic 
airway disease. However, how the interaction between DCs and microbial stimuli 
influences Th2 sensitization remains unclear. Currently, the main approaches used to 
elucidate the molecular mechanism of DCs in hygiene hypothesis are animal models. In 
an elegant study performed by Eisenbarth SC et al., using a mouse model of allergic 
sensitization, they demonstrated that by acting through TLR4, low level of inhaled LPS 
signaling was necessary to induce Th2 immune responses to inhaled antigens. In contrast 
to low levels of LPS, inhalation of high levels of LPS with antigen resulted in Th1 
responses. The in vitro results further suggested that DCs might be the responsive APCs.  
High doses of LPS could stimulate DCs to produce large amount of IL-12, whereas, there 
was no IL-12 production when stimulating with low dose of LPS (Eisenbarth SC et al., 
2002). 
 
Many other groups have also reported the protective effect of natural or synthetic TLR2 
and/or TLR4 ligands in allergen-induced lung inflammation (Akdis C et al., 2003; Patel 
M et al., 2005; Revets H et al., 2005). This results in the hypothesis that TLR2 and/or 
TLR4 ligands may modulate allergic responses. Noteworthy, early life administration of 
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bacterial cytosine-guanine pairs in the bacterial DNA (CpG motifs) which containing 
immunostimulatory DNA sequences, through the recognition by TLR9, has also been 
shown to exert a protective effect against allergic inflammation in a murine model of 
maternal asthma transmission (Fedulov A et al., 2005). The same group also 
demonstrated that TLR9 ligand conferred protection against a classic allergen challenge 
(Fedulov A et al., 2005). The possible mechanism again could be that exposure to 
microbes skews the Th1/Th2 balance toward Th1 response (Schnare M et al., 2001). We 
should note that DC is not the only type of APCs that expresses TLRs. As mentioned 
earlier, other APCs such as B cells and macrophages express TLRs as well (Dasari P et 
al., 2005; Maris NA et al., 2006).  The possible role of B cells as APCs in the 
pathogenesis of allergic disease is the question we want to address in this thesis. 
 
1.3.2.2 Endotoxin dose 
 
Low dose and high dose endotoxin exposure have significantly different immunological 
effects (Liu AH. 2002; Eisenbarth SC et al., 2003). As mentioned earlier, the study 
performed by Eisenbarth SC et al., is one of the typical examples. Several recent studies 
have also addressed the role of LPS in preventing the development of experimental 
allergic asthma in prenatal, neonatal as well as adult mice (Eisenbarth SC et al., 
2002; Delayre-Orthez C, et al., 2004; Blümer N et al., 2005; Piggott DA et al., 
2005; Gerhold K et al.,  2006; Wang Y et al., 2006). Consistent conclusion has been 
drawn from these studies indicating that low dose of LPS favors Th2 type polarization, 
leading to asthma development whilst high dose of LPS preferentially induces Th1 type 
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immunity to prevent airway inflammation. Therefore, these studies suggest that the level 
of LPS exposure can determine the type of inflammatory response, which provides 
potential mechanistic explanations of epidemiological data on endotoxin exposure and 
asthma prevalence. 
 
The absolute endotoxin dose is difficult to define. It varies in the literature.  In general, in 
mouse models, high doses of LPS refer to the doses of 1µg/mL to 100µg/mL; whereas 
low doses of LPS are regarded as the doses from 0.1ng/mL to 100ng/mL (Eisenbarth SC 
et al., 2002; Delayre-Orthez C et al., 2004). The content of endotoxin in airborne 
sampling in homes has been rarely reported, but so far the measured levels are quite low 
(Liu AH. 2002). Dust endotoxin levels in farm homes, rural homes, and farm barns are 
much higher than those in urban and non-farm homes (Gereda JE et al., 2000; von 
Mutius E et al., 2000). 
 
Taken together, experimental results and epidemiological studies further support the 
notion that higher levels of endotoxin may have protective effect against the priming and 
sensitization of allergy and asthma. 
 
1.3.2.3 Regulatory T cells (Tregs)  
 
Tregs have the dramatic suppressive ability on both innate and adaptive immune 
responses (Sakaguchi S. 2004; Lim HW 2005; Maloy KJ et al., 2005). Murine CD4+ T 
cell subsets containing Treg cells express TLR4, TLR5, TLR7, and TLR8. Exposure to 
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LPS provokes CD4+CD25 + cells to up-regulate several activation markers and enhance 
Treg cells survival and proliferation, independent of APCs (Caramalho I et al., 2003). 
PAMPs may also activate APCs such as DCs through TLR4 or TLR8, producing IL-6 
and other immune stimulatory agents.  Activated APCs also have the mature stimulatory 
function by up-regulation of CD86 and GITR ligand (GITRL). Effector T cells will bind 
to these factors and become insensitive to Tregs suppression which is important for 
immunity. In other words, upon activation by environmental PAMPs, Tregs may initiate 
the modulatory property accordingly, either through direct interaction with PAMPs, or 
indirectly through DCs’ regulation, which loom balance between tolerance and 
responsiveness (Belkaid Y et al., 2002; Wing K et al., 2006). However, reduced 
microbial burden would jeopardize the regulatory ability of Treg cells, which will further 




In the innate immunity phase, binding of PAMPs to their specific TLRs induces APCs to 
secrete a series of cytokines such as tumor necrosis factor-α (TNF-α), type I IFNs, IL-1, 
IL-6, IL-10 and IL-12 (Sabroe I et al., 2003). 
 
1.3.2.4.1 Cytokines that favor Th1 immune response 
 
IL-12 is the well-known and major player to drive Th1 responses produced by DCs. 
Upon encounter pathogens during infection, DCs and macrophages produce IL-12, a 
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heterodimeric pro-inflammatory cytokine that induces the production of IFN-γ, favors the 
differentiation of Th1 cells and forms a link between innate and adaptive immunity. In 
addition, other related Th1-inducing cytokines such as IL-23 and IL-27 have been 
identified recently. Indeed, several recent clinical and animal studies have identified an 
inverse relationship between IL-12 and Th2-mediated lung disease (Belladonna ML et al., 
2002; Pflanz S et al., 2002; Takeda A et al., 2003; Trinchieri G. 2003). However, B cells 
cannot produce IL-12, which is one of the explanations why B cell by default is the kind 
of APC that confers Th2 polarization (Guery JC et al., 1997; Gould HJ et al., 2003). 
 
1.3.2.4.2 Cytokines that favor Th2 immune response 
 
IL-4 and several other cytokines, including IL-13, IL-18, IL-25 and IL-6, have been 
implicated in the induction of Th2 responses. The novel cytokine IL-25 was found to 
induce the production of Th2 cytokines in models of both infectious and pulmonary 
allergic disease (Fort MM et al., 2001; Hurst SD et al., 2002). IL-6 is a cytokine 
produced by DCs and other cell types. It was also discovered that IL-6 played important 
roles in the abrogation of tolerance and in Th2 induction in several non-allergic models of 
disease (Diehl S et al., 2002; Pasare C et al., 2003). In addition, the production of IL-6 by 
pulmonary DCs may favor Th2 differentiation by inhibiting Th1 responses (Dodge IL et 
al., 2003). 
 
1.3.2.4.3 Cytokines that favor T regulatory immune response 
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IL-10 
 
The initial name of IL-10 was described as cytokine synthesis inhibitory factor (CSIF) 
and was first found to inhibit cytokine secretion from mouse Th1 cells,  therefore 
characterized as a Th2 cytokine. However, the pleiotropic effects of IL-10 have been 
reported widely. IL-10 has anti-inflammatory and suppressive effects on most 
haematopoeitic cells and is involved in the induction of peripheral tolerance via its effects 
on T-cell-mediated responses (Moore KW et al., 2001). IL-10 indirectly suppresses T 
cells responses by potently inhibiting the antigen-presenting capacity of APCs, including 
DCs, Langerhans cells and macrophages. IL-10 down-regulates expression of MHC class 
II and co-stimulatory molecules such as ICAM-1, CD80 and CD86. IL-10 potently 
inhibits the secretion of cytokines and chemokines by APCs, which influence T cells 
differentiation, proliferation and migration (Moore KW et al., 2001). In addition, IL-10 
directly regulates T cells by inhibiting their ability to proliferate (Bejarano MT et al., 
1992; Taga K et al., 1993) and to produce IL-2, TNF-α (De Waal Malefyt R, et al., 1993) 
and IL-5 (Schandene L et al.,1994). The inhibitory effect of IL-10 plays a key role in 
inducing anergy, hence playing an important role in allergen-specific immunotherapy. 
 
Some clinical studies indicate an association between increased IL-10 productions and 
decreased allergic reactions. Studies with bronchoalveolar lavage fluid from asthmatic 
patients have revealed lower IL-10 levels than in healthy controls, and the T cells from 
children suffering from asthma have been shown to produce less IL-10 mRNA than T 
cells from healthy children (Borish L et al., 1996; Koning H et al., 1997). As Treg cells 
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are the major source of IL-10, it has been speculated that Treg cells secreting IL-10 are 
involved in the suppression of allergic Th2 cell responses in human, which is supported 
by several human allergen-specific immunotherapy studies (Koning H et al., 1997; Akdis 
CA et al., 1998; Pierkes M et al., 1999). 
 
Most bacteria, either Gram-negative or Gram-positive, directly induce IL-10 secretion by 
monocytes, macrophages and DCs. Other immune cells, including Treg cells, CD8+ T 
cells, B cells, natural killer (NK) T cells and neutrophils, are also biologically significant 
producers (Moore KW et al., 2001). In the context of the hygiene hypothesis, IL-10 plays 
a counter-regulation role. Whether it is a Th1 stimulus, or a Th2 stimulus or neither, 
chronic or serial infection or colonization with various microbial agents leads to the up-
regulation of IL-10 production, secondarily suppressing an underlying predisposition to 
allergy. Furthermore, IL-10 might play an indirect role on CD4+CD25+ Treg cells by 
involving in Treg-cell-mediated suppression effect (Wills-Karp M et al., 2001).  It is 
unlikely that the counter-regulatory role is carried out by IL-10 alone. TGF-β is another 
cytokine that seems to be important as well (Roncarolo MG et al., 2001). 
 
Transforming growth factor-β (TGF-β) 
 
TGF-β is an important pleiotropic cytokine with potent immunoregulatory properties and 
is essential for the maintenance of immunological self-tolerance in the CD4+ T cell 
compartment.  T cells are influenced by TGF- β at all stages of their development. TGF- 
β inhibits T cells proliferation, cytokine production and cytotoxicity. TGF- β may also 
                                                                                                                                 Chapter 1 Introduction 37
down-regulate several B cells functions, including immunoglobulin production, and 
natural killer NK cells activities. Furthermore, cytotoxic T cells are also down-regulated 
in the presence of TGF- β (Letterio JJ et al., 1998; Taylor A et al., 2006). Resolution of 
inflammation, particularly during chronic inflammation, results in fibrogenesis and 
angiogenesis. Both are also under close control of TGF- β. TGF- β expression has been 
observed in mucosal tissues. The expression pattern in the mucosal tissues of the gut and 
nose initiates a number of investigations in the field of mucosal tolerance. There is ample 
evidence that particularly on the mucosal site, TGF- β is directly involved in the 
regulation and maintenance of oral tolerance (Haneda K et al., 1997; Haneda K et al., 
1999; Wiedermann U et al., 1999). 
 
1.4 Characteristics and functions of B cells 
 
1.4.1 B cells and subsets 
 
In mouse, functional peripheral subsets of B cells generate from pluripotent 
hematopoietic stem cells in the liver during mid-to-late fetal development. They mature 
within the bone marrow and leave the bone marrow expressing a distinctive antibody 
molecule known as B cell receptor (BCR) on their membrane after birth (Hardy RR et al., 
2001).  Since the majority of B cells can constitutively express MHC class II molecule 
and are able to bind antigens with its antigen-specific membrane immunoglobulin (Ig), 
these cells are classified as APCs. A naïve B cell, upon encountering the antigen for 
which its membrane bound antibody is specific, the cell begins to divide rapidly, and the 
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progeny differentiates into memory cells and effector cells called plasma cells. Memory 
cells have a longer life span and continue to express membrane-bound antibody with the 
same specificity as the original parent cells. Plasma cells do not express membrane bound 
antibody but produce antibody in a form that can be secreted. Due to their potential for 
high affinity antigen binding, B cells are uniquely endowed with the capacity to 
accumulate low concentration of antigen on their surface, endocytose, process and 
present it in the context of antigenic peptide in association with MHC class II on their 
surface for T cells (Klaus G et al., 1990; Lanzavecchia A. 1990).  
 
The differentiation of B cells into IgE expressing cells is dependent upon three types of 
signals. The first signal is delivered through the B cell antigen receptor and is pivotal in 
determining the antigenic specificity of the response (Oshiba A et al., 1999). The second 
signal is provided primarily by cytokines derived from Th2 cells, i.e. IL-4 and IL-13 (Del 
Prete G et al., 1988; Gauchat JF et al., 1990; Punnonen J et al., 1993; Defrance T et al., 
1994; Pawankar R et al., 1997). These cytokines are under tight regulation and their roles 
appear to be the stimulation of transcription through the Ig constant region genes. Finally, 
the third signal is provided via the interaction between the constitutively expressed CD40 
molecule on B cells and CD154 (CD40 ligand), a molecule expressed on T cells 
following activation (Pawankar R et al., 1997; Challa A et al., 1999).  
 
Mouse B cells can be classified into three different subsets, namely B-1 cells 
(CD45(B220)lowIgMhighCD23-CD43+IgDlow), conventional B-2 (follicular) cells and 
marginal zone B cells on the basis of the different tissue distribution, phenotype and 
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function (Allman D et al.,  2008 and Table 1.2 ). The current dogma is that the B-1 
lineage appears to be predominantly of fetal origin and the B-2 lineage is of adult origin. 
B-1 cells are self-renewing B cells, mainly found in peritoneal and pleural cavities. They 
have larger size and exhibit more side scatter than B-2 cells on flow cytometry analysis. 
B-1 cells in the peritoneal cavity, not in the spleen, also express CD11b (Mac 1) marker. 
Originally, B-1 cells were identified by their expression of CD5, but a population of 
peritoneal CD5 negative B-1 cells was being identified. By consensus, CD5+ B-1 cells 
are referred to as B-1a cells and CD5- B-1 cells as B-1b cells. The development of B-1a 
cells primarily occurs in the fetal and perinatal periods. They also exhibit self-renewal 
capacity (Berland R et al., 2002).  In mice, B-1 cells constitute up to 25% of splenic B 
cells during the first 2 weeks of neonatal stage, followed by a sharp reduction to about 
5% of splenic B cells in adults, but they are absent from peripheral lymph nodes (Sun 
CM et al., 2005). The neonatal splenic B cells can be further divided into three subsets: 
CD5+CD23- [CD19highCD43+B220lowAA4.1−IgMhigh], CD5-/dimCD23+ 
[CD19+CD43−B220highAA4.1−IgM+], and CD5-CD23- 
[CD19+CD43+/−B220+AA4.1+IgM+/−]. These subsets are shown to exhibit differential 
responses to innate activation by TLRs-ligands (Zhang X et al., 2007). The B-1 cells 
produce natural antibodies against bacterial antigens in a T-cell-independent manner and 
play an important role in innate immune response (Hardy RR et al., 2001; Berland R et 
al., 2002). 
 
In adult mice, conventional B-2 cells are a subset of bone marrow derived, long-lived, re-
circulating follicular B cells populating lymphoid organs. Upon antigen encounter and T 
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cell help, follicular B cells will differentiate into memory cells or antibody-secreting 
plasma cells (Hardy RR et al., 2001). Moreover, there is a distinct extrafollicular naïve 
and memory B-2 B cell populations reside in the marginal zone of the spleen at the 
boundary between red and white pulps, known as marginal zone B cells (MZB). MZB 
(IgMhighIgDlowCD21highCD23low) cells participate in early T-cell-independent antibody 
responses against blood-borne particulate antigens. B-2 cell compartment is poorly 
developed at the neonatal stage, and MZB cells can only be found from 3 weeks of life. 
In general, both B-1 and MZB cells elicit the predominant T-independent innate immune 
response, whereas follicular B cells (FOB) elicit the dominant T-dependent immunity. 
The MZB and FOB cells could be differentiated by the surface marker expression of 
CD21+CD23dim and CD21+CD23+, respectively.  
 
Both B-1 and MZB cells are perceived as part of a “natural immune memory” (reviewed 
in Martin F et al., 2000). B-1a and MZB cells share many phenotypic characteristics and 
they appear to develop in response to T-independent type 2 antigens (Berland R et al., 
2002). In adult mice, CD5+ B-1a cells are the main source of B-cell derived IL-10 
(O'Garra A 1992). Neonatal CD5+ B cells are an important source of natural antibodies 
that protect against infections (Martin F et al., 2000; Berland R et al., 2002), and these B 
cells produce IL-10 after TLR triggering. It has been shown that the innate activation of 
these IL-10 producing CD5+ B cells could influence the DCs functions for T cell 
activation (Sun CM et al., 2005). A recent study reported that the neonatal regulatory 
CD5+ B cells could effectively regulate the production of proinflammatory cytokines by 
neonatal plasmacytoid DCs and conventional DCs, in an IL-10 dependent manner (Zhang 
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X et al., 2007). These studies clearly demonstrated the profound impact of B cells in the 
neonatal environment on the priming of T cells.  
 
MZB cells constitute the majority of B cells in the spleen. MZB cells also exhibit more 
potent antigen presenting functions than FOB on priming of naïve CD4+ T cells 
(Attanavanich K et al., 2004). Upon LPS stimulation, it has been shown that splenic 
MZB, but not splenic FOB cells, exhibit early LPS driven proliferation (Oliver AM et al., 
1999). In addition, MZB cells are shown to produce IgM more rapidly and express higher 
levels of RP105, a co-receptor for LPS on B cells, than FOB cells (Gunn KE et al., 2006). 
These published results indicate that MZB cells are more responsive to LPS stimulation 
than FOB cells. The involvement of MZB cells as important APCs acting at the early 
innate immune response has been clearly demonstrated by Burke F et. al. In this study, 
MZB cells, but not the conventional B cells, demonstrated preferential production of IL-
10 in contrast to the DCs, which produced IL-12, upon bacterial stimulation; and the 
production of IL-10 occurred in the absence of T cell help. Moreover, the MZB cells had 
the ability to stimulate naïve T cells (Burke F et al., 2004). Taken together, these data 
implicate that MZB cells may be involved in initiating the polarization of a primary 
immune response. The preferential induction of IL-10 cytokine may also have a role in 
the activation of regulatory immune responses. Mouse MZB cells express high levels of 
CD1d, the non-classical MHC I molecule that is the restriction element of NKT cells 
(Roark JH et al., 1998). It is suggested that ligation of CD1d could result in rapid 
production of IL-10. In addition, a study by Sonoda et al., has suggested that the 
interaction of MZB cells with NKT cells is required for the induction of antigen-specific 
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regulatory T cells (Sonoda KH et al., 2002). Another study showed that T cell 
unresponsiveness could not be induced in B cell-deficient JHD mice following 
respiratory exposure to antigen, indicating that B cells played a critical role in the 
development of T cell tolerance to aeroallergens (Tsitoura DC et al., 2002).  
 
In summary, MZB cells are uniquely located in marginal zone of the spleen, a region 
richly endowed with macrophages and DCs, thus these B cells are strategically positioned 
themselves to encounter antigen both via the blood flow and active transport of 
circulating APCs. MZB cells interact with DCs and macrophages and could directly 
activate T cells during T-dependent and T-independent immune responses (Lopes-
Carvalho T et al., 2005).  
 
1.4.2 The antigen presentation function of B cells  
 
B cell is one type of APC. It represents the most abundant leukocyte with the capacity of 
internalizing, processing and presenting antigen to the responding T cells. In contrast to 
macrophages, both B cells and DCs possess limited lysosomal proteolytic activity, which 
in turn renders these APCs more efficient to generate longer peptides suitable for MHC II 
molecule assembly (Delamarre L et al., 2005). B cell can constitutively express MHC 
class II molecule and also has the ability to bind antigens with its antigen-specific 
membrane immunoglobuline (Ig), therefore it is well designed to present antigen to CD4+ 
T cells (Lanzavecchia A. 1990; Parker DC et al., 1991). For complete T cell activation, 
APCs also have to express a variety of co-stimulatory molecules such as CD40, CD80 
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and CD86, which provide a second signal that is required for CD4+ T cells activation. A 
lot of work has been carried out to study the role of B cells as APCs (Baumgarth N. 
2000). The pioneer studies on antigen presentation function of B cells mainly focused on 
developing model system for the research purpose. In one of the studies, Chesnut et al., 
(Chesnut RW et al., 1981) developed an in vitro model system to determine whether 
normal B cells could present the bound antigen through its cell surface Ig. They 
demonstrated that normal B cells could present antigen-specific Ig but not non-specific 
Ig, indicating that antigen-specific B cells are more potent APCs. The potential of B cells 
to present antigen in vivo has largely been evaluated with the anti-μ-treated mouse model, 
the mouse model that was injected monoclonal antibody to B cell antigen. In the 
subsequent studies, the important contribution of B cells’ antigen presentation to T cell 
activation has been demonstrated mostly in in vivo studies.  By depletion of B cells using 
in vivo mouse model, antigen-induced T cell activation decreased. This indicates that B 
cells not only drive CD4+ T cells to expansion, but also direct CD4+ T cells differentiation 
toward helper effector function (Ron YP et al., 1981; Ron YP et al., 1987; Jones K et al., 
1988). In addition, antigen presentation by B cells to activated or primed T cells induced 
these cells to secrete cytokines and express molecules that are important stimuli of B cells 
proliferation and differentiation (Sanders VM, et al., 1986; Poo WJ et al., 1988; Armitage 
RJ et al., 1992; Lederman S et al., 1992; Noelle RJ et al., 1992). In vivo experiment also 
demonstrated that in the absence of B cells, priming of effectors with the capacity to 
produce the Th2 cytokines such as IL-4, IL-5 and IL-13 was profoundly reduced (Bradley 
L et al., 2002), indicating the special function of B cells in the Th2 sensitization. All the 
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above experiments mainly used artificial animal model system, which may not reflect the 
actual situation in human immune system.  
 
Another focus on B cell antigen presentation function is to define the potency of B cells 
as antigen presentation cells.  It is quite clear that antigen presentation function of B cells 
differs from that of DCs and macrophages. DCs are the so-called professional APCs, 
which are the most potent type of APCs (Eisenbarth SC et al., 2003). B cell status also 
determines the antigen presentation potency. One of the factors is B cell size. Krieger and 
colleagues found that the smaller the B cells, the less potent. Another factor is B cell 
activation state. Whether resting or naїve B cells have enough potency to function as 
professional APCs is the question that attracted many researchers to answer. Krieger and 
co-workers also reported that naїve B cells could function as APCs, but were less potent 
as compared with DCs, macrophages or activated B cells (Krieger JI et al., 1985). In the 
activated B cells, antigens uptake through BCR were more potently presented, because 
antigen bound to BCR increased the efficacy of antigen presentation. Nevertheless, naїve 
B cells, when recognizing antigen, could express CD40 to interact with CD40 ligand on T 
cells, which also could perform the antigen presentation function to induce T cell to 
activate and proliferate (Rodríguez-Pinto D. 2005). The third factor is the form of the 
antigen that determines the preference of cell type to perform antigen presentation 
function. Peptide antigens are taken up preferentially by DCs, whereas proteins antigens 
are taken up by antigen-specific B cells in vivo. (Constant S et al., 1995). 
 
Like DCs, B cells express TLRs as well (Dasari P et al., 2005). It is demonstrated that the 
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primary signal, TLR4/LPS binding, is also capable of activating B cells and priming 
naïve T cells (Hosken NA et al., 1995). As it is evident that LPS is one of potent 
mitogens of B cells that drives robust effect on B cells in vitro (Coutinho A et al., 1974;  
Dziarski R. 1982), it is tentative to speculate whether this signal pathway has a specific 
effect on T cells priming, or by combination with mite allergens to exert T cell 
polarization. In fact, it is well established that unlike DCs and macrophage counterparts, 
B cells do not produce the Th1 type signature cytokine, IL-12 (Guery JC et al., 1997). 
This distinct functional feature between B cells and TLR4 expressing DCs subsets hints 
that B cell as an APC might play a part in initiating and/or maintaining antigen-specific 
Th2-skewed immunity. Indeed, this notion is supported by several studies showing that 
activated splenic B cells were able to initiate antigen-specific Th2-skewed responses 
(Hosken NA et al., 1995; Mason D. 1996; Stockinger B et al., 1996; Gould H J et al., 
2003). Based on these studies, the “default hypothesis” had been formulated to propose 
that B cells act as APCs in driving Th2-skewed immunity (Gould H J et al., 2003).  
 
B cells may also regulate DCs in antigen presentation process to drive CD4+ T cells 
polarization. Linton P et al., reported that DCs that localized in the T cell zones were the 
primary APCs for the initial expansion of naïve CD4+ T cells. But shortly after a response 
is underway, B cells could become competent APCs that play a critical role in regulating 
the expansion of CD4+ T cells, and, as such, are requisite for the optimal priming of 
memory in the CD4+  T cell population, indicating DCs and B cells have coordination 
effect (Linton P et al., 2000). Moulin V et al., employed the B cell–deficient and wild–
type mice to compare the development of antigen specific responses. It was demonstrated 
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that in the B cell–deficient mice, the development of IL-4–secreting cells was impaired. 
In addition, DCs from B cell–deficient mice had a reduced capacity to induce IL-4 
production. However, DCs from this type of mice produce higher levels of IL-12, 
indicating that B cells regulate the capacity of DCs to promote IL-4 secretion, possibly by 
down-regulating their secretion of IL-12. Therefore, these observations also suggest that 
B cells regulate the Th1/Th2 polarized effector function of DCs in vivo (Moulin V et al., 
2000).  
 
In summary, previous studies have developed both the in vitro and in vivo system to 
demonstrate B cell antigen presentation function. It is shown that B cell is one type of the 
professional APCs that has the ability of antigen presentation function. The intrinsic 
properties of B cells imply that B cell may have a special antigen presentation role in 
allergic diseases. This is the question that we want to address in this thesis. 
 
1.4.3  Regulatory B cells (Breg) 
 
In recent years, the existence of an immunoregulatory B cells subset possessing 
regulatory functions (designated as Bregs) in inflammatory conditions to dampen on-
going pathological inflammatory responses has been reported in a number of 
experimental models of chronic inflammation, autoimmunity and cancer. To date, the 
precise functional anti-inflammatory mechanisms of Bregs cells have not been fully 
elucidated. It has been suggested that Breg-mediated suppression is an important 
mechanism for the maintenance of peripheral tolerance. It is also indicated that the 
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regulatory function appears to be directly mediated by the production of regulatory 
cytokines such as IL-10 and/or TGF-β and by the ability of B cells to interact with 
pathogenic T cells to dampen harmful immune responses (Mizoguchi A et al., 2006; 
Mauri C et al., 2008). 
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Figure 1.1. Structure of Escherichia coli LPS. 
LPS from Escherichia coli is composed of three covalently linked regions: lipid A or 
endotoxin, a core oligosaccharide and an O antigen. 
 
Adopted from Miyake K. 2004. 
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Figure 1.2.  Components of the TLR4–MD2–CD14 receptor complex. Different 
TLR4 regions are shown: leucine-rich repeats (LRR), a hypervariable region (HYP) and 
the intracellular TIR domain. 
 
Adopted from Miller SI et al., 2005. 





Figure 1.3. LPS processing, signaling and clearance. LPS in the outer membrane of 
Gram-negative bacteria has to be processed by LPS-binding protein (LBP) and CD14. 
LBP removes LPS from the outer membrane and forms complexes consisting of LPS, 
LBP and soluble CD14 (sCD14). These complexes deliver LPS to membrane CD14 for 
LPS signaling. LPS processing for signaling is depicted by solid lines. LPS is neutralized 
by its transfer to high-density lipoprotein (HDL) from LBP or CD14. LPS clearance is 
shown by dotted lines. LPS bound to CD14 is transferred to Toll-like receptor (TLR) 4–
MD-2, which undergoes oligomerization and triggers a signal. The signal via TLR 
activates immediate and acquired immune responses. 
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Figure 1.4. Structure of RP105/MD-1 and TLR4/MD-2. RP105 associates with MD-1 
to form a heterodimer and expresses on the B-cell surface. The extracellular domain of 
RP105 consists of 22 leucinerich repeat (LRR) motifs. TLR4 forms a heterodimer with 
MD-2. It also contains 22 extracellular LRR motifs. The cytoplasmic portion contains a 
TIR domain that transmits the activation signal into the cell. Note that RP105 lacks the 
cytoplasmic TIR domain. 
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Figure 1.5. Hypothetical model for the immune recognition of bacteria. 
(a) Lipopolysaccharide-binding protein (LBP) binds and catalyses the transfer of 
lipopolysaccharide (LPS) to membrane-bound CD14 (mCD14).  
(b) Signalling molecules are recruited to the site of CD14–LPS ligation. LPS is 
released from CD14 in the lipid bilayer, and the intercalated LPS binds to a 
complex of receptors [based on our findings, chemokine receptor 4 (CXCR4), 
heat shock proteins (Hsps) 70 and 90, growth differentiation factor 5 (GDF5) and 
possibly CD55].  
(c) Signal transducing molecules, such as Toll-like receptor 4 (TLR4) complexes 
with MD-2, Toll-like receptors (TLRs) and/or integrins CD11 or CD18 are further 
recruited into the activation cluster, triggering multiple signaling cascades. 
 
Adopted from Triantafilou M et al., 2002b. 
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Figure 1.6. GPCR signaling components regulate TLR signaling. The ability of 
GPCR regulatory proteins to interact with components of multiple pathways allows them 
to mediate signaling crosstalk between GPCRs and non-GPCRs, such as the TLRs. Gray 
arrows depict potential crosstalk mechanisms including transactivation of GPCRs, such 
as CXCR4, in response to the TLR agonist and GPCR regulatory component mediation 
of signaling downstream of non-GPCRs, such as NF-κB, TRAF6, ERK1/2, JNK, and 
p38. Mal, MyD88 adapter-like; TPL2, tumor progression locus-2; TRIF, Toll/IL-1R 
translation initiation region domain-containing adaptor-inducing IFN-β; IRAK, IL-1R-
associated kinase; IRF3, IFN regulatory factor 3; MEKK1, MEK kinase 1; ATF2, 
activating transcription factor 2. 
 
Adopted from Lattin J et al., 2007. 
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Figure 1.7. The signaling pathways of Toll-like receptor (TLR) 4–MD-2. TLR4–MD-
2 triggers two distinct signaling pathways. One is dependent on Toll–interleukin (IL)-1 
receptor (TIR) domain-containing adaptor protein (TIRAP) and MyD88. The other is 
dependent on TRIF-related adaptor molecule (TRAM) and TIR domain-containing 
adaptor inducing interferon (IFN)-β (TRIF, also known as TICAM-1). The MyD88 
dependent pathway uses the members of IL-1 receptor-associated kinases (IRAKs) and 
tumor necrosis factor (TNF) receptor–associated factor 6 (TRAF6) to finally activate the 
MAP kinase pathways and nuclear factor (NF)-κBs. The other pathway mediated by 
TRAM and TRIF activates not only NF-κBs but also IFN regulatory factor 3 (IRF3), 
inducing type I IFN production. 
 
Adopted from Miyake K. 2004. 
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Figure 1.8. Differentiation of CD4+ T-cell subsets. Cytokines control the differentiation 
of naive CD4+ T cells (Tn) into subsets that are defined by their cytokine production 
profile. 
 
Adopted from Grazia M et al., 2001.  
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Figure 1.9. Sequence alignment of MD-2 homologues and proteins with highest fold 
recognition score. huMD2, human MD-2; mMD2, murine MD-2; hmMD2, hamster 
MD-2; bMD2, bovine MD-2; rbMD2, rabbit MD-2; eMD2, equine MD-2; mMD1, 
murine MD-1; huMD1, human MD-1; cMD1, chicken MD-1; Der p2, Der p2 allergen 
from dust mite; NPC2, bovine cholesterol-binding protein involved in Niemann-Pick type 
2 disease. Within the alignment of MD-2 homologues along with NPC2 and Der p 2, 
locations of six of the cysteine residues present in all of them were congruous suggesting 
conservation of disulfide-bonding topology. 
 
Adopted from Gruber A et al., 2004. 
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TLR1 Tri-acyl lipopeptides (bacteria, mycobacteria) 
Soluble factors (Neisseria meningitides) 
Ubiquitous 
TLR2 Lipoprotein/lipopeptides (a variety of pathogens) 
Peptidoglycan (Gram-positive bacteria) 
Lipoteichoic acid (Gram-positive bacteria) 
Lipoarabinomannan (mycobacteria) 
A phenol-soluble modulin (Staphylococcus 
epidermidis) 
Glycoinositolphospholipids (Trypanosoma Cruzi) 
Glycolipids (Treponema maltophilum) 
Porins (Neisseria) 
Zymosan (fungi) 
Atypical LPS (Leptospira interrogans) 
Atypical LPS (Porphyromonas gingivalis) 
Myeloid cells, mast cells, 
NK cells, Kupffer cells, 
mDCs, T cells, Tregs 
TLR3 Double-stranded RNA (virus) mDCs, NK cells, T cells 
TLR4 LPS (Gram-negative bacteria) 
Taxol (plant) 
Fusion protein (RSV) 
Envelope proteins (MMTV) 
Type III repeat extra domain A of fibronectin (host)
Oligosaccharides of hyaluronic acid (host) 
Polysaccharide fragments of heparan sulfate (host) 
Fibrinogen (host) 
Monocytes, mast cells, 
neutrophils, Tregs, T 
cells, B cells, Kupffer 
cells 
TLR5 Flagellin (bacteria) NK cells, mDCs, 
monocytes, neutrophils, 
T cells, Tregs  
TLR6 Di-acyl lipopeptides (mycoplasma) Myeloid cells, NK cells, 
mast cells, neutrophils, B 
cells, Tregs 
TLR7 Imidazoquinoline (synthetic compounds) 
Loxoribine (synthetic compounds) 
Bropirimine (synthetic compounds) 
NK cells, pDCs, 
neutrophils, eosinophils, 
B cells, T cells, Tregs 
TLR8 ? NK cells, T cells, B cells, 
myeloid cells, Tregs 
TLR9 CpG DNA (bacteria) pDCs, neutrophils, T 
cells, B cells, NK cells 
TLR10 ? Neutrophils, B cells, 
pDCs 
Modified from Takeda K, et al., 2003; Dasari P et al., 2005; Alegre ML et al., 2008.  
                                                                                                                                 Chapter 1 Introduction 58
 




























                                                                                                                                 Chapter 1 Introduction 59
 
1.5 Rationale and specific aims of the study 
 
1.5.1 Rationale of the study 
 
Allergic and asthmatic diseases represent a big health problem in the developed 
countries, where as much as 30% of the population suffers from diseases such as rhinitis, 
conjunctivitis, atopic dermatitis, and bronchial asthma.  Allergic cascade is a 
tremendously redundant process with numerous cell types, mediators, and pathways 
involved in the development of allergic inflammation. This redundancy provides 
investigators with many potential targets for investigation in the understanding and 
suppression of allergic diseases. Therefore, understanding of the cellular and molecular 
mechanisms in the initiation and induction in animal settings is essential to facilitate the 
development of new therapeutic strategies.  
 
The group 1 (Der p 1 and Der f 1) and group 2 (Der p 2 and Der f 2) mite allergens are 
potent dust mite allergens, causing sensitization in >80% of mite allergic patients. Early 
epidemiological studies showed that the concentration of dust mite allergen in domestic 
environment could be a good predictor of future mite sensitization (Wahn U et al., 1997) 
and it could serve as a good index for the prevalence of mite sensitization (Peat JK et al., 
1996).  A subsequent seminal study by Richard Sporik et al., emphasized the critical 
effect of allergen dose by showing that the prevalence of dust mite allergen specific 
sensitization in atopic children was associated with the highest domestic concentration of 
group 1 mite allergens (Der p 1 and Der f 1) (38µg/g; range 24-150µg/g), and the 
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environmental levels of group 1 mite allergen routinely fell in a window that represented 
the highest risk for sensitization. However, the study also revealed that there was no 
strong relationship between current asthma and the highest domestic mite allergen 
concentration (Sporik R et al., 1999). Moreover, Der p 2, another potent mite allergen, 
causing sensitization in >90% of mite allergic patients at exposure levels that were 
usually 2–10 fold lower than that of Der p 1.  Taken together, these studies suggested that 
besides the levels of allergens in the environment, other factors may play important roles 
in determining the prevalence of allergen sensitization, which renders allergic individuals 
to develop asthma. 
 
Endotoxin LPS is ubiquitous in the environment and is often present in household dusts 
(Park JH et al., 2001).  Indoor allergens such as dust mite allergens often co-exist with 
LPS in natural domestic environments (Platt-Mills TA et al., 1995). Several lines of 
evidence implicated the environmental endotoxin/LPS is a critical determining factor for 
allergen sensitization and development of allergic diseases such as asthma. However, the 
precise roles of LPS in modulating allergen-specific immune responses and allergic 
reactions remain unclear. Published epidemiological studies observed that endotoxin 
exposure during childhood could protect against the development of asthma later in life 
(Braun-Fahrlander C et al., 2002; Kamradt T et al., 2005), while other studies indicated 
that endotoxin exposure was a risk factor for asthma (Michel O et al., 1996; Rizzo MC et 
al., 1997; Park JH et al., 2001). Studies using animal models for asthma also showed 
conflicting experimental data. Some data indicated that exposure to LPS could protect 
against asthma (Tulic MK et al., 2000; Tulic MK et al., 2001; Tulic MK et al., 
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2002; Velasco G et al., 2005), whereas other data indicated that the exposure to LPS 
exacerbate asthma (Wan GH et al., 2000; Eisenbarth SC et al., 2002; Stephens R et al., 
2002; Delayre-Orthez C et al., 2004). To date, a comprehensive understanding of the 
molecular and cellular mechanisms by which LPS affects allergic responses remains 
lusive. 
t al., 1990; 
chon-Hegrad MA et al., 1991; Secrist H et al., 1995; Ricera A et al., 2001). 
e
 
It is well accepted that allergic diseases are characterized by Th2 immune responses. The 
mechanistic studies at cellular level on the sensitization of allergic diseases are focused 
mainly on the antigen presentation role of DCs, as it is believed that DCs are the most 
potent APCs; they are the master regulator dictating the Th1/Th2 deviation.  In this 
situation, low doses of antigen presented by DCs induce Th2 differentiation (Eisenbarth 
SC et al., 2003). Only a few works have been performed on other APCs such as B cells. 
Even in those studies that are carried out on B cells, none of them has addressed the role 
of B cells as APCs in environmental factors such as endotoxin, major mite allergen 
sensitization and regulation of the Th1/Th2 differentiation (Mudde GC e
S
 
The B cell is another class of APC. It is the largest subset of leukocyte with the capacity 
of internalizing, processing and presenting antigen to the responding T cells. Similar to 
DCs, B cells also possess limited lysosomal proteolytic activity, which in turn renders 
these APCs more efficient to generate longer peptides suitable for MHC II molecule 
assembly and function in antigen presentation (Delamarre L, et al., 2005) In addition, B 
cells constitute a major lymphocyte subset in neonates and infants, which are likely to 
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rlying the 
PS –mediated effects in the initiation and development of allergic responses.  
1.5.2 pecific aims of the study 
he research project aims to:  
of Lipopolysaccharide (LPS) stimulated B cells 
n differential T cell polarization 
house dust mite allergens on Lipopolysaccharide (LPS) 
stimulated murine B cells 
play important roles in driving the development of the immune system in early life— the 
critical window/ occasion for the initiation of allergy (Pillai S et al., 2005; Sun CM et al., 
2005; Hardy RR. 2006; Montecino-Rodriguez E, et al., 2006; Dorshkind K et al., 2007). 
Furthermore, unlike their DCs and macrophage counterparts, B cells do not produce the 
Th1 type signature cytokine, IL-12. This distinct functional feature hints that B cell as an 
APC might play a part in initiating and/or maintaining antigen-specific Th2-skewed 
immunity (Guery JC et al., 1997; Gould HJ, et al., 2003). The most common 
environmental factor endotoxin LPS happens to be a potent B cells mitogen, which can 
exert a robust interaction with B cells, emphasizing the special and unique roles of B cells 
in the sensitization and shaping the Th1/Th2 balance of host immune deviation (Coutinho 
A et al., 1974; Dziarski R. 1982). On the basis of its unique properties, the B cell is 







1. Investigate the modulatory effects 
o
 
2. Study the effects of major 
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Specific pathogen free (SPF) BALB/c mice were purchased from the Centre for Animal 
Resources, Singapore and housed under clean conditions at the Animal Holding Unit, 
National University of Singapore. TCR transgenic C.Cg-Tg (DO11.10)10Dlo/J mice, 
which bearing I-Ad restricted TCR recognizing OVA323-339 peptide, were purchased from 
The Jackson Laboratory, Bar Harbor, ME, USA, bred and maintained under SPF 
conditions at the Satellite Animal Holding Unit, National University of Singapore. All 
mice used in experiments were female aged at 6-8 weeks old. Animal experiments were 
performed according to the guidelines set by the Institutional Animal Care and Use 
Committee (IACUC), National University of Singapore. 
 
2.2 Culture medium, antibodies and lipopolysacharride 
 
Mouse splenocytes, splenic B cells and T cells were cultured in complete RPMI 1640 
culture medium. The complete RPMI 1640 culture medium was prepared using RPMI 
1640 culture medium (HyClone, South Logan, UT, USA) supplemented with 1mM 
sodium pyruvate (HyClone), 2 mM L-glutamine, antibiotics (100 U/mL penicillin and 
100 μg/mL streptomycin) and 5.5 × 10−2 mM 2-β mercaptoethanol (Gibco BRL Life 
Technologies, Paisley, UK) with 10% heat-inactivated bovine calf serum (HyClone). The 
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LPS level in main culture medium components, including RPMI1640 culture medium, 
deionized water and fetal calf serum was below 0.09EU/mL, as assayed by Limulus 
Amebocyte Lysate (LAL) QCL-1000 (50-648U, Cambrex Bio Science Walkersville, MD, 
USA).  
 
Allophycocyanin (APC) conjugated anti-CD19 (clone 1D3), fluorescein isothiocyanate 
(FITC) conjugated anti-CD40 (clone 3/23), FITC conjugated anti-ICAM-1 (Clone 3E2), 
phycoerythrin (PE) labeled anti-CD86 (clone GL1), PE-labeled anti-IgM (clone R6-60.2), 
PE-labeled anti-CXCR4 (clone 2B11/CXCR4), PE-labeled anti-IL-4(clone 11B11), PE-
labeled anti-IL-10 (clone JES0516E3), peridinin chlorophyll protein (PerCP) labeled anti-
CD5 (clone 53-7.3), PerCP-labeled anti-I-Ad (clone AMS-32.1) antibodies were 
purchased from PharMingen (San Diego, California, USA). FITC conjugated anti-CD80 
(clone 1G10) mAb was obtained from Southern Biotech (Birmingham, Alabama, USA). 
 
Recombinant mouse IL-4 (Cat no.550067), recombinant mouse IFN-γ (cat no. 555106) 
and recombinant mouse IL-10 (cat no. 550070); Rat anti-mouse IL-4 (clone BVD4-1D11) 
and anti-IFN-γ (clone R4-6A2) antibodies; biotinylated rat anti-mouse-IL-4 (clone 
BVD6-24G2) and anti-mouse-IFN-γ (clone XMG1.2) were purchased from BD 
PharMingen (San Diego, CA, USA). Recombinant mouse TNF-α (410-MT, R&D), rat 
anti-mouse TNF-α (clone AF-410-NA.), biotinylated rat anti-mouse-TNFα (clone 
BAF410), rat anti-mouse IL-10 (clone JES052A5), biotinylated rat anti-mouse- IL-10 
(clone BAF417) were purchased from R&D Systems (Minneapolis, MN, USA.).   
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Lipopolysaccharide (LPS, cat no. L4391, E. coli serotype 0111:B4, Sigma-Aldrich, St. 
Louis, MO, USA) was supplied as lyophilized γ-irradiated powder and reconstituted in 1 
× PBS according to the manufacturer's instructions. Briefly, 1 mL sterile 1 × PBS was 
added to the vial (1mg) and gently swirled until the powder was completely dissolved. 
Desired working concentrations were further diluted with RPMI1640 culture medium. 
 
2.3 Preparation of single cell suspension 
 
Spleens were harvested from mice and placed in Petri dishes in the presence of 10 mL of 
1× Hanks Balanced Salt Solution (HBSS) (Sigma-Aldrich). Single cell suspension was 
made by disrupting the tissues using two frosted slides. Red blood cells (RBCs) were 
lysed by adding 1mL per spleen of RBC lysis buffer (10 mM Tris, 0.83% NH4Cl, pH8.3) 
for 90 seconds. The cells were washed 3 times with 1 × HBSS and the cell number was 
determined by using hematocytometer. The cells were suspended in RPMI1640 culture 
medium for further use. 
 
2.4 Splenic B cells purification  
 
Splenic CD19+ B cells from mice spleen were purified according to the manufacturer’s 
protocol. Briefly, every 107 single splenocyte suspensions were resuspended in 90 μL of 
staining buffer (0.5% bovine serum albumin (BSA, Sigma-Aldrich), 2mM EDTA (1st 
BASE, Singapore) in 1 × PBS, pH 7.4) and 10μL of CD19 MicroBeads were added. 
After incubation for 15-20 min at 4 °C and extensive washing with staining buffer, the 
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cells were subjected to magnetic separation using AutoMACS (Miltenyi Biotec GmbH 
Bergisch Gladback, Germany). Cells at the concentration of 2×106 cells/mL in RPMI1640 
culture medium seeded in 24-well or 96-well cell culture plates (Nalge Nunc, Roskilde, 
Denmark) were prepared, maintained and used for all experiments. The concentrations of 
the stimuli used in each experiment were detailed in the result sections. In the subsequent 
sections, unless otherwise stated, B cell(s) refer to purified splenic CD19+ B cells. 
 
2.5 Splenic cell cultures 
 
Splenocytes were cultured in the complete RPMI1640 medium and incubated at 37 °C in 
the presence of 5% CO2. Cells were seeded at a concentration of 2×106 cells/mL either in 
24-well flat-bottomed plate or in 96-well flat bottomed plate (Nalge Nunc). The cell 
culture volume for 24-well plate was 1mL/well; whereas the cell culture volume for 96-
well plate was 200µL/well, unless otherwise stated.  
 
2.6 B cell proliferation assays 
 
2.6.1 Tritiated thymidine incorporation assays 
 
Purified splenic B cells from BALB/c mice were seeded at 1×105 cells in 200µL of 
RPMI1640 culture medium per well in 96-well U bottomed-plate (Nalge Nunc).  These 
wells were incubated with various doses of LPS, Der p 1, Der p 2 or combined Der p 2 
and LPS (detailed in the relevant result sections) for 48 hours or 72 hours. Tritiated 
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thymidine ([3H]-TdR, 1μCi/well) (Amersham Pharmacia Biotech, Piscataway, NJ, USA) 
was added at the last 16-18 hours before cell harvesting. [3H]-TDR incorporation was 
measured by liquid scintillation spectrophotometer (Beckman Coulter, CA, USA). The 
results were expressed as the mean counts per minute (cpm) of [3H]-TdR incorporated by 
B cells. 
 
2.6.2 Staining of splenic B cells with CFSE  
 
The staining protocol was modified from the method of Lyons AB et al., (Lyons AB et 
al., 1994). Briefly, splenic B cells from BALB/c mice were resuspended at 4 × 107/mL in 
0.1% BSA in 1×PBS. A 5 mM stock solution of 5-and-6-carboxyfluorescein diacetate 
succinimidyl ester (CFSE, Molecular Probes, Eugene, OR, USA) in DMSO (stored 
desiccated at -20°C) was added to a final concentration of 5μM and incubated at 37°C for 
10 min. At the end of the incubation period, the cells were immediately washed for three 
times in cold 1 × PBS containing 0.1% BSA. The cells were then resuspended in 
RPMI1640 culture medium for in vitro cultures. 
 
2.6.3 BrDU incorporation assay  
 
Purified splenic B cells from BALB/c, C3H/HeJ mice were seeded at 2×106 cells/mL 
either in 24-well flat bottomed-plate or in 96-well flat bottomed plate (Nalge Nunc).  
These wells were incubated with various doses of LPS, Der p 1, or combined Der p 1 and 
LPS (detailed in the relevant result sections) for 48 hours or 72 hours. BrdU labeling was 
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performed by adding 40μM of BrdU (Sigma-Aldrich, USA) to the stimulated B cell 
culture for the last 16-20 hours of incubation. Cells were harvested by centrifugation and 
then resuspended in 50μL of FACS buffer (1% FCS in 1 × PBS). After immunostaining 
for the cell surface markers (detailed below), cells were proceeded to permeabilization, 
DNase digestion and followed by fluorescein isothiocyanate (FITC) conjugated anti-
BrdU staining using BrdU Flow Kit (Becton Dickinson, Franklin Lakes, NJ, USA). Cells 
were then resuspended in 500-1000μL of 1% paraformaldehyde and analyzed by flow 
cytometry (FACScan, Becton Dickinson, USA). 
 
2.7 B cell surface molecule immunostaining 
 
After stimulation by stimuli such as LPS, Der p 1, Der p 2 or LPS in the combination 
with Der p 1 or Der p 2, the splenocytes or purified B cells were harvested by 
centrifugation and then resuspended in 50μL of FACS buffer (1% FCS in 1 × PBS). Cell 
suspensions were adjusted at the concentration between 1×107 to 2×107 cells/mL, and 
incubated with fluorescein isothiocyanate (FITC) conjugated anti-CD80, CD40, 
phycoerythrin (PE) labeled anti-CD86, IgM, CXCR4, peridinin chlorophyll protein 
(PerCP) labeled anti-CD5, I-Ad, and allophycocyanin (APC) conjugated anti-CD19 
monoclonal antibodies for 30 min at 4oC. Cells were then fixed with 500-1000μL of 1% 
paraformaldehyde and analyzed by gating CD19+ cell population by FACSCalibur flow 
cytometer with CellQuest software (Becton Dickinson, Franklin Lakes, NJ, USA). 
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2.8 Analysis of cells population by flow cytometry 
 
Cells stained with fluorescence labeled mAb were analyzed by flow cytometry (FACScan, 
Becton Dickinson, USA). Cells were identified on the basis of fluorescein or 
phycoerythrin emission and light scatter analysis. 10000-20000 cells of interests were 
analyzed in the experiment. CELLQuest TM software (Becton Dickinson) was used for 
data analysis. 
 
2.9 Detection of cytokine concentration by sandwich ELISA 
 
Purified rat antibodies to mouse IFN-γ (clone R4-6A2), IL-4 (clone BVD4-1D11), IL-10 
(clone JES052A5, R & D systems, Minneapolis, MN, USA) and TNF-α (clone AF-410-
NA, R & D systems) were diluted in coating buffer to a final concentration of 2 μg/mL. 
All antibodies and recombinant proteins were purchased from BD Bioscience 
PharMingen (San Diego, CA, USA) unless otherwise stated. Costar high binding 96-well 
ELISA plates were coated with 25 μL of the diluted antibodies and incubated at 4°C 
overnight. After washing with 0.05% Tween/PBS, the plates were blocked with 100 µL 
of blocking buffer at room temperature for 2 hours. The plates were then washed and 
incubated with 25µL of supernatant overnight at 4ºC. The supernatant were used as neat 
or diluted in blocking buffer of 1:2 (for measurement of IFN-γ). For quantization purpose, 
25µL of the mouse recombinant cytokines: recombinant mouse IL-4 (Cat no.550067), 
recombinant mouse IFN-γ (cat no. 555106), recombinant mouse IL-10 (cat no. 550070) 
and recombinant mouse TNF-α (410-MT, R&D systems) were prepared in two folds 
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serial dilution in blocking buffer and included in each plate. The plates were then washed 
and added 25 µL biotinylated polyclonal antibodies to mouse IFN-γ (clone XMG1.2), IL-
4 (clone BVD6-24G2), IL-10 (clone BAF417, R&D systems) and TNF-α (clone BAF410, 
R&D systems). The concentrations for biotinylated IFN-γ and IL-4 were 2µg/mL, IL-10 
was 400ng/mL, TNF-α was 300 ng/mL. Next, the plates were washed and incubated with 
25µL of ExtraAvidin-alkaline phosphatase (Sigma-Aldrich) (1:2000 of dilution) for 1 
hour at room temperature. Finally, the reactions were developed with 25µL of Sigma Fast 
pNitrophenyl phosphatase substrate (Sigma-Aldrich) and optical density was measured at 
405 nm on a microplate reader. The detection limit for the IFN-γ, IL-4, IL-10 and TNF-α 
assays were 20pg/mL, 10pg/mL, 40pg/mL and 20pg/mL, respectively.  
 
2.10 Analysis of endocytotic capacity of B cells  
 
Purified B cells (2×106 cell/mL) were cultured with LPS (1,000ng/mL) or Der p 1 
(30µg/mL) for 12, 24, 48 or 72 hours at 37oC in 5% CO2 incubators. After harvesting and 
extensive washing, the cells were then incubated with Dextran-FITC (25µg/mL) or 
Lucifer yellow (1mg/mL) (Molecular Probes) at 37 ºC for 1 hour. Cells were then 
harvested and washed completely before subjected to flow cytometry analysis.  
 
2.11 Adoptive B cell transfer experiment 
 
Purified B cells (2×106 cell/mL) were stimulated with Der p 1 (30μg/mL) or GST 
(30μg/mL) at 37oC for 24 hours. The cells were harvested, washed completely with 
                                                                                                             Chapter 2 Materials and Methods 71
excess 1×HBSS to remove unloaded antigens. Then the cells (106 cell/mouse) were 
diluted in 50μL 1×PBS and transferred into the lateral tail vein of BALB/c mice on day 0 
and day 7. On day 21, mice were sacrificed and spleens were removed. The splenocytes 
were stimulated with Der p 1 (10μg/mL, for the group that transferred Der p 1-pulsed B 
cells) or GST (10μg/mL, for the group that transferred GST-pulsed B cells) for 3 days, 
recombinant IL-2 was added on days 3, 5 and 7. On day 10, the cells were harvested, 
dead cells were removed by Ficoll-Hypaque density gradient centrifugation. The cells 
were then re-stimulated with Der p 1 (10μg/mL) and GST (10μg/mL) respectively for 3 
days in the presence of APCs. The culture supernatants were collected. Cytokines in the 
culture supernatant were assayed by enzyme-linked immunosorbent assay (ELISA).  
 
 
2.12 Assay of Th1/Th2 polarization by pulsed B cells (in vitro) 
 
Purified B cells (2×106 cells/mL) from BALB/c mice were cultured in the presence or 
absence of varying doses of LPS (0.1ng/mL to 10,000ng/mL), Der p 2 (30µg/mL),  Der p 
1 (30µg/mL) or GST (30µg/mL) in 5% humidified CO2 incubator at 37oC for 24 hours. 
The cells were harvested and washed thoroughly. CD4+ T cells (95-98% purity as 
assessed by flow cytometry) from DO11.10 TCR transgenic mice were obtained by 
positive selection method using AutoMACS, according to manufacturer’s instruction. In 
brief, the splenocytes were stained with CD4 MicroBeads and were sorted by 
AutoMACS (Miltenyi Biotec GmbH Bergisch Gladback, Germany). The co-culture 
system was modified from Hosken et al.,’s study (Hosken NA et al., 1995). Briefly, 
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1×105 CD4+ DO11.10 T cells in 0.1mL RPMI1640 were co-cultured with 1×105 
stimulated-B cells in 0.1mL at 0.2mL/well in 96-well U-bottom plate in the presence or 
absence of OVA323-339 peptide (AnaSpec, Inc., San Jose, CA, USA. 0.2µM or 5µM, 
detailed in the result section) at 37oC in a 5% humidified CO2 incubator. In another set of 
experiment, the stimulated-B cells were treated with 50µg/mL of mitomycin C (Roche 
Diagnostics GmbH, Mannheim, Germany) at 37oC for 20 min followed by three washes 
with PBS before used in the B/T co-culture experiment. After 48 hours, culture 
supernatants were collected. Cytokine level in the culture supernatant was determined by 
ELISA.  
 
2.13 Assay of Th1/Th2 polarization by pulsed B cells (in vivo) 
 
In the in vivo experiment, purified B cells (2×106 cell/mL) from BALB/c mice were 
cultured with or without Der p 1 (30µg/mL), Der p 2 (dosage detailed in the result 
section), GST (30µg/mL) or LPS (dosage detailed in result section) at 37oC for 24 hours, 
OVA323-339 (dosage detailed in result section) was added to culture medium during the last 
6 hours. After cells harvesting and complete washing, pulsed B cells (1×106 cells/mouse) 
were adoptive transferred to DO11.10 TCR transgenic mice by intraperitoneal injection. 
Nine days later, mice were sacrificed and splenocytes suspensions were prepared. The 
splenocytes were co-cultured with OVA323-339 (dosage detailed in result section) for 48 
hours. Cytokine level in the culture supernatant was also assayed by ELISA. 
 
2.14 Total RNA extraction  
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 Total RNA was extracted from the purified splenic B cells by using RNeasy Mini kit 
(Qiagen Inc, CA, USA) according to the manufacturer’s protocol. The quality of RNA 
was verified by the detection reading of Optical Density (OD) 260/280 which fell within 




Total RNA was reverse transcribed into cDNA using Moloney-Murine Leukaemia Virus 
(M-MLV) Reverse Transcriptase (Promega, Madison, WI, USA) as recommended by the 
manufacturer. Briefly, one µg of total RNA was mixed with 1µg of oligo dT (Research 
Biolaboratory, Singapore), and topped up with DEPC water to a final volume 30µL. The 
mix was incubated at 70ºC for 10 min and put on ice immediately. The mix was then 
added with 1µL of dNTPs (10mM) (Promega), 8µL of 5 × MMLV buffer, 1µL of 
recombinant RNase inhibitor (40U/µL) (Promega) and 1 µL of MMLV reverse 
transcriptase (10U/µL), and incubated at 42ºC for 1 hour. The cDNA was stored at -80ºC.  
 
2.16 Quantification of cytokine gene expression level by conventional PCR 
 
To quantify the cytokine gene expression level, HPRT was normalized in each sample so 
as to standardize the amount of cDNA sample used in each PCR. One to 2µL of the 
cDNA was added to a reaction mixture containing 1µL of sense and anti-sense cytokine 
primers (10pmol), 1µL of dNTP (10mM) and 1µL of Taq DNA polymerase (2.5U/µL) 
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(Promega) and 5µL of 10× PCR buffer. Each sample was top up to a final volume of 50 
μL with ddH2O. The mix was incubated in a DNA thermal cycler (Perkin Elmer Gene 
Amp PCR system 9700, PE applied biosystems, USA) for a total of 30 cycles. Each cycle 
consists of 30 sec at 94˚C, 30 sec at 58˚C and 1 min at 72˚C 1 min. A starting of 5 min 
incubation at 94˚C and a final extension of 10 min at 72˚C was included in each reaction. 
All primers were purchased from Research Biolaboratory, Singapore. The cytokine 
primers sequences are listed in Table 2.1. 
 
2.17 Preparation of the spent mite extracts 
 
Spent Dermatophagoides pteronyssinus mite medium was a gift from Commonwealth 
Serum Laboratories. Spent mite extract was prepared by suspending one gram of spent 
mite medium in 10 mL of 1× Tris-buffered saline (TBS; 10mM Tris, 150mM NaCl pH 
7.4) plus 2 mM PMSF at 4˚C for 2 hours. Supernatants were prepared by centrifugation 
at 17,000 g in 4˚C for 30 min. The extract aliquots were stored in -80˚C. Protein 
concentration was quantified with the Bio-Rad Protein Assay reagent (Bio-Rad, 
Richmond, CA, USA) with bovine serum albumin as a standard. 
 
2.18 Preparation of native Der p 1 by monoclonal antibody affinity purification 
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Native Der p 1 was purified from spent mite medium by monoclonal antibody (mAb) 
4C1 affinity chromatography. mAb was coupled with Cynogen Bromide-activated 
Sepharose 4B (Pharmacia, Uppsala, Sweden) according to the manufacture’s instruction. 
Spent mite media extracts were passed through tandem 4C1 column and the column were 
washed with 1×TBS until the OD280 had reached zero. The bound native Der p 1 was 
eluted with 10mM Glycine, 50% ethylene glycol, pH 10. The eluents were neutralized 
with 1M Tris-HCl, pH 6.5. The purified native Der p 1 was dialyzed against 1 × PBS and 
stored in -80˚C. 
 
2.19 Preparation of recombinant Der p 2  
 
The cDNA of mature Der p 2 was amplified by polymerase chain reaction (PCR) from 
the plasmid pGEX-2T-Der p 2 (Chua KY et al., 1990b) using the sense primer 5′ -
GCCTCGAGAAAAGAGATCAAGTCGATGTCAAA-3′ and anti-sense primer 5′-
GCGAATTCTTAATCGCGGATTTTAGC-3′. The 5′ XhoI and 3′ EcoRI sites were used 
for directional in-frame cloning with the α-factor signal sequence driven by the alcohol 
oxidase gene promoter in pPIC9 vector. The PCR reaction was carried out at 94°C for 30 
sec, 50°C for 30 sec, 72°C for 1 min for 30 cycles with pfu DNA polymerase (Promega) 
and the insert in pPIC9 was completely sequenced. The pPIC9-Der p 2 was linearized 
with BglII and transformed into Pichia pastoris strain GS115 by lithium chloride method 
as described in the Pichia expression manual (version E) (Invitrogen Corporation, 
Carlsbad, CA, USA). The His+Muts clones were selected for Der p 2 protein expression. 
The yeast media containing the recombinant Der p 2 were applied to a Sephadex G25 
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molecular sieving column (5 × 20 cm; Pharmacia) equilibrated with 20 mM sodium 
acetate, pH 5.5. Recombinant Der p 2-containing fractions were pooled and applied to a 
SP-Sepharose fast flow column (2.6 × 15 cm; Pharmacia) equilibrated with the previous 
buffer. Bound proteins were eluted with 600 mL of a linear sodium chloride gradient 
from 0 to 500 mM. The purity of recombinant Der p 2 was examined by SDS-PAGE 
followed by silver staining. 
 
2.20 Preparation of recombinant glutathione S-transferase (GST) 
 
Glutathione S-transferase (GST) is the GST enzymes of Schistosoma japonicum worms 
which terms as Sj26. Vector pGEX2T-1 (Amersham Pharmacia Biotech) was 
transformed into E. coli strain TG1 for expression of GST. The protein product was 
induced with 0.1mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 30°C for 1 hour. 
Recombinant Sj26 was obtained by passing the lysate of IPTG induced E. coli culture 
containing the pGEX-2T-1 vector through glutathione agarose bead (Sigma-Aldrich) and 
eluted with 10mM of reduced glutathione (Sigma-Aldrich). The detailed method was 
described in Chua et al., 1990b. 
 
2.21 LPS concentration measurement 
 
The concentration of LPS in the experimental reagents including native Der p 1, 
recombinant Der p 2, LPS (Sigma-Aldrich), GST, RPMI-1640 culture medium, serum, 
PBS, HBSS were measured using Limulus Amebocyte Lysate (LAL) QCL-1000 (50-
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648U, Cambrex Bio Science, Walkersville, MD, USA), according to manufacture’s 
instruction. In detail, microplate pre-equilibrated to 37°C was dispensed 50μL of sample 
or standard into the appropriate microplate wells.  The blank wells containing 50μL of 
LAL Reagent Water instead of sample was also included. After incubation for 10 min, 
100μL of substrate solution was added to each well and interacted for 6 min before 
adding 100μL of stop reagent to termination the reactions. The optical density was 
measured at 405-410 nm on a microplate reader. 
 
2.22 Removal LPS  
 
Removal of LPS and LPS-associated molecules from Der p 1, Der p 2 and GST using 
Polymyxin B-Agarose (Sigma-Aldrich) was performed according to manufacturer’s 
instruction and the method from Gao B et al., (Gao B et al., 2003) with modifications. 
10mL of Polymyxin B-Agarose were poured into disposable polypropylene columns 
(Pierce, Rockford, IL, USA) and washed three times in 20 volumes of 1 × PBS. The 
Polymyxin B-Agarose was then poured into a 50mL polypropylene tube (BD). Mite 
allergens such as Der p 1, Der p 2 or GST proteins at 1mg/mL were added to Polymyxin 
B-Agarose at a ratio of 5mg protein to 10mL Polymyxin B-Agarose. The mixture was 
then preceded shaking for overnight at 4˚C. Next, the Polymyxin B-Agarose was re-
packed into the disposable polypropylene columns, washed with 1× PBS until the 
absorbance at 280nm of the eluents dropped to baseline. The eluents containing the 
protein of interest, which were excluded from the Polymyxin B-Agarose, were collected, 
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concentrated by Amicon cell, and assayed for endotoxin levels using the Limulus 
Amebocyte Lysate (LAL) QCL-1000 (Cambrex Bio Science, USA). 
 
2.23 Stain for Intracellular Cytokines  
After stimulation by stimuli LPS, Der p 2 or LPS in the combination with Der p 2, 
Monensin (2 μM) was added to the cell culture 6 hours before the cell harvesting. The 
purified B cells were then harvested and stained for the surface molecule CD19 first. 
After that, the cells were undergone the intracellular cytokines staining.  The staining 
protocol for the Intracellular Cytokines IL-4 and IL-10 was adopted from the 
manufacturer’s method with modification. Briefly, after staining for surface molecule 
CD19, 5×105 --1×106 B cells were fixed and permeabilized in 250µL Cytofix/Cytoperm 
solution (Becton Dickinson, USA) at 4°C for 1 hour. The fixed/permeabilized B cells 
were thoroughly resuspended in 50 μL of a saponin-containing buffer (Perm/Wash buffer, 
Becton Dickinson, USA) and incubated with 1µL PE labeled anti-IL-4 (Becton 
Dickinson, USA) or PE labeled anti-IL-10 (Becton Dickinson, USA) at 4°C for 1 hour in 
the dark. Cells were then fixed with 500-1000μL of 1% paraformaldehyde and analyzed 
by gating CD19+ cell population by FACSCalibur flow cytometer with CellQuest 
software (Becton Dickinson, USA). 
 
2.24 Data analysis 
 
All data were represented as mean±SD and were analyzed by two-tailed student t test. 
Differences between groups were considered statistically significant when P values were 
less than 0.05. 
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Table 2.1: Primer sequences for cytokine genes 
 
Gene Primer sequence 
HPRT (300 bp) 
(Accession 
no.  NM_013556) 
Sense 5’ GTTGGATACAGGCCAGACTTTGTTG 3’ 
Anti-sense 5’ GAGGGTAGGCTGGCCTATGGG 3’ 
IL-4 (215 bp) 
(Accession 
no.  BC027514) 
Sense 5’ CATCGGCATTTTGAACGAGGTCA 3’ 
Anti-sense 5’ CTTATCGATGAATCCAGGCATCG 3’ 
IL-10 (317 bp) 
(Accession no. 
BC120612)  
Sense 5’ CCAGTTTTACCTGGTAGAAGTGATG 3’ 






Chapter 3  
Modulatory Effects of Lipopolysaccharide Stimulated B Cells on 




Allergic asthma is a pulmonary inflammatory disease initiated by allergen-specific Th2 
cells with characteristics of persistent aberrant inflammation triggered by commonly 
inhaled antigens, the aeroallergens. It is characterized as a Th2 aberrant immune response, 
in which Th2 cytokines such as interleukin 4 (IL-4), IL-5 and IL-13 play an essential role 
(Sears MR. 1991; Nakajima H et al., 1992; Robinson DS et al., 1992; Holgate ST. 1999;   
Liu AH 2002). Despite only a subset of population are sensitized and allergic to the 
aeroallergens, recent epidemiological studies revealed that the prevalence of allergic 
disease has been drastically increasing in the developed countries during the recent 
decades (Redd SC. 2002).  
 
In the allergy pathogenesis, the innate phase of immune recognition relies on germ-line 
encoded receptors known as pattern recognition receptors (PRRs), which recognize a 
wide range of molecular structures in groups of microorganisms, commonly known as 
pathogen-associated molecular patterns (PAMPs). A major component of the 
environmental microbial products is endotoxin or lipopolysaccharide (LPS). This 
represents one of the most well studied PAMPs; it is an immunostimulatory product of 
gram negative bacteria that signals through Toll-like receptor 4 (TLR4) (Akira S. 




2006;  Dauphinee SM e t al. 2006). Active research focusing on the interactions of LPS 
and its TLRs expressed by the innate immune response cells such as dendritic cells (DCs), 
macrophages and B cells have been driven by the well accepted “hygiene hypothesis”,  
which proposes that the microbial environment interfaces with the innate immune system 
and modulates antigen specific adaptive immune responses in early life (Strachan DP 
1989). Of these, exposure to LPS is an attractive candidate in this hypothesis because it 
may be the link between microbial exposures and the development of allergic diseases 
such as asthma and rhinitis through its effects on innate immunity and its subsequent 
impact on the adaptive immunity. 
 
Because LPS is the most frequent TLR4 ligand contaminating commonly inhaled 
antigens and its quantitative content has been closely associated with the prevalence of 
allergic asthma, several recent studies have addressed the role of LPS in preventing the 
development of experimental allergic asthma in prenatal, neonatal as well as adult mice. 
The consistent conclusion drawn from these studies indicates that low dose of LPS favors 
Th2 type polarization leading to asthma development, whilst high dose of LPS 
preferentially induces Th1 type immunity to prevent airway inflammation (Eisenbarth SC 
et al., 2002; Delayre-Orthez C, et al., 2004; Blümer N et al., 2005; Piggott DA et al., 
2005; Gerhold K et al.,  2006; Wang Y et al., 2006). The molecular mechanism of the 
hygiene hypothesis has mainly focused on the study of interactions between bacterial 
products such as LPS and TLRs using allergy or asthma animal models (Eisenbarth SC, 
et al., 2002; Wang Y et al., 2006.). However, among these studies, only Eisenbarth SC, et 
al., had investigated the cellular mechanism governing the Th1/Th2 differentiation 




following LPS stimulation. Their in vitro results suggested that DCs may be the 
responsive antigen presenting cells (APCs) for producing large amount of interleukin 12 
(IL-12) following high dose of LPS stimulation versus no IL-12 production when 
stimulating with low dose of LPS. They claimed that the key APC player involved in the 
process is DC. The precise in vivo mechanisms for the LPS-mediated DCs’ effects mainly 
addressed the global effects of LPS on allergic responses (Dabbagh K et al., 
2002; Piggott DA et al., 2005). Due to the complexity of in vivo animal model system, 
the crucial missing link in the understanding of the immunomodulatory roles of LPS on 
both innate and adaptive immunity in allergic responses is the elucidation of the direct 
effects of LPS on individual immune cell populations, particularly APCs such as DCs, 
macrophages and B cells. The main objective of this proposed study is to address this 
question from the B cell perspective. 
 
Beside DCs and macrophages, B cells are the largest subset of leukocytes with the 
capacity to internalize, process and present antigen to the responding T cells. In contrast 
to macrophages, both B cells and DCs possess limited lysosomal proteolytic activity, 
which in turn renders these APCs more efficient at generating longer peptides suitable for 
MHC II molecule assembly (Delamarre L et al., 2005). Despite possessing many DC-like 
functions, it is general accepted that B cells are not professional APCs for their 
dependency on help from activated CD4+ T cells. However, under certain circumstance, 
for instance, through primary signal of B cell receptor (BCR) crosslinking, B cells can be 
competent in priming naïve CD4+ T cells in vitro and in vivo (Morris SC 1994; Constant 
S et al., 1995; Constant S. 1999; Rodríguez-Pinto D et al., 2005). Furthermore, it is also 




true that another primary signal, the TLR4/LPS binding, is capable of activating B cells 
to prime naïve T cells (Hosken NA et al., 1995; Stockinger B et al., 1996).  In addition, B 
cells constitute a major lymphocyte subset in neonates and infants, which are likely to 
play important roles in driving the development of the immune system in early life (Pillai 
S et al., 2005; Sun CM et al., 2005; Hardy RR. 2006; Montecino-Rodriguez E, et al., 
2006; Dorshkind K et al., 2007). Therefore, B cells also serve as an important link 
between innate and adaptive immune systems. The important contribution of antigen 
presentation of B cells to T cell activation has been demonstrated both in vitro and in vivo. 
In vitro studies have shown that the capacity of activated B cells to activate naïve CD4+ T 
cells is almost as effective as that of DCs (Cassell DJ et al., 1994). In vivo studies using 
the absence or depletion of B cell in animal models have demonstrated a decrease in Ag-
induced T cell activation (Morris SC et al., 1994; Constant S et al., 1995; Constant S. 
1999), implying that B cells may contribute to the level of T cell priming. 
 
During the past decades, much of the clinical and experimental research work has 
focused on DC subset as it is believed that DCs are the master of regulator dictating the 
Th1/Th2 deviation. In contrast, little attention has been paid on the role of B cells in 
regulating the Th1/Th2 differentiation in vitro and in vivo (Eisenbarth SC  et al., 2003;  
Grunig G et al., 2005). Nevertheless, two elegant studies on B cell role in regulating 
Th1/Th2 differentiation were carried out in the mid nineties by Hosken et al., and 
Stockinger et al., (Hosken NA et al., 1995; Stockinge B et al., 1996). Both studies used 
splenic B cells stimulated by high dose of LPS to induce Th1/Th2 differentiation in naïve 
transgenic CD4+ T cells bearing T cell receptor (TCR) specific for OVA323-339 or C5 




peptide. Interestingly, both groups were able to demonstrate the differentiation of naïve 
CD4+ T cells to Th2 cells by producing high levels of interleukin 4 (IL-4), the Th2 
hallmark cytokine.  
 
LPS is a potent mitogen of B cells and the in vitro responses of B cells to LPS are 
extremely robust (Coutinho A et al., 1974; Dziarski R. 1982). Previous studies had 
shown that like myeloid and lymphoid-tissue-resident DCs, B cells exhibit up-regulation 
of CD86, CD40, ICAM-1, OX40L, IgM and MHC class II molecules, as well as 
production of IL-10 upon stimulation with LPS (Burger C et al.,. 1991; O'Garra A et al., 
1992; Hathcock KS et al., 1994; Gieni RS et al., 1997). However, unlike the DCs and 
macrophages counterparts, they do not produce the Th1 type signature cytokine, IL-12 
(Guéry JC et al., 1997). This distinct functional feature between B cells and DC subsets 
hints that B cells as APCs might play a part in initiating and/or maintaining antigen-
specific Th2-skewed immunity. Indeed, studies by Secrist H et al., had demonstrated that 
B-lymphocyte enriched population preferentially induced antigen-specific CD4+ T cells 
to produce IL-4 (Secrist H et al., 1995). Moreover, this notion is further supported by two 
independent studies showing that LPS-activated splenic B cells are able to initiate 
antigen-specific Th2-skewed response in vitro using specific T cell receptor (TCR) 
transgenic CD4+ T cells (Hosken NA et al., 1995; Stockinge B et al., 1996). Based on 
these parallels, the default hypothesis of the role of B cells as APCs in driving Th2-
skewed immunity is proposed (Gould HJ et al., 2003). 
 
In the first part of the study, I attempted to re-elucidate the role of B cells in regulating 




primary Th1/Th2 differentiation upon receiving various strength of LPS stimulus in vitro. 
I first constructed the proliferative kinetic profile of splenic B cells stimulated by various 
LPS doses ranging from 0.1ng/mL to 10μg/mL. This was followed by defining the 
internalization capacity of splenic B cells stimulated by high dose of LPS. Most 
importantly, I analyzed the dose-dependent kinetic profiles of cytokines produced by and 
the density of various accessory and co-stimulatory surface molecules on splenic B cells 
following varying doses of LPS stimulation. Finally I employed the B/T cell co-culture 
system to elucidate the Th1/Th2 polarizing potential of B cells stimulated by varying 
doses of LPS on naïve DO11.10 CD4+ T cells.  
 
 






3.2.1 Activation of B cells by varying doses of LPS  
 
LPS belongs to one class of thymus-independent antigens TI-1 antigens. It can stimulate 
polyclonal mouse B cell proliferation and is long regarded as a mitogen for mouse B cells. 
I first studied the effect of LPS on the proliferation response of purified B cells from 
BALB/c mice. Increasing doses of LPS were incubated with B cells for 48 hours. Cell 
proliferations were measured by [3H]-thymidine incorporation. Figure 3.1 showed that at 
the concentrations ranging from 100ng/mL to 10,000ng/mL, LPS could enhance [3H]-
thymidine incorporation in B cells in a dose-dependent manner; whereas lower doses (1 
and 10ng/mL) of LPS had no proliferative effect on B cells.  
 
To further confirm the [3H]-thymidine incorporation result of LPS-induced B cell 
proliferation, carboxyfluoroscein succinimidyl ester (CFSE) incorporation assay was 
applied in the study. CFSE is cleaved by non-specific esterases after entering the cell and 
thereafter remains in the cytoplasm of the cell for days to months. If the cells are 
undergoing division, the amount of CFSE present in each daughter cell after a division is 
half that of the parent (Lyons AB et al., 1994), thereby providing visual evidence of cell 
division. Splenocytes were labeled with CFSE and stimulated with varying doses (0-
10,000ng/mL) of LPS. The B cell proliferation was analyzed by flow cytometry.  
Twenty-four hours after LPS stimulation, LPS-stimulated B cell proliferation was not 
observed. At the doses of 0.1-10ng/mL, LPS triggered B cells proliferation was not 




obvious at 48 hours. However, LPS promoted prominent B cell proliferation at the doses 
above 100ng/mL and the B cell proliferative responses increased in a dose-dependent 
manner at 48 hours (Figure 3.2). Therefore, CFSE incorporation result was consistent 
with that of the [3H]-thymidine incorporation, indicating that in my cell culture system, 
after LPS stimulation for 48 hours, B cells could proliferate at the doses of 100ng/mL 
onwards. 
 
Morphological studies demonstrated that during the 24 hours stimulation of titrated doses 
of LPS, all the cultured B cells were “quiet”; there were no obvious morphological 
changes. After 24 hours incubation, the morphological changes of B cells happened. 
Figure 3.3 clearly demonstrated that after co-culture for 48 hours, from LPS 100ng/mL 
onwards, as LPS concentrations increased, the percentage of small B lymphocytes 
decreased and the percentage of cells morphologically resembling large lymphocytes 
increased. At 48 hours, large "blast-like" cells with eccentric nuclei, relatively prominent 
nucleoli and abundant cytoplasm were relatively common. The blast or blast-like cells in 
LPS 1 and 10μg/mL culture composed more than 50% of the stimulated culture.  
 
3.2.2 LPS stimulation enhances mannose-receptor mediated endocytosis and 
pinocytosis in B cells 
 
To investigate the effect of LPS on augmenting the antigen internalization ability of B 
cells, pinocytosis or endocytosis of lucifer yellow or FITC-labeled dextrans was 
employed to monitor the uptake kinetics over a period of 72 hours after stimulation with 




1μg/mL of LPS. Twelve hours post LPS stimulation, B cells began to exhibit some 
degree of increment in taking up lucifer yellow with mean fluorescence intensity (MFI) 
of 12.4 compared with the background value of 10.7 in the un-stimulated B cells. The 
endocytosis capability on lucifer yellow uptake reached the maximum at 48 hours (MFI = 
39.4) post LPS stimulation (Figure 3.4A), then declined to MFI of 29.2 at 72 hours post 
LPS stimulation. Moreover, slightly increment in FITC-dextran uptake activity was 
observed in B cells 12 hours post LPS stimulation; and this FITC-dextran internalization 
activity was progressively enhanced and reached to plateau activity when B cells received 
48 hours of LPS stimulation (MFI = 10.6) (Figure 3.4B). To further analyze the kinetics 
effect of LPS on the uptake of lucifer yellow and FITC-dextran, data were summarized 
and plotted in a different way indicating the statistical significance. As it was shown in 
Figure 3.4C, the uptake of lucifer yellow was significantly enhanced after LPS 
stimulation for 48 and 72 hours. As for FITC-dextran internalization, there were 
significant increments for all the 4 time points performed. It was detectable 12 hours post 
LPS stimulation, reached a plateau at 48 hours post LPS stimulation and persisted till 72 
hours (Figure 3.4D). 
 
3.2.3 Dose-dependent up-regulation of MHC II molecule, CD86, CD40, IgM and 
ICAM-1 but down-regulation of CD5 and CXCR4 expression on B cells by LPS 
 
LPS is known to provoke differentiation and maturation of subsets of immature DCs with 
characteristics of high level expression of surface MHC II molecule, CD86, CD80 and 
CD40 molecules (Berthier R et al.,  2000; Elkord E  et al., 2005). Recent in vitro and in 




vivo studies have shown that the surface density of MHCII molecule and CD86 
molecules on DCs may play a key role in regulating the Th1/Th2 polarization (Rogers PR 
et al., 1999; Rogers PR et al., 2000). With this regard, I analyzed the surface expression 
profiles of MHC class II molecule I-Ad, CD86, CD40, CD5, CXCR4, ICAM-1 and 
membrane bound IgM on in vitro LPS-stimulated splenic B cells by flow cytometry. As 
shown in Figure 3.5, 24 hours after LPS stimulation, there was marked, dose-dependent, 
up-regulation of surface expression of CD40, CD86, I-Ad, ICAM-1 and membrane bound 
IgM; whereas LPS could dose-dependently down-regulated CD5 and CXCR4 expression. 
Detailed analysis revealed that CXCR4, CD5 and membrane bound IgM were more 
sensitive to LPS stimulation; their expression levels begun to change at a dose of 
0.1ng/mL of LPS. Elevation of surface expression of I-Ad, CD86 and ICAM-1 molecules 
was observed only at a higher dose (1ng/mL) and LPS doses of 10ng/mL or more were 
required to up-regulate the surface expression of CD40 molecule. When B cells were co-
cultured with LPS for 48 hours, the profile of cell surface markers expression level 
remained unchanged, but it was not as prominent as that of 24 hours (data not shown), 
suggesting that at 24 hours after LPS stimulation, B cells were more active as indicated 
by cell surface molecules up-regulation. 
 
3.2.4 Dose-dependent effect of LPS on triggering B cell IL-10 production 
 
Beside the overall signal strength delivered by the MHC/TCR cognate interaction and the 
binding of co-stimulatory molecules/ligands of APCs and the responding T cells, 
cytokines such as IL-12, IFN-γ, IL-4 and IL-6 produced by the activated APCs, natural 




killer cells, natural killer T cells, basophils, eosinophils, mast cells or γδ T lymphocytes 
also play an essential role in modulating Th1/Th2 polarization (Constant SL et al., 
1997; Diehl S et al., 2002; Münz C et al., 2005; Corthay A. 2006). I therefore 
investigated the effects of various doses of LPS, ranging from 100pg/mL to 10μg/mL of 
concentration, on purified B cell cytokine production. After stimulation with LPS, the B 
cell supernatants were analyzed for the production of TNF-α, IL-10, IL-6, IL-4, IFN-γ, 
and IL-12 using ELISA.  Among these cytokines, only IL-10 was consistently produced 
by B cells following LPS stimulation. As shown in Figure 3.6A, B cells stimulated with 
LPS doses between 100pg/mL and 10ng/mL secreted low levels of IL-10 (threefold 
above the background level), while LPS dose of 100ng/mL or above was able to 
stimulate B cells to produce enormous levels of IL-10 in a dose-dependent manner 
(between 10- and 30-fold of the background level). The secretion of TNF-α by B cells 
following varying doses of LPS stimulation was not consistent in my experiments. Figure 
3.6B was one representative data of two experiments showing low doses (100pg/mL to 
10ng/mL) of LPS significantly activate B cells to produce TNF-α; whereas at high doses 
(100ng/mL to 10,000ng/mL), LPS could not induce TNF-α production. However, in 
other two separate experiments, this result could not be reproduced. Cytokines IFN-γ, IL-
12, IL-6 and IL-4 were consistently undetectable in all the B cell culture supernatants 
tested (data not shown). 
 
3.2.5 Dose-dependent effect of LPS in conferring differential T cell polarizing 
capability on B cells  
 




The level of LPS exposure is known to modulate antigen specific T cell polarization via 
TLR4 signaling pathway in vivo and has been presumed to be mediated by DCs 
(Eisenbarth SC et al., 2002; Delayre-Orthez C et al., 2004; Blümer N et al., 2005; Piggott 
DA et al., 2005; Gerhold K et al.,  2006; Wang Y et al., 2006). To investigate whether B 
cells, like DCs, would also acquire similar Th type polarizing capability after receiving a 
varied strength of LPS stimulus, an in vitro APCs/T-cell co-culture system for assessing 
the T cell phenotype profile was employed (Hosken NA et al., 1995). B cells activated by 
increasing doses of LPS, ranging from 0.1ng/mL to 10μg/mL, were co-cultured with 
CD4+ T cells from DO.11.10 TCR transgenic mice in the presence of 0.2 μM OVA323-339 
peptides for 48 hours. Similar B/T co-cultures without peptide were included as controls. 
As shown in Figure 3.7, B cells activated by 0.1 to 10 ng/mL of LPS induced IL-4 
production; however, when B cells received LPS stimuli of increasing strengths (> 
100ng/mL), an inverse relationship in IL-4 production was observed (Figure 3.7A, closed 
bar). On the other hand, both IFN-γ (Figure 3.7B, closed bar) and IL-10 (Figure 3.7C, 
closed bar) steadily increased with increasing doses of LPS. In the absence of OVA323-339 
peptide, the IL-10 levels produced were remarkably attenuated (Figure 3.7C, open bar). 
These results suggested that both peptide activated T cells and the B-cells activated with 
high-dose LPS were capable of producing IL-10 in an LPS-dose-dependent manner. 
CD4+ DO11.10 T cells alone produced very low levels of IL-4, IFN-γ and IL-10 in the 
presence of OVA323-339 peptide (IL-4: 8.71pg/mL, IFN-γ: 0.49 ng/mL and IL-10: 
37.0pg/mL). 
 




To address the question whether the lower levels of IL-4 in the B-T cells co-cultures 
could be due to consumption of IL-4 by the proliferative B cells upon LPS stimulation, I 
used mitomycin C-treated B cells to perform the B/T-cell co-culture experiments. The 
profile of cytokine production analyzed by ELISA showed that in the absence of 
proliferative B cells, the levels of IL-4 produced by T cells co-cultured with high dose 
LPS-activated,  mitomycin-C- treated B cells remain low, indicating that the low level of 
IL-4 production was not due to the consumption of IL-4 by the proliferative B cells 
(Figure 3.7D). The B/T co-culture experiments performed with LPS activated B cells 
with or without mitomycin C treatment produced similar cytokine profiles, but the levels 
of cytokine produced were lower when mitomycin-C-treated B cells were used in the co-
culture experiments (Figure 3.7D, E, F). 
 
In summary, corresponding to the original thought of “hygiene hypothesis”, these pieces 
of data indicated that high doses of LPS stimulation in B cells, which was defined as a 
dose ranging from 0.1 to 10μg/mL, favored T helper type 1 like regulatory polarization; 
whilst low doses of LPS stimulation in B cells, which was defined as a dose ranging 
between 1 and 10ng/mL, preferentially initiated Th2 polarization.  
 





























   
Figure 3.1. Proliferative response of B cells to LPS stimulation. B cells (1 × 105 in 
200µL) from BALB/c mice were cultured in triplicates in the presence or absence of 
varying concentrations of LPS (1-10,000ng/mL) for 48 hours and assayed for [3H]-TdR 
incorporation. The results are expressed as the mean cpm incorporated + SD of triplicate 
wells. These data are representative of three independent experiments.  
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Figure 3.2. Proliferative response of B cells to LPS stimulation. B cells (4 × 107/mL) 
from BALB/c mice were labeled with 5μM CFSE for 10 minutes, washed thoroughly and 
resuspended in RPMI-1640 culture medium. The cells (2 × 106 cells) were then cultured 
in the presence or absence of varying concentrations of LPS (0.1-10,000ng/mL) for 24 
and 48 hours and assayed for CFSE level by flow cytometry. The numbers indicate the 
percentage of cell in the quadrants. These data are representative of two independent 
experiments. 
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Figure 3.3.  Morphological changes of B cells after stimulation with different doses 
of LPS. B cells (2 × 106/mL) from BALB/c mice were cultured in the presence or 
absence of varying concentrations of LPS (0.1-10,000ng/mL) for 48 hours. The 




















































          
             C 
 































                  
           
 
             D 
                 




































Figure 3.4. Effect of LPS stimulation on B cell’s antigen internalization. B cells (2 x 
106/mL) from BALB/c mice were cultured in the presence or absence of LPS 
(1000ng/mL) for 12, 24, 48 or 72 hours. The cells were then incubated with (a) Lucifer 
yellow or (b) Dextran-FITC at 37 ºC for 1 hour. After subjected to extensive washes with 
flow cytometry staining buffer, the B cells were measured for the fluorescence intensity 
by flow cytometry. Filled area represents the un-stimulated B cells, the bold lines 
represent the LPS-treated B cells. The numbers indicate in the histogram plot are the MFI 
of LPS-stimulated B cells whilst the numbers shown on the top of histogram are the MFI 
of LPS un-stimulated B cells. These data are representative of four independent 
experiments. Figure (c) and (d) are another way of expression indicating the statistical 
significance of the uptake of Lucifer yellow and Dextran-FITC, respectively. Ctrl 
indicates the un-stimulated B cells. *: p<0.05. 
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Figure 3.5.  Expression profiles of co-stimulatory and accessory molecules on LPS-
stimulated B cells. Splenocytes (2×106 cells/mL) from BALB/c mice were cultured in 
the presence or absence of varying concentrations of LPS (0.1-10000ng/mL) for 24 hours. 
Surface expression levels of CD40, CD86, I-Ad, ICAM-1, IgM, CXCR4 and CD5 
molecules on CD19+ cells (B cells) were analyzed by flow cytometry. The numbers on 
top of each plot indicate the LPS concentrations. The numbers in the CD40, CD86, I-Ad, 
ICAM-1, IgM and CXCR4 histogram plots represent the mean fluorescent intensity (MFI) 
of that surface molecule. The numbers in the CD5 histogram plot represent the 
percentage of B cells expressing surface CD5 molecules. Filled areas represent the 
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Figure 3.6. Cytokine production of B cells stimulated with LPS.  B cells (2 × 106/mL) 
from BALB/c mice were cultured in the presence or absence of varying concentrations of 
LPS (0.1-10,000ng/mL) for 48 hours and the culture supernatants were collected for IL-
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Figure 3.7. Cytokine profiles of CD4+ DO.11.10 T cell co-cultured with activated B 
cells. B cells (2×106 cells/mL) from BALB/c mice were cultured in the presence or 
absence of varying doses of LPS (0.1–10000ng/mL) for 24 hours. The B cells were 
thoroughly washed and co-cultured with CD4+ DO.11.10 T cells in the presence (A, B & 
C, closed bar) or absence (A, B & C, open bar) of 0.2 μM OVA323-339 peptide for 48 
hours and the culture supernatants were measured for levels of IL-4 (A), IFN-γ (B) and 
IL-10 (C) by ELISA. In another set of experiment, the LPS stimulated B cells from 
BALB/c mice were treated with mitomycin C before co-cultured with CD4+ DO.11.10 T 
cells in the presence of 0.2 μM of OVA323-339 peptide for 48 hours (D, E, F). The culture 
supernatants were measured for the levels of IL-4 (D), IFN-γ (E) and IL-10 (F) by ELISA. 
T cells alone represent T cells cultured with OVA323-339 peptide without B cells. These 
data are the representative results of three independent experiments. 
     






This study examined the accessory roles of LPS-activated murine splenic B cells in 
initiating or modulating T cell immune responses. Results showed that LPS in a dose-
dependent manner induced up-regulation of IgM, CD86, CD40, MHC II and ICAM-1 
molecules as well as accompanied by down-regulation of CD5 and CXCR4 molecules in 
B cells (Figure 3.5). B cells stimulated with 100-10,000ng/mL of LPS produced 
significant levels of IL-10, but B cells stimulated with low doses of  LPS (0.1-10ng/mL) 
produced IL-10 at basal levels of (Figure 3.6A). Other cytokines, such as IL-12 and IL-6 
were not detected. Importantly, the functional assays revealed that LPS-activated B cells 
acquired differential modulatory effects on the polarization of T cells. Such modulatory 
effects of B cells on T cells are dependent on the dose of LPS. Low doses of LPS-
stimulated B cells (0.1-100ng/mL) were capable of driving Th2 polarization, as 
demonstrated by production of high levels of IL-4, accompanied by low levels of IFN-γ 
by DO11.10 TCR transgenic CD4+ T cells. In contrast, high doses of LPS-stimulated B 
cells (1-10µg/mL) polarized T cells producing high levels of IFN-γ and IL-10 (Figure 
3.7), resembling the Tr1 phenotype (Akbari O,  Umetsu DT. 2004). 
The surface antigen expression profiles analysis of the LPS-activated B cells revealed a 
LPS dose-dependent down-regulation of CD5 and CXCR4 molecules in B cells that was 
dependent on the LPS dose (Figure 3.5). CD5, a 67 KDa molecular weight 
transmembrane glycoprotein, has been defined as an inhibitory receptor of B cells 
(Berland R et al., 2002). CD5 negatively regulated the activation of B1a subsets of B 
cells. B1a cells respond poorly to B cell receptor stimulation. However, the absence of 




CD5 restored the capacity of B1a cells to full proliferation upon B cell receptor activation. 
In addition, CD5 was a necessary molecule that maintains tolerance in anergic B cells. 
The possible mechanism of the inhibition effect of CD5 on B cell receptor could be due 
to the tyrosine residue Y429 of its cytoplasmic domain. CD5 uses Y429 to inhibit the B 
cell receptor activation (Hippen KL et al., 2000). Hence, in this study, the dose-
dependent down-regulation of CD5 expression after LPS stimulation may signal the 
activation of B cells. CXCR4, a chemokine receptor, is found on a variety of B cell 
subsets including the B-1, B-2 and pro-B cells (Kim CH H et al., 1999; Pease JE et al., 
2006). It has been shown that this receptor, mediated via its ligand CCL12, plays a role in 
promoting the migration of B cells to the secondary lymphoid organs, (Kim CH et al., 
1999; Stein JV et al., 2005). However, the discovery of CXCR4 as a member of the 
putative LPS activation clusters, which include heat shock protein 70, heat shock protein 
90 and growth differentiation factor 5 in monocytes/epithelial cells, argues for an 
addition role of CXCR4 in operating the TLR4/LPS signaling pathway (Triantafilou K et 
al., 2001). To my knowledge, even though in vitro and in vivo studies on monocytes and 
macrophages have well illustrated this phenomenon (Juffermans NP et al., 2002; Verani 
A, et al., 2002), the down-regulation of CXCR4 expression in B cells following LPS 
stimulation has not been reported before. Recently, Kishore et al., showed that CXCR4 
can exert local regulatory control on TLR4 signaling pathway, implying that there is 
cross-talk between TLR4 and CXCR4 (Kishore SP 2005). Molecular signaling studies 
will be required to determine whether such cross-talk between G-protein-coupled 
receptor-mediated and TLR-mediated pathways exist to co-regulate the activation and 




mediate the bimodal effects of the LPS-stimulated B cells on T cells as seen in this study 
(Lattin J et al., 2007). 
IL-10 is a pleiotropic cytokine that modulates the interaction between innate and adaptive 
immune response, but its role on T cell responses remain ambiguous as reflected by 
conflicting findings of several studies (Mocellin S et al., 2003). Indeed, the roles of IL-10 
produced by DCs in innate immunity remain unclear despite extensive studies. 
Langenkamp et al., (Langenkamp A et al., 2000) demonstrated that LPS-stimulated 
human monocytes-derived DC produced IL-10 from 6 hours post-stimulation and this 
production was sustained at least up to 24 hours. This IL-10 production preceded IL-12 
production. Animal studies showed that IL-10 secreted by DCs has been associated with 
Th2 T cell type (Edwards AD et al.,  2002;  Dillon S et al., 2004). However, IL-10-
secreting DCs were shown to be associated with T regulatory phenotype in studies using 
B. pertussis infection model. The filamentous hemagglutinin of B. pertussis inhibited IL-
12 and stimulated IL-10 production by DCs, and then induced polarization of IL-10-
producing T regulatory cells (McGuirk P et al., 2002). Furthermore, it has been reported 
that signaling through TLR4 in response to B. pertussis activates IL-10 production by 
DCs and macrophages, which promotes IL-10-producing T cells (Higgins SC et al., 
2003). However, a recent study demonstrated that DCs derived IL-10 is not required for 
the induction of Th1 or Th2 induction in vivo, but IL-10 could regulate the outcomes of 
DCs-driven immune response (Perona-Wright G et al., 2006). 
In the B cells scenario, the notion that antigen presentation by B cells preferentially 
drives the development of Th2 cells had been suggested by several studies (DeKruyff RH 




et al., 1992; Secrist H et al., 1995). It was further suggested that the production of IL-10, 
but not IL-12, by B cells is the critical determining factor for Th2 induction and 
polarization. Both CD5+ and CD5- naïve murine B cells have been shown to have the 
capacity to produce IL-10 in response to LPS stimulation (O'Garra A et al., 1992; Gieni 
RS et al., 1997). However, the effects of LPS dose on these naïve B cells and the 
subsequent modulatory effects of the LPS-induced activated B cells on T cells 
polarization have not been fully elucidated. My data derived from the LPS dosage studies 
showed that B cells stimulated with low-dose LPS (0.1-10ng/mL) produced only basal 
levels of IL-10 (Figure 3.6A) and these LPS-stimulated B cells were shown to drive Th2-
polarization (Figure 3.7). Whereas B cells stimulated with high-dose LPS (1-10µg/mL) 
polarized T cells to produce high levels of IFN-γ and IL-10 (Figure 3.7), resembling the 
Tr1 phenotype (Akbari O et al., 2004). In previous studies on the role of B cells in 
regulating T helper cells differentiation (Hosken NA et al., 1995; Stockinge B et al., 
1996), splenic B cells stimulated by high doses of LPS were used for co-culture 
experiments with naïve transgenic CD4+ T cells bearing TCRs specific for OVA323-339 or 
C5 peptides. Interestingly, both groups were able to demonstrate the differentiation of 
naïve CD4+ T cells to Th2 cells by producing high levels of IL-4, the Th2 signature 
cytokine. In contrast, my data showed that the acquisition of Th1-like T-regulatory 
phenotype polarizing capacity by B cells following stimulation with high doses of LPS, 
which therefore challenge their hypothesis that a default pathway operated by B cells 
acting as APCs initiate Th2 polarization (Gould HJ et al., 2003). My results suggested 
that LPS can exert a dose-dependent bimodal effect on splenic B cells, in which B cells 
stimulated with low-dose LPS were capable of driving Th2-skewed T cell polarization, 




whilst high-dose LPS-stimulated B cells drove Th1-like T regulatory cells polarization. 
 
IFN-γ and IL-10 producing Th1-like T regulatory cells had been observed in T cell line 
specific for Borrelia burgdorferi (Pohl-Koppe A et al., 1998) and in animals infected 
with Toxoplasma gondii (Jankovic D et al., 2002). Stock et al., (Stock P et al., 2004) 
reported that antigen specific IFN-γ and IL-10 producing Th1-like regulatory cells 
induced by CD8α+ DCs could potently inhibit the development of airway hypersensivity. 
More recently, Anderson et al., (Anderson CF et al., 2007) reported that the immune 
suppression seen in chronic cutaneous leishmaniasis was mediated by IL-10 produced by 
CD4+CD25-Foxp3- Th1 cells. The role of IL-10 produced by the Th1-like cells have been 
extensively reviewed by O’Gara and Vieira (O'Garra A et al., 2007), but the molecular 
mechanisms that regulate the production IL-10 by these Th1-like cells remain unclear. 
For example, Gerosa et al., (Gerosa F et al., 1996) reported that IL-12 could prime 
human T cell clones to produce high levels of both IL-10 and IFN-γ; but data derived 
from T. gondii infection model demonstrated that production of IL-10 by Th1 cells was 
independent of IL-12 (Jankovic D et al., 2002). My unique finding that high dose LPS-
activated B cells were capable of polarizing IL-10- and IFN-γ-producing Th1-like cells in 
the absence of IL-12 is interesting, but the cellular signals and molecular mechanisms 
involved remain to be elucidated. It is unlikely that such observations were the result of 
trace contamination by splenic residual DCs during B cell sorting leading to production 
of IL-12 in the B/T-cells co-culture, because B cells used in this study were positively 
isolated by anti-CD19 MicroBeads with purity greater than 95%. It is also unlikely that 
contamination by CD4+CD8- splenic DCs during positive isolation of DO11.10 CD4+ T 




cells contributed to such observations, since CD4+CD8- splenic DCs are poor producer of 
IL-12 (Hochrein H et al.,  2001). This notion is further supported by the evidence that 
only background levels of IFN-γ or IL-4 were produced by CD4+ DO11.10 T cell in the 
presence of OVA323-339 peptide. In addition, although I cannot rule out the possible trace 
contamination of CD19+ DCs during B cell sorting, these CD19+ DCs do not express 
TLR4 and hence are unable to respond to LPS stimulation (Boonstra A et al.,  
2003; Munn DH et al., 2004). It is highly possible that additional signal(s) delivered by 
yet defined cytokine(s) or accessory molecules from high dose LPS-activated B cells 
might play an instrumental role in orchestrating the polarization of Tr1 regulatory cells. 
Nevertheless, like the current scenario seen in DCs, the cellular signals and molecular 
mechanisms that induced Tr1 regulatory cells by LPS-activated B cells, as observed in 
my study, remain to be elucidated. Future study will also include blocking experiments 
using anti-IL-10 neutralization antibody to determine whether the differential modulatory 
effects on T cells polarization are mediated solely by the relative amounts of IL-10 
produced by the LPS-stimulated B cells. 
 
Alternatively, despite a lack of direct evidence to support this postulation in the present 
study, the “co-signal strength” model proposed by Rogers and Croft, who hypothesized 
that Th1/Th2 differentiation is directly dependent on the overall signal strength of T-cell 
epitope affinity and/or dose and the accessory molecule might be able to help explain, at 
least partly, my unique finding (Rogers PR and Croft M. 1999; Rogers PR and Croft M. 
2000). This is mainly in the light of my observation that the dynamic changing from low 
to high surface density of CD86, CD40 and I-Ad on B cells that well coincides with the 




Th2 to Th1 phenotype shifting of CD4+ T cells, which seems to correspond to the “co-
signal strength” model.  
 
The results derived from the current study may have some significant implications in the 
physiological settings. In the context of systemic infection, the activation of APCs by 
pathogen is an essential step towards the generation of effective immune responses to 
ensure rapid clearance of pathogens by the host. As a counter regulatory mechanism to 
prevent the detrimental effects of excessive inflammatory response linked to potent 
immune activation, the production of anti-inflammatory cytokines, such as IL-10, by 
APCs and T cells is essential (Bachmann MF  et al.,  2002). In this regard, the Th1-like 
Tr1 cells driven B cells stimulated with high-dose LPS may play a significant role in 
maintaining a balance between protective immunity and detrimental immunopathology. 
The amount of LPS encountered by systemically infected individuals is difficult to 
quantify and, to the best of my knowledge, there is no such report has been published. It 
is also noteworthy that exposure to microbes can occur in the absence of infection. For 
example, endotoxin (LPS) is one of most commonly found non-viable microbial products 
in the living environment and is likely to play an important role in modulating immune 
responses to environmental allergens (Braun-Fahrländer C et al., 2002). Additionally, it 
is also well established that LPS frequently coexists with the major inhalant allergens 
(Platt-Mills T et al., 1995). Allergen exposure is a major triggering factor associated with 
the development and persistence of Th2-mediated allergic diseases; however, the 
mechanisms for the initiation and development of such Th2 responses remain ambiguous. 
Animal and human studies have been carried out to elucidate the role(s) of LPS in 




initiating/maintaining allergen-specific T cell immune responses. A study using a mouse 
model of allergic sensitization showed that low-dose endotoxin promotes Th2 responses 
to allergen (Eisenbarth SC et al., 2002). Furthermore, Alexis et al., reported that airways 
challenged with low doses of endotoxin resulted in a Th2 skewed airway inflammatory 
response in humans (Alexis NE et al., 2004). Additionally, epidemiological studies have 
shown that the levels of exposure to LPS is inversely correlated to atopy and related 
allergic diseases. High-level exposure to environmental endotoxin in early life might 
protect against the development of atopy and allergic diseases (von Mutius E et al., 2000), 
but the underlying mechanisms for such protective immunity against atopy remain 
unclear. Taken together, these studies imply that in the context of allergen sensitization 
and development of allergic diseases, the effect of LPS on the immune response depends 
on the level of exposure (low levels directing Th2 responses and high levels dampens 
these responses). The mechanism of this paradox of differential adjuvant activities 
associated with high- and low-dose LPS has yet to be fully resolved. Here I would like to 
propose that the observations that B cells activated by low doses of LPS-activated drive T 
helper type 2 (Th2) polarization, whilst those activated by high doses of LPS resulted in 
T regulatory type 1 cells (Tr1) polarization, may offer a possible mechanistic explanation 
for the opposing influences of low and high levels of environmental LPS on the 
development of allergic diseases. This notion is further supported by the observation that 
B cells represent a dominant population of APCs co-existing with DCs in the respiratory 
tract (von Garnier C et al., 2005) and that these respiratory tract APCs play an important 
immunomodulatory role in controlling the balance between tolerance and immunity in 
response to environmental antigens, such as pathogens or allergens, in the respiratory 










In conclusion, my data demonstrated that LPS-activated B cells acquire differential 
modulatory effects on T cell polarization. Such modulatory effects of B cells on T cells 
are dependent on the stimulation with LPS in a dose-dependent manner. Low-dose LPS 
(<100ng/mL) stimulation of B cells results in Th2 polarization, whereas high-dose LPS 
(>1µg/mL) stimulation of B cells results in Tr1 polarization. Further studies are necessary 
to evaluate the cellular and molecular mechanisms of this phenomenon. Knowledge 
gained from such studies will shed new light on the understanding of the effects of LPS 
on the underlying responses of innate and adaptive immunity driving and modulating the 
development of the Th2 mediated allergic responses. Understanding of the signaling 
pathways involved in the interaction between B cells and LPS can potentially provide 
useful information for developing novel strategies to prevent allergy onset or treat 
allergic diseases by therapeutic manipulation of the innate immune system. 
 
 
Chapter 4  
Effects of House Dust Mite Allergens on Lipopolysaccharide  




In the previous chapter, the potential roles of murine splenic B cells, in initiating or 
modulating antigen-specific T cell immune responses, using varying doses of LPS as 
stimuli to induce B cells activation have been investigated. In summary, the results 
showed that LPS in a dose-dependent manner induced up-regulation of IgM, CD86, 
CD40 and MHC II molecules as well as accompanied by down-regulation of CXCR4 
molecules in B cells (Figure 3.5). B cells stimulated with 1000-10,000ng/mL of LPS 
produced significant levels of IL-10, but the low doses (0.1-100ng/mL) of LPS-
stimulated B cells failed to produce IL-10 (Figure 3.6). Other cytokines such as IL-12, 
and IL-6 were not detected. Interestingly, the functional assays revealed that low-dose 
LPS-stimulated B cells (0.1-100ng/mL) were capable of driving Th2 polarization, as 
demonstrated by production of high levels of IL-4, accompanied by low levels of IFN-γ 
in DO11.10 TCR transgenic CD4+ T cells in culture. In contrast, high doses of LPS-
stimulated B cells (1-10µg/mL) polarized T cells producing high levels of IFN-γ and IL-
10 (Figure 3.7), resembling the Tr1 phenotype (Akbari O et al., 2004). On the basis of 
these data, we hypothesize that LPS-activated B cells acquire differential modulatory 
effects on the polarization of antigen specific T cells, and is influenced by LPS 
stimulation in a dose-dependent manner. 
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 Given that LPS is frequently coexisting with the major inhalant allergens (Platt-Mills 
TAE et al., 1995), it would be interesting to elucidate the roles of LPS in initiating or 
maintaining allergen-specific T cell immune responses. A study by Eisenbarth et al., had 
shown that low levels of inhaled LPS, signaling through Toll-like receptor 4 (TLR4) was 
necessary to induce Th2 responses to inhaled antigens in a mouse allergen sensitization 
model (Eisenbarth SC et al., 2002). High levels of LPS plus antigen exposure, in contrast, 
resulted in Th1 responses. This study also concluded that the mechanism of LPS-
mediated Th2 sensitization was involved in the activation of antigen-containing DCs. 
However, the in vivo mechanisms for the LPS-mediated DCs effects mainly addressed 
the global effects of LPS on allergic responses (Dabbagh K et al., 2002; Piggott D et al., 
2005).  The crucial missing link in our understanding of the immunomodulatory roles of 
LPS on both innate and adaptive immunity in allergic responses is the elucidation of the 
direct effects of LPS on individual immune cell populations, particularly antigen 
presenting cells such as DCs, macrophages and B cells. The main objective of this 
chapter is to address this question from the B cell perspective by investigating the effects 
of two major house dust allergen Der p 1 and Der p 2 on B cells stimulated with varying 
doses of LPS.  
 
It is well established that Der p 1 and Der p 2 are the two clinically most important major 
house dust mite allergens (Arlian LG. 1991; Thomas WR et al., 2002). They have been 
classified under the group 1 and group 2 mite allergens, respectively. Der p 1 and Der p 2 
are two structurally distinct proteins, they do not share any significant primary DNA and 
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protein sequence homology (please refer to section 1.2.5 in chapter 1 for more detailed 
literature review of these two allergens).  
 
Der p 1 allergen was chosen as the dust mite allergen in the experiments described in the 
first part of this chapter. Due to the great difficulty in producing conformationally intact 
allergenic recombinant Der p 1 (Chua KY et al., 1992) ,  the native form of Der p 1 
affinity purified from the spent mite medium was used for the in vitro and in vivo studies. 
Further purification of the Der p 1 protein involving removal of LPS by polymyxin B-
agarose from the affinity purified Der p 1 was found to be problematic (refer to the 
following section 4.2). Nevertheless, in vitro and in vivo studies were performed as 
planned because to certain extent, these studies can mimic the existence of Der p 1 in 
natural environmental conditions, of which LPS-free mite allergen does not exist. Given 
the constraints of LPS contamination in Der p 1 protein, the focus of the studies was on 
the combined effects of LPS and Der p 1 on B cells as accessory and antigen presenting 
cells.  
 
In order to address whether the phenomena observed in native Der p 1 was unique in mite 
allergen Der p 1, the recombinant Der p 2 with similar level of LPS was used to repeat 
the experiments in the second part of this chapter. In the subsequent studies, highly 
purified recombinant Der p 2 protein produced in Pichia pastoris yeast was used instead. 
The cell proliferation assayed by thymidine uptake and surface marker expression 
profiles analyzed by flow cytometry of B cells stimulated (1) with Der p 2 protein alone; 
(2) with varying doses of LPS in the presence or absence of Der p 2, were performed. 
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The LPS-activated B cells (with or without Der p 2) were used to evaluate the T helper 
(Th) cells polarizing capacity on naive DO11.10 CD4+ T cell. LPS (with or without Der p 
2) activated B cells were loaded with the respective OVA peptides and the peptide loaded 
B cells were adoptively transferred to the naive DO11.10 mice. Subsequently, the T cells 
from the recipients were collected at day 9 and re-stimulated with respective OVA 
peptides to phenotype the Th polarization by cytokine profiling.   
 
4.2 Methods and materials 
 
The removal of LPS from the native Der p 1, recombinant Der p 2 and recombinant GST 
proteins was performed by Polymyxin B-Agarose treatment. The LPS concentration 
present in the proteins was determined by Limulus Amebocyte Lysate (LAL) QCL-1000. 
Detailed methods were described in section 2.21.  
 
The control protein glutathione s- transferase (GST) was purified from recombinant 
E.coli by a method described in section 2.20.  The LPS concentrations in GST before and 
after LPS removal were 0.12ng LPS per µg and 2.2×10-4 ng LPS per µg GST, 
respectively (Table 4.1). This protein is designated as rGST. 
 
Native Der p 1 was purified by monoclonal affinity chromatographic method as described 
in method section 2.18. The removal of LPS from the affinity purified Der p 1 protein 
performed by Polymyxin B-Agarose treatment (section 2.22) was unsuccessful. 
Approximately 3.5ng of LPS was present in 1µg of Der p 1. The corresponding amount 
                  Chapter 4 Effects of House Dust Mite Allergens on Stimulated B cells 127 
 
of LPS in each dose of native Der p 1 used in the subsequent in vitro and in vivo studies 
was listed in Table 4.1. For simplicity, the term for native Der p 1 (abbreviated as nDer p 
1) in the subsequent sections will be referred as Der p 1 protein plus a known amount of 
LPS as shown in Table 4.1.  
Recombinant Der p 2 was purified from Pichia pastoris yeast by a method described in 
section 2.19. The LPS concentrations in recombinant Der p 2 before and after LPS 
removal were 2.8ng and 0.006ng LPS per 1µg recombinant Der p 2, respectively (Table 
4.1). This protein is designated as rDer p 2. 
 
 








4.3.1 Activation of B cells by nDer p 1 allergen 
 
4.3.1.1 Enhancement of B cells proliferation by nDer p 1 allergen 
 
Initially, study on the dosage effect of dust mite allergen nDer p 1 on the proliferative 
response of B cells from BALB/c mice was performed. B cells were co-cultured with 
increasing doses of nDer p 1 for 72 hours. LPS and rGST were used as positive and 
negative control, respectively. BrdU incorporation was measured by flow cytometry 
(method section 2.6.3).  Figure 4.1 showed that at the concentrations ranging from 
10μg/mL to 100μg/mL, nDer p 1 could enhance BrdU incorporation in B cells in a dose-
dependent manner. The percentage of BrdU+ B cells increase ranged from 9.49-32.75%. 
LPS, as a control mitogen, stimulated B cells to proliferate, but the increased magnitude 
was 44.58%, which was much higher as compared with that of nDer p 1-induced BrdU 
incorporation. The negative control protein of rGST did not have such effect. From the 
measurement of endotoxin, the LPS level in nDer p 1 was 3.5ng of LPS per µg of nDer p 
1. Thus, as illustrated in Table 4.1, 30µg/mL of nDer p 1 contained approximately 
105ng/mL LPS. The nDer p 1 at 30µg/mL concentration was chosen for the subsequent 
experiments, due to the following reasons: firstly, at 30µg/mL of concentration, nDer p 1 
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could induce B cells to proliferate significantly as shown by the enhanced BrdU 
incorporation of B cells at 72 hours (Figure 4.3). Secondly, at this dose of nDer p 1, the 
LPS content may be crucial, in combination with nDer p 1, to activate B cells to confer 
Th2 polarization capability (Figure 3.7).  
 
4.3.1.2 Combination of nDer p 1 and LPS could enhance B cell proliferation  
 
BrdU incorporation was used to compare the difference between B cell proliferation 
induced by LPS alone and in combination with nDer p 1. B cells from BALB/c mice 
were co-cultured with increasing doses of LPS ranging from 0.5ng/mL to 5µg/mL in the 
presence or absence of nDer p 1 (30µg/mL). After 72 hours incubation, BrdU 
incorporation of B cells was analyzed by flow cytometry. Figure 4.2A showed that in 
both LPS alone and when B cells were co-cultured with nDer p 1 in the presence of 
increasing doses of LPS ranging from 0.5ng/mL to 5µg/mL, only LPS concentration of 
100ng/mL and above could stimulate B cells to enhance proliferation. At lower 
concentrations, LPS was unable to stimulate proliferation in B cells.  Noteworthy, the 
baseline B cell proliferation induced by 30µg/mL of nDer p 1 (containing 100ng/mL of 
LPS) stimulation was about 40%, which was about 2 times higher as compared with the 
effect of 100ng/mL of LPS alone. Similarly, B cell proliferation after 200ng/mL of LPS 
stimulation was about 30%, whereas the proliferative response of B cells to the 
combination of 30µg/mL of nDer p 1 and 100ng/mL of LPS (which had equivalent 
amount of 200ng/mL LPS) was about 50% (Figure 4.2B). This piece of data indicated 
that the combination of nDer p 1 and LPS may have synergistic effect on B cell 
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proliferation. In C3H/HeJ mice, that are resistant to LPS stimulation, the magnitude of 
BrdU incorporation in B cells was reduced, indicating that the nDer p 1’s B cells 
stimulation effect was mainly due to LPS (Figure 4.2C). 
 
4.3.1.3 Up-regulation of B cells surface markers by nDer p 1 allergen 
 
Previously, LPS was shown to up-regulate the expression of a series of B cell surface 
markers in a dose-dependent manner. This experiment was designed to determine 
whether the nDer p 1 showed similar effect, whereby the B cell surface molecules such as 
MHC II molecule I-Ad, CD86 and CD40 were analyzed. As it was shown in Figure 4.4,  
after stimulation for 72 hours, nDer p 1 (30μg/mL) could up-regulate B cell surface 
molecules I-Ad, CD86 and CD40 expression similar to the profiles stimulated with 100 
ng/mL of LPS (Figure 3.5). The profile from the negative control protein rGST was 
similar to the medium control. 
 
4.3.1.4 B cells cytokine production induced by nDer p 1 allergen 
To determine the effect of nDer p 1 on B cell’s cytokine production profiles, B cells were 
incubated with nDer p 1 (30μg/mL) and rGST (30μg/mL) for 48 hours. The RNA of 
cytokines IL-4, IL-10, IL-5, IL-6, IL-12, IL-1α, TNF α and IFN-γ were detected by RT-
PCR. As shown in Figure 4.5, there was a high level of IL-10 RNA and a low level of IL-
4 RNA detected in nDer p 1-stimulated, but not in the rGST-stimulated B cells.  RNA for 
all the other cytokines measured could not be detected (data not shown). 
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4.3.2 nDer p 1 could enhance endocytosis and pinocytosis in B cells 
 
To investigate the antigen internalization in B cells stimulated by nDer p 1, uptakes of 
FITC labeled Dextran and Lucifer Yellow (LY) were used to monitor the processes of 
endocytosis and pinocytosis. Results indicated that B cells, after nDer p 1 stimulation for 
72 hours, could uptake both Dextran and Lucifer yellow (Figure 4.6), which was similar 
to the profiles of B cells activated by high dose (1µg/mL) of LPS (Figure 3.4).  
 
4.3.3 nDer p 1-activated B cells acquired accessory function to prime antigen 
specific T cells 
 
Results from the above experiments indicated that nDer p 1 has the ability to stimulate B 
cells by enhancing cell proliferation, upregulate expression of cell surface markers, 
production of cytokines IL-4 and IL-10 and uptake of antigen, which might play an 
important accessory role in antigen-specific T cells activation. To investigate the 
accessory function of B cells triggered by nDer p 1, in vivo functional assay using 
adoptive cell transfer of nDer p 1 or rGST-pulsed B cells was performed. B cells were 
pulsed with nDer p 1 or rGST for 24 hours, washed completely to remove the stimuli 
before adoptive transfer to the recipient mice via intravenous administration. These cell 
transfer procedures were performed twice with a one-week interval. Fourteen days after 
the second cell transfer, splenocytes from the two groups of recipient mice were obtained 
and stimulated with nDer p 1 or rGST. The cells were then re-stimulated with nDer p 1 or 
rGST and the supernatants were collected for cytokine ELISA assay. Cell proliferation 
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was assayed by 3[H]-thymidine uptake. The nDer p 1 specific IL-4 and IFN-γ were 
detected from splenocytes of mice that received nDer p 1-pulsed B cells and cytokine 
production was significantly enhanced as compared with the rGST specific IL-4 and IFN-
γ production from splenocytes of mice that received rGST-pulsed B cells (Figure 4.7A 
and B). Splenocytes from mice that received nDer p 1 pulsed B cells also showed 
significant increase of cell proliferation after nDer p 1 stimulation as compared with the 
splenocytes from mice that received rGST pulsed B cells and stimulated with rGST 
(Figure. 4.7C). From these data, it appears that the after co-culturing with n Der p 1, B 
cells were capable of uptake and process the Der p 1 protein and subsequently present 
Der p 1-derived peptides to T cells, resulting in priming of Der p1-specfic T cells. 
 
4.3.4 nDer p 1-activated B cells skewed Th2 cell polarization  
 
In chapter 3, it was demonstrated that low dose LPS (0.1 to 100ng/mL)-stimulated B cell 
could induce Th2 polarization, whilst high dose LPS (1 and 10 μg/mL)-stimulated B cell 
favored the Th1-like regulatory polarization. The above result (Figure 4.7) indicated that 
nDer p 1-activated B cells acquired the accessory function to induce T cells proliferation 
and cytokine production. Whether n Der p 1-activated B cells could also acquire similar 
T-helper cell polarizing capability was the question to be addressed. Firstly, the in vitro 
APCs/T-cell co-culture system for profiling the T-helper cell phenotypes was performed. 
B cells of BALB/c mice pulsed with nDer p 1 or rGST were incubated with CD4+ T cells 
from DO11.10 TCR transgenic mice, in the presence of peptide OVA323-339. The nDer p 
1-stimulated B cells could induce CD4+ T cells from DO11.10 TCR transgenic mice to 
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secrete Th2 cytokine IL-4, whereas rGST-stimulated B cells could not induce CD4+ T 
cells from DO11.10 TCR transgenic mice to secrete IL-4. There was no difference in 
Th1-type signature cytokine IFN-γ production. The IL-4 to IFN-γ ratios in CD4+ T cells 
co-cultured with nDer p 1-stimulated B cells was also increased as compared to that of 
CD4+ T cells co-cultured with rGST-stimulated B cells (Figure. 4.8). To further confirm 
this in vitro experimental result, B cells stimulated with nDer p 1, rGST or medium alone 
were transferred intraperitoneally into the DO11.10 TCR transgenic mice. Splenocytes 
from mice that received nDer p 1-pulsed B cells secreted significantly higher level of Th2 
cytokine IL-4 when co-cultured with peptide OVA323-339. The levels of Th1 type cytokine 
IFN-γ remained unchanged among the three groups. The IL-4 to IFN-γ ratios also 
significantly increased in splenocytes from mice that received nDer p 1-pulsed B cells 
(Figure. 4.9).  These results further indicated that nDer p 1 could activate B cells to 
become accessory cells and showed the ability to differentiate T cells into Th2 
polarization. 
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Part II 
Effects of LPS Contaminated rDer p 2 on Lipopolysaccharide  




4.4.1 B cells stimulated with LPS contaminated Der p 2 polarized Th2 cells 
 
It was shown that nDer p 1 (contaminated with LPS) - activated B cells could polarize 
Th2 cells (Figure 4.8 and Figure 4.9). To further address whether this is unique to nDer p 
1, LPS contaminated rDer p 2 was used to perform similar in vitro and in vivo functional 
assays using OVA TCR transgenic DO.11.10 mice. The rDer p 2 (30µg/mL), which had 
approximately 84 ng/mL of LPS, was used to stimulate B cells. Subsequently, APCs/T-
cell co-culture system was used for T cell phenotyping.  B cells of BALB/c mice pulsed 
with rDer p 2 or rGST were incubated with CD4+ T cells from DO11.10 TCR transgenic 
mice, in the presence of peptide OVA323-339. The cytokine productions of the CD4+ T 
cells were determined by ELISA using the culture supernatants.  Results showed that 
rDer p 2-stimulated B cells could induce IL-4 (the signature cytokine for Th2 cells) 
production. There was no difference in Th1-type signature cytokine IFN-γ production. 
The IL-4 to IFN-γ ratios in CD4+ T cells co-cultured with rDer p 2-stimulated B cells was 
also increased as compared to that of CD4+ T cells co-cultured with rGST-stimulated B 
cells (Figure. 4.10). To further confirm this in vitro experimental result, B cells 
stimulated with rDer p 2, rGST or medium alone were adoptively transferred 
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intraperitoneally into the DO11.10 TCR transgenic mice. Upon pulsing with peptide 
OVA323-339, splenocytes from mice that received rDer p 2-stimulated B cells secreted 
significantly higher levels of Th2 cytokine IL-4. The levels of Th1 type cytokine IFN-γ 
remained unchanged for all three experimental groups. The IL-4 to IFN-γ ratios were also 
significantly increased for mice that received nDer p 2-pulsed B cells (Figure. 4.11). 
These data suggested that rDer p 2 contaminated with 84 ng/mL of LPS could stimulate 
B cells with ability to polarize Th2 cells. 
 
4.4.2 Effect of clean rDer p 2 on LPS-induced B cell proliferation  
 
Since the LPS in the rDer p 2 protein could be removed by Polymyxin B-Agarose 
treatment, clean rDer p2 was available to perform a more systematic investigation on the 
effects of mite allergen on the immunological responses and accessory functions of LPS-
activated B cells. The effect of LPS alone or in combination with titrated doses of rDer p 
2 on the proliferative response of B cells from BALB/c mice was assessed. B cells were 
co-cultured with increasing doses of LPS or in combination of LPS with rDer p 2 for 72 
hours. Cell proliferation was measured by [3H]-thymidine uptake. At concentrations 
ranging from 100ng/mL to 10,000ng/mL, LPS alone could enhance B cells proliferation 
in a dose-dependent manner; whereas lower doses (1 and 10ng/mL) of LPS had no 
proliferative effects on B cells. As shown in Figure 4.12 A-E, concentrations ranging 
from 1ng/mL to 10μg/mL and rDer p 2 alone could not enhance [3H]-thymidine 
incorporation in B cells. The [3H]-thymidine incorporation remained at basal level and 
was comparable with those of rGST and un-stimulated B cells. However, by adding 
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titrated doses of clean rDer p 2 together with the titrated doses of LPS to cell cultures, the 
[3H]-thymidine uptake data  clearly demonstrated that at 100ng/mL and above, rDer p 2 
could enhance LPS-induced B cell proliferation after stimulation for 72 hours (Figure 
4.12 C, D&E). By adding titrated doses of rGST to the cell culture and in combination 
with titrated doses of LPS, the effects were similar as those of LPS alone, indicating that 
rGST, as a control protein, had no effect on LPS-induced B cell proliferation (Figure 
4.12).  
 
4.4.3 Effect of rDer p 2 on LPS-induce B cell surface marker expression  
 
As shown in chapter 3 (Figure 3.5), LPS could markedly up-regulate B cells’ surface 
expression of CD86, I-Ad, CD40, ICAM-1 and membrane bound IgM in a dose-
dependent manner; whereas LPS dose-dependently down-regulated CXCR4 expression 
on B cells. In order to investigate whether clean rDer p 2 had any effects on LPS-induced 
B cell surface marker expression profile, the surface expression profiles of MHC class II 
molecule I-Ad, CD86, CD80, CD40, CXCR4, and membrane bound IgM on B cells 
stimulated with varying doses of LPS alone or in combination with two doses (1μg/mL 
and 10μg/mL) of rDer p 2 were analyzed by flow cytometry. As it was shown in Figure 
4.13, incubation with rDer p 2 for 48 hours did not have significant effect on the I-Ad, 
CD86, CD80 expression levels on B cells. There was a slight up-regulation of the 
expression of CD40 and membrane bound IgM, but these increased levels were similar as 
those of rGST controls. Therefore, it was not a specific feature of rDer p 2. Moreover, 
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rDer p 2 had no profound effect on LPS induced IgM, I-Ad, CD86, CD80 and CD40 
expression in B cells.  
 
As previously shown in Chapter 3 (Figure 3.5), LPS present at 1ng/mL and above could 
dose-dependently down-regulate CXCR4 expression on B cells. In accordance with the 
results of previous chapter, LPS at 100ng/mL alone could reproducibly down-regulate 
CXCR4 expression. Interestingly, rDer p 2 alone at 10μg/mL could up-regulate CXCR4 
expression. However, when B cells were co-stimulated with rDer p 2 (10μg/mL) and LPS 
(100ng/mL), there was an enhanced down-regulation of CXCR4 expression on stimulated 
B cells; whereas rGST protein plus LPS co-stimulated B cells did not show such 
enhanced CXCR4 down-regulation. Thus, it appears that rDer p 2 could exert a 
modulatory effect on LPS-induced CXCR4 down-regulation on B cells (Figure 4.14).  
 
4.4.4 Effect of rDer p 2 on LPS-induce B cell cytokine production 
  
As shown in Figure 3.6A, LPS at doses between 100pg/mL and 10ng/mL were able to 
activate B cells to secrete substantial low levels of IL-10 (3-fold above the background 
levels), while LPS doses at 100ng/mL or above were able to stimulate B cells to produce 
enormous levels of IL-10 (IL-10 levels ranging between 10-fold to 30-fold of the 
background levels) in a dose-dependent manner. Whether rDer p 2 alone could activate B 
cells to produce cytokines, and whether combination of rDer p 2 and LPS could enhance 
LPS-induced IL-10 secretion from B cells, are the questions to be addressed here. As 
shown in Figure 4.15, after varying doses of rDer p 2 stimulation for 48 hours, all the 
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tested cytokines IL-10 (Figure 4.15), IL-6, TNFα, IL-12, IL-4 and IFN-γ (data not 
shown) were at the basal levels similar to that from control protein rGST stimulated B 
cells. Furthermore, the data also showed that combination of titrated doses of rDer p 2 
and various titrated doses of LPS did not exert significant modulatory effects on the IL-
10 production by stimulated B cells.  
To further elucidate the B cell cytokines profile, intracellular cytokine staining of IL-4 
and IL-10 was performed on B cells after stimulation with LPS alone, rDer p 2 alone or 
with a combination of titrated doses of rDer p 2 and LPS. As shown in Figure 4.16 , B 
cells stimulated with LPS doses at 100ng/mL and 1000ng/mL showed  increased levels of 
IL-10 and IL-4 production in a dose-dependent manner (between 2- and 3-fold of the 
background level). Stimulation of rDer p 2 alone at 10µg/mL and 100µg/mL did not 
affect the intracellular IL-4 and IL-10 expression by B cells (Figure 4.16 B and D).  In a 
separate experiment, detailed statistical analysis indicated that 1µg/mL LPS stimulation 
could significantly elevated the intracellular IL-4 and IL-10 production by B cells (Figure 
4.17 A and C, respectively). Interestingly, in the presence of 100 µg/mL rDer p 2 with 
0.1ng/mL LPS, there was significant increased production of intracellular IL-4 and IL-10 
by B cells (Figure 4.17 B and D, respectively).  
 
4.4.5 Accessory functions of B cells co-stimulated with low dose of rDer p 2 and low 
dose of LPS 
 
In the earlier study of this chapter, it was demonstrated that 30μg/mL of rDer p 2 (with 
about 84ng/mL LPS) could confer B cells with capability to polarize Th2 cells. In order 
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to assess whether lower doses of LPS (1ng/mL) and rDer p 2 (100ng/mL) could confer B 
cells with similar Th2 polarization effect, in vivo functional assays of such B cells were 
performed in DO11.10 mice.  Figure 4.18 showed the production profiles of the OVA323-
339 peptide-pulsed splenocytes from DO11.10 mice received LPS-stimulated B cells and 
LPS plus rDer p 2-stimulated B cells. Splenocytes from both groups of mice showed 
enhanced IL-4 production as compared to un-stimulated B cells. Splenocytes from mice 
adoptively transferred with LPS and rDer p 2 co-stimulated B cells produced significantly 
higher levels of IL-4 as compared to the IL-4 production from splenocytes of mice 
adoptively transferred with un-stimulated B cells. However, there were no significantly 
increase of IL-4 production from splenocytes of mice receiving LPS and rDer p 2 co-
stimulated B cells as compared to that of the corresponding LPS controls (Figure 4.18A). 
As for the IFN-γ production, the splenocytes from mice receiving LPS and rDer p 2-
stimulated B cells produced significantly attenuated levels of IFN-γ than that of the 
corresponding LPS controls (Figure 4.18B). However, the IL-4/IFN-γ ratio for these 
splenocytes was not significantly higher than that of the corresponding LPS controls 
(Figure 4.18C). Taken together, although rDer p 2 protein and LPS can cooperatively 
enhance the Th2 polarization effects of B cells, addition of low dose (100ng/mL) of rDer 
p 2 protein had no significant impact on low dose (1ng/mL) LPS-activated B cell-
conferred Th2 polarization.   
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n Der p 1* 
0.3 5.0 1.2 
1 16.6 3.5 
3 49.8 10.5 
10 166 35.0 
30 498 105.0 
100 1660 350.0 
rDer p 2 ** 1 (before LPS removal) 12.5 2.8 
1 (after LPS removal) 0.028 0.006 
rGST 1 (before LPS removal) 0.55 0.12  




The conversion factor is 1ng of LPS =4.5 EU (Endotoxin Unit). Conventionally, the 
acceptable level of LPS contamination in protein is 1EU/mg protein (i.e. 0.22ng LPS/mg 
protein).  
 
* Native Der p 1 protein contaminated with LPS is designated as nDer p 1, the amount of 
LPS in each dose of nDer p 1 is indicated.  
 
** rDer p 2 protein is designated as clean rDer p 2 after LPS removal.  
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Figure 4.1. nDer p 1 induced B cells to proliferate in a dose-dependent manner. B 
cells were positively sorted by AutoMACS.  The cells (2×106/ mL) were co-cultured with 
increasing doses of nDer p 1 ranging from 0.3μg/mL to 100μg/mL, rGST (30μg/mL) and 
LPS (5μg/mL) for 72 hours. Proliferation was assayed by BrdU incorporation. The purity 
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Figure 4.2. Proliferative responses of B cells to nDer p 1 and LPS. B cells (2×106/ 
mL) from BALB/c mice or C3H/HeJ were cultured with nDer p 1 (30μg/mL) in the 
presence of increasing doses of LPS. BrdU incorporation was assayed at 72 hours (for 
BALB/c mice) or 48 hours (for C3H/HeJ mice). The purity of sorted B cells was more 
than 95% as analyzed by flow cytometry. Figure A shows the dosage response of B cells 
to LPS alone or LPS in combination with 30μg/mL of nDer p 1 in BALB/c mice. Figure 
B indicates the B cell proliferation profiles to LPS and n Der p 1 that contained 
equivalent amount of LPS. Figure C shows the dosage response of B cells to LPS alone 
or LPS in combination with 30μg/mL of nDer p 1 in C3H/HeJ mice. 


























Figure 4.3. B cells proliferation induced by nDer p 1. B cells were positively sorted by 
AutoMACS.  The cells were incubated with nDer p 1 (30μg/mL), rGST (30μg/mL) and 
LPS (5μg/mL) for 72 hours. Proliferation was assayed by BrdU incorporation. The purity 
of sorted B cells was more than 95% as analyzed by flow cytometry. Results from five 
experiments are shown as mean± SD (* p<0.001). 
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Figure 4.4. Activation of B cells by nDer p 1. B cells were positively sorted by 
AutoMACS.  The expressions of I-Ad, CD86 and CD40 on B cells after nDer p 1 
(30μg/mL) stimulations for 72 hours were analyzed by flow cytometry. Faint lines 
represent the profile of un-stimulated B cells. Bold lines represent the profile of B cells 
after culturing with different stimuli (as shown on the top of each panel). Dotted lines 
represent the respective isotype controls. These data are representative of three individual 
experiments. 























Figure 4.5. Cytokine mRNA expression profile of B cells stimulated with nDer p 1.  
B cells were incubated with nDer p 1 (30μg/mL) and rGST (30μg/mL) for 48 hours. 
After mRNA was extracted, reverse transcription was performed. Result shown here is a 
representative of RT-PCR result obtained from five separate experiments. PCR products 
were electrophoresed in a 1.2% argarose gel and presence of the cytokine mRNA 




                                                                                  
    
 
 























Figure 4.6. Effects of nDer p 1 stimulation on antigen internalization of B cells. B 
cells were cultured with nDer p 1 (30μg/mL) or rGST (30μg/mL) for 72 hours. The cells 
were harvested and washed completely, and then incubated with Dextran-FITC 
(25µg/mL) or Lucifer yellow (1mg/mL) at 37 ºC for 60min before subjected to flow 
cytometry analysis. Lines represent the un-stimulated B cells. Bold lines represent the 
profile of B cells after culturing with different stimuli (as shown on the top of the figure). 
Dotted lines represent the non-stained B cells. In (A), the profile of Dextran-FITC 
internalization by B cells after incubation with respective stimuli is as shown. Likewise, 
(B) shows the profile of Lucifer Yellow internalization by B cells after different stimuli 
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Figure 4.7. In vivo functional assay of nDer p 1 or rGST-pulsed B cells in BALB/c 
mice. B cells (2×106/ mL) pulsed with nDer p 1 (30μg/mL) or rGST (30μg/mL) for 24 
hours were adoptively transferred into lateral tail vein of mice on day 0 and day 7. On 
day 21, mice were sacrificed and spleens were removed. The splenocytes were stimulated 
with nDer p 1 (10μg/mL, for the group that received nDer p 1-pulsed B cells) or rGST 
(10μg/mL, for the group that received rGST-pulsed B cells) for 3 days. Recombinant IL-
2 was added on day 3, 5 and 10. On day 10, after removal of dead cells, live cells were 
re-stimulated with both nDer p 1 (10μg/mL) and rGST (10μg/mL) for 3 days in the 
presence of APCs. The culture supernatants were collected and used for cytokines ELISA 
assay. The results were expressed as mean ng of cytokines produced by 3×105 cell in 
triplicate cultures. Cell proliferations were assayed by [3H]-thymidine uptake. Results is 
shown as mean± SD (* p<0.05, ** p<0.01). Figure A and B show the cytokines IL-4 and 
IFN-γ productions, respectively, whereas Figure C shows the cell proliferation profiles.  
Each experimental group consisted of 5 mice per group (n=5). 
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Figure 4.8. In vitro accessory functional assay of nDer p 1-pulsed B cells co-cultured 
with CD4+ T cells from DO11.10 mice. B cells (2×106 cell/mL) from BALB/c mice 
were cultured with or without nDer p 1 (30μg/mL) and rGST (30μg/mL) for 24 hours. 
The cells were harvested, treated with mitomycin C (50μg/mL) and washed completely. 
CD4+ T cells from DO11.10 TCR transgenic mice were co-cultured with B cells in the 
presence of OVA323-339 (5µM) for 72 hours. Cytokines in the culture supernatant were 
assayed by ELISA. Figure A and B show the result of IL-4 and IFN-γ, respectively. 
Figure C indicates the ratio of IL-4 to IFN-γ. Data shown are representative of three 
independent experiments.     
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Figure 4.9. In vivo accessory functional assay of nDer p 1-pulsed B cells in DO11.10 
mice.  B cells (2×106 cell/mL) from BALB/c mice were cultured with or without nDer p 
1 (30μg/mL) and rGST (30μg/mL) for 24 hours. OVA323-339 (10µM) was added to the 
culture medium during the last 6 hours. Allergen-pulsed B cells (1×106 cells/mouse) were 
harvested and completely washed before adoptively transferred to DO11.10 TCR 
transgenic mice. Nine days later, mice were sacrificed and splenocytes suspensions were 
co-cultured with OVA323-339 (10µM) for 48 hours. Cytokines in the culture supernatant 
were assayed by ELISA. Figure A and B show the result of IL-4 and IFN-γ respectively. 
Figure C indicates the ratio of IL-4 to IFN-γ. Data are shown as mean±SD (* p<0.05). 
Data shown are representative of three independent experiments. 
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Figure 4.10. In vitro accessory functional assay of rDer p 2-pulsed B cells co-
cultured with CD4+ T cells from DO11.10 mice. B cells (2×106 cell/mL) from BALB/c 
mice were cultured with or without rDer p 2 (30μg/mL) and rGST (30μg/mL) for 24 
hours. The cells were harvested, treated with mitomycin C (50μg/mL) and washed 
completely. CD4+ T cells from DO11.10 TCR transgenic mice were co-cultured with B 
cells in the presence of OVA323-339 (5µM) for 72 hours. Cytokines in the culture 
supernatant were assayed by ELISA. Figure A and B show the result of IL-4 and IFN-γ, 
respectively. Figure C indicates the ratio of IL-4 to IFN-γ. Data shown are representative 
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Figure 4.11. In vivo accessory functional assay of rDer p 2-pulsed B cells in DO11.10 
mice. B cells (2×106 cell/mL) from BALB/c mice were cultured with or without rDer p 2 
(30μg/mL) and rGST (30μg/mL) for 24 hours. OVA323-339 (10µM) was added to the 
culture medium during the last 6 hours. Allergen-pulsed B cells (1×106 cells/mouse) were 
harvested, completely washed and subsequently adoptively transferred to DO11.10 TCR 
transgenic mice.  Nine days later, mice were sacrificed and splenocytes suspensions were 
prepared. The splenocytes were co-cultured with OVA323-339 (10µM) for 48 hours after 
which the respective culture supernatants were assayed by ELISA. Figure A and B 
represent the result of IL-4 and IFN-γ respectively. Figure C indicates the ratio of IL-4 to 
IFN-γ. Data are shown as mean±SD (* p<0.05). Data shown are representative of three 
independent experiments. 
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Figure 4.12. Proliferative response of B cells to the stimulation by LPS alone or LPS 
in combination with rDer p 2. B cells (1 × 105) from BALB/c mice were cultured in 
triplicates in the presence or absence of varying concentrations of LPS (1-10,000 ng/mL) 
or titrated doses of rDer p 2 (1-10,000 ng/mL) containing varying concentrations of LPS 
for 72 hours. Proliferation was assayed by [3H]-thymidine incorporation. rGST was used 
as the control protein. These data are representative of three independent experiments. * 
indicated data for B cells stimulated with rGST or rDer p 2 alone.  
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Figure 4.13. Expression profiles of costimulatory and accessory molecules on LPS-
treated B cells and the combination of rDer p 2 and LPS-treated B cells. B cells 
(2×106/mL) from BALB/c mice were cultured in the presence or absence of varying 
concentrations of LPS (1-10,000 ng/mL) or in the combination of rDer p 2 and LPS for 
48 hours. Surface expression levels of IgM, CD86, CD40, I-Ad and CD80 molecules on B 
cells were analyzed by flow cytometry. The y-axis in each plot indicates the mean 
fluorescent intensity (MFI) of the respective surface molecule except for CD80, which 
was the percentage of CD19+CD80+ cells over CD19+ cells. The x-axis indicates the 
various LPS dosage used. rGST was used as control protein. These data are 
representative of two independent experiments. * indicated data for B cells stimulated 
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Figure 4.14. Cell surface molecule CXCR4 expression of B cells stimulated with LPS 
alone or in combination with rDer p 2.  B cells (2 × 106/mL) from BALB/c mice were 
co-cultured with LPS (100ng/mL) alone, rDer p 2 (10μg/mL) alone or LPS  in 
combination with rDer p 2 or rGST (10μg/mL) for 48 hours. rGST was used as the 
control protein. Expression levels of CXCR4 surface molecules on B cells were analyzed 
by flow cytometry. Figure A indicates the histogram profile of the CXCR4 surface 
molecules after LPS stimulation (light green line). The CXCR4 expression profile after 
rGST stimulation is indicated in dark green line, whereas the relevant isotype control is 
indicated by pink dotted line.  Figure B shows the histogram profile of the CXCR4 
molecules after rDer p 2 stimulation (light green line). Figure C shows the histogram 
profile of the CXCR4 molecule after co-stimulation with rDer p 2 and LPS stimulation 
(light green line). The combined effect of rGST and LPS on CXCR4 expression is 
indicated by a light blue line.  
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Figure 4.15. The cytokine profile of B cells stimulated with LPS alone or in 
combination with rDer p 2 examined by ELISA.  B cells (2 × 106/mL) from BALB/c 
mice were cultured in the presence or absence of varying concentrations of LPS (0.1-
10,000 ng/mL) or in the combination of rDer p 2 and LPS for 48 hours. rGST was used as 
the control protein. The cell culture supernatants were assayed for IL-10 cytokine by 
ELISA. These data are representative of two independent experiments. *  indicated data 
for B cells stimulated with rGST or rDer p 2 alone.  
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Figure 4.16. The cytokine profile of B cells stimulated with LPS alone or in 
combination with rDer p 2 examined by intracellular cytokine staining.  B cells (2 × 
106/mL) from BALB/c mice were cultured in the presence or absence of varying 
concentrations of LPS (0.1-1,000 ng/mL) or rDer p 2 (10 µg/mL or 100 µg/mL) for 48 
hours.. Panels A and B show the IL-4 production profiles, and panels C and D show the 
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Figure 4.17. Statistical analysis of the cytokine levels produced by B cells stimulated 
with LPS alone or in combination with rDer p 2.  B cells (2 × 106/mL) from BALB/c 
mice were cultured in the presence or absence of LPS (0.1 ng/mL or 1,000 ng/mL) or 
rDer p 2 (10 µg/mL or 100 µg/mL) for 48 hours. The cytokines IL-4 and IL-10 were 
assayed by intracellular cytokine staining. Results were expressed as the mean percentage 
of IL-4+CD19+ or IL-10+CD19+ cells over CD19+ B cells. Results are shown as mean± SD 
(* p<0.05, ** p<0.01). Panels A and B show the IL-4 cytokine production profiles; and 
panels C and D show IL-10 cytokine production profiles.  The experimental data were 
derived from splenic B cells of five individual mice.  
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Figure 4.18. In vivo accessory functional assay of combined LPS and rDer p 2-
pulsed B cells in DO11.10 mice. B cells (2×106/ mL) were cultured in the presence or 
absence of LPS (1ng/mL) or LPS in the combination with rDer p 2 (100ng/mL). After 18 
hours, 5µM of OVA323-339 were added into the B cells culture and incubated for 6 hours. 
The cells were then harvested, washed thoroughly and injected intraperitoneally into 
DO11.10 mouse (1×106 cells per mouse). After 9 days, the mice were sacrificed and 
splenocytes were cultured in the presence of 5 µM OVA323-339 for 48 hours. The culture 
supernatants assayed for IL-4 and IFN-γ by cytokine ELISA. Figure A and B show the 
result of IL-4 and IFN-γ respectively. Figure C shows the ratio of IL-4 (pg/mL) to IFN-γ 
(ng/mL). Each experimental group consisted of 4 mice (n=4).  * p<0.05, ** p<0.01. 
 














To date, a comprehensive understanding of the molecular and cellular mechanisms by 
which LPS affects allergic responses remains elusive. The aim of this chapter is to 
address certain aspects of this important area of research from the B cell prospective. The 
focus of the study is to explore the possible modulatory effects of Der p 1 and Der p 2 on 
the accessory and antigen presentation functions of the LPS-mediated TLR- stimulated B 
cells.  
 
In the first part of this study, immunoaffinity purified native Der p 1 (nDer p 1) protein 
was prepared for the in vitro and in vivo experimental works as allergenic recombinant 
Der p 1 with correctly folded structural conformation was unavailable during the course 
of this study. However, it was found that the purified nDer p 1 was consistently 
contaminated with substantial levels of LPS; removal of LPS from nDer p 1 by a 
common conventional polymyxin B agarose method was not satisfactory, although such 
method could effectively remove LPS from rDer p 2 and rGST proteins (Table 4.1). 
Given such constraints, the experimental works were performed with n Der p 1 
containing known concentration of LPS. As shown in the dose response experiments, B 
cells stimulated with a dose of 30µg/mL of nDer p 1 (containing about 105ng/mL of 
LPS) could induce B cell proliferation (Figure 4.1). It was further demonstrated that 
30µg/mL of nDer p 1 alone or 30µg/mL of nDer p 1 plus additional 100ng/mL of LPS 
could enhance B cell proliferation as compared with that of LPS alone (Figure 4.2 A and 
B). Similar experiments conducted using B cells from the LPS-resistant C3H/HeJ mice 
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showed similar trends but with much reduced magnitude of B cell proliferation, 
suggesting that such B cell activation was largely induced by LPS-mediated TLR4-
stimulation pathway (Figure 4.2C). These results also implied that nDer p 1 and LPS may 
work cooperatively or synergistically to enhance B cell activation. Given that LPS-free 
Der p 1 is unavailable, it is difficult to further explore the mechanisms underlying this 
interesting observation. Native Der p 1 has been frequently used by researchers in 
numerous in vitro studies for years, but the effects of LPS co-existing with native Der p 1 
have not been assessed properly in most published studies. Recently, Velickovic et al., 
reported that very low dose of LPS (50pg/mL) increased rFel d 1-stimulated proliferation 
of PBMCs from both subjects of IgE-positive and subjects negative to cat allergens. The 
authors concluded that LPS could enhance proliferation and decrease the apparent 
threshold level for cell activation, prompting careful evaluation of allergen stimulated T 
cell activation in vitro (Velickovic TC et al., 2008). In view of the findings of Velickovic 
et al., and the results of this current study, it is worthwhile to re-evaluate the findings 
derived from the past publications on studies involving the use of native Der p 1 in cell 
culture work. 
 
It is well documented that in the natural environment, LPS is frequently co-existing with 
the major inhalant allergens. It is conceivable that the natural effects of allergens are most 
likely to be the combined effect of allergen and LPS. Thus the study with the LPS-
contaminated nDer p 1 may yield some meaningful results that confer biological or 
clinical significance.  In view of this notion, further experiments were performed to 
explore the functional aspects of nDer p 1-activated B cells. A dose of 30µg/mL of nDer 
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p 1 containing about 105ng/mL of LPS was chosen for all the subsequent experiments. B 
cells stimulated with 30µg/mL of nDer p 1 showed increased expression of MHC class II 
molecules, CD86 and CD40 (Figure 4.4), production of IL-4 and IL-10 cytokines (Figure 
4.5), as well as enhanced ability of antigen internalization (Figure 4.6). To assess the in 
vivo accessory functions of these nDer p 1 - activated B cells, adoptive cell transfer 
experiments were performed using the wild type BALB/c mice. The splenic T cells 
obtained from the recipient mice showed antigen-specific cell proliferation and cytokine 
production upon restimulation with n Der p 1 protein in the in vitro T cell culture assays 
(Figure 4.7). This result suggested that the nDer p 1-activated B cells could exhibit some 
in vivo antigen presenting or accessory functions to prime Der p 1-specfic T cell 
responses. Upon nDer p 1 stimulation, both IL-4 and IFN-γ were produced by T cells in 
an antigen specific manner with no obvious indication of Th1 or Th2 polarization. It is 
unclear whether these B cells act as primary or secondary antigen presentation cells 
(APCs) in such a physiological microenvironment, where various subsets of APCs such 
as DCs and macrophages co-exist with the transferred donor B cells. Nevertheless, these 
data provide some direct evidence that nDer p 1-activated B cells have some capability to 
prime Der p 1-specific T cell responses by certain mechanisms to be further elucidated. 
From this study, the possible coherent function of B cells and DCs in T cell priming 
cannot be ruled out. Increasing evidence suggested that B cells may function as a cellular 
source of cytokines, chemokines, and auto-antibodies that are critically involved in the 
process of maturation, migration, and other functions of DCs. One of the potential effects 
of B cells on DCs is, by promoting the production of IL-10, B cells may regulate the level 
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of IL-12 production by DCs and the onset of Th2 response (Moulin V et al., 2000; Bayry 
J et al., 2005). 
 
The next question to be addressed was whether the combination of mite allergen and LPS 
could modulate the T cell polarization driven by activated B cells. Functional assays of B 
cells stimulated with either 30µg/mL of nDer p 1 (contaminated with 105ng/mL of LPS) 
or 30µg/mL of rDer p 2 (contaminated with 84ng/mL of LPS) were performed using 
DO11.10 TCR transgenic mice. As shown in Figures 4.8 and 4.9, the results from both in 
vitro and in vivo functional assays suggested that B cells stimulated with 30µg/mL of 
nDer p 1 containing relatively low dose (approximately 105ng/mL) of LPS could polarize 
a Th2 phenotype. Similar results were obtained with B cells stimulated with 30µg/mL of 
rDer p 2 containing 84ng/mL of LPS (Figure 4.10 and 4.11). This is in accordance with 
the previous results showing the low dose (0.1-100ng/mL) of LPS-stimulated B cells 
preferentially induced Th2 polarization. It appears that the presence of 30µg/mL of Der p 
1 or Der p 2 did not have a profound modulatory effect on Th2 polarization driven by the 
low dose LPS-activated B cells. Taken together, these data may infer that the 
environmental levels of LPS co-existing with allergens could have a critical adjuvant 
effect on the prevalence of allergen sensitization. The levels of allergens in the living 
environment may or may not be a critical determining factor in such a scenario. 
 
The concept of using LPS as an adjuvant together with allergen for prevention and 
treatment of allergy and allergic diseases have been explored actively in recent years. 
Wang et al., demonstrated that in an OVA-asthma mouse model, neonatal exposure to 
LPS and/or allergen prevented airway diseases (Wang Y et al., 2006). In this study, mice 
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exposed to LPS in the neonatal period developed T cells expressing CD25 and IL-10, 
accompanied by attenuated Th2 allergic responses on sensitization and challenge. Mice 
exposed to both LPS and OVA developed a response characterized by IL-10 and IFN-γ-
expressing T cells. However, the underlying cellular and molecular mechanisms 
remained unclear. On the basis of the observation in this current study that high doses 
(>0.1μg/mL) of LPS stimulation of B cells resulted in the polarization of T cells 
producing both IL-10 and IFN-γ cytokines (i.e. a Tr1 phenotype), it would be worthwhile 
to conduct further studies to determine whether B cells pulsed with allergen containing 
higher doses of LPS (1-10µg/mL) could drive regulatory T cell activity in allergen–
specific manner. If such a concept can be proven, it may represent a B cell-targeting 
strategy to generate antigen-specific regulatory T cells to down-regulate Th2-mediated 
inflammatory responses in allergic diseases.  
 
Unlike the scenario with nDer p 1, the LPS presented in rDer p 2 protein could be 
efficiently removed by polymyoxin B agarose method. After polymyoxin B treatment, 
the LPS concentration is about 0.006ng of LPS per µg of rDer p 2, the availability of this 
clean form of rDer p 2 with very minute amount of contaminating LPS facilitated a more 
systematic approach to investigate the effects of mite allergen alone or in combination 
with titrated doses of LPS, on the T cell polarization driven by the activated B cells. Our 
results indicated that rDer p 2 alone did not show any effect on B cells proliferation 
(Figure 4.12), cell surface molecules expression (IgM, CD86, CD80, CD 40 and MHC II, 
Figure 4.13), nor could it affect the IL-10 cytokine production profile (Figure 4.15). 
However, B cells co-stimulated with various titrated doses of rDer p 2 in the presence of 
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titrated higher doses of LPS (100ng/mL-10µg/mL) showed enhanced cellular 
proliferation (Figure 4.12 C-E) without showing significant up-regulation of surface 
expression of accessory or co-stimulatory molecules such as CD86, CD80, CD40 and 
MHC class II (Figure 4.13). Moreover, upon stimulation with 10µg/mL of rDer p 2 alone 
or in combination with 100ng/mL of LPS, the CXCR4 expression profiles of B cells 
showed some intriguing data. As it was showed in Figure 4.14 B, B cells stimulated with 
10µg/mL of clean rDer p 2 protein alone showed a slight up-regulation of CXCR4 
expression as compared with rGST protein control. Interestingly, B cells stimulated with 
a mixture of rDer p 2 (10µg/mL) and 100ng/mL of LPS showed enhanced down-
regulation of CXCR4 expression (Figure 4.14 C) as compared with the profile of B cells 
stimulated with 100ng/mL of LPS alone (Figure 4.14 A) or a mixture of 100ng/mL plus 
10ug/mL of rGST protein (Figure 4.14 C). The enhanced down-regulation of CXCR4 
expression on B cells stimulated with a mixture of LPS plus rDer p 2 could be conceived 
as an indicator for increased B cell activation. It may partly explain the enhanced cell 
proliferation seen in B cells co-stimulated with titrated doses of LPS plus rDer p 2 as 
shown in Figure 4.12 C-E. 
 
Structurally, CXCR4 is one of the members of G-protein-coupled receptor (GPCR). The 
extent of CXCR4 internalization is conventionally being conceived as an indicator for B 
cell activation (Daaka Y et al., 1998; Lodish H et al., 2004). Recently, we have shown for 
the first time that splenic B cells stimulated with titrated doses of LPS exhibited down-
regulation of CXCR4 in a dose-dependent manner (Xu H et al., 2008). CXCR4 is found 
to express on various B cell subsets including B-1, B-2 and pro-B cells (Kim CH, 
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Broxmeyer HE. 1999; Pease JE, Williams TJ. 2006). It is proposed that CXCR4 has a 
dual function.  As shown by a recent study, CXCR4 signaling can exert significant 
impact on TLR4 signaling pathway.  CXCR4 could bind to LPS and trigger mitogen-
activated protein kinases signaling pathway. In addition, the study also showed that co-
clustering of CXCR4 with other LPS receptors might be crucial for LPS signaling, thus 
suggesting that CXCR4 was a functional part of the multimeric LPS “sensing apparatus” 
(Triantafilou M et al., 2008).  However, the precise functional role of CXCR4 in LPS-
activation cluster remained elusive. A previous study by Kishore et al., (Kishore SP et 
al., 2005) suggested that CXCR4 could exert selective and localized suppressive effects 
on TLR4 activation by very low dose (less than 10ng/mL) of LPS.  They have further 
demonstrated that the inhibitory signal delivered by CXCR4 was likely being mediated 
by the βγ subunit of the heterotrimeric GPCR. Such inhibitory effects may not be 
effective when TLR4 activation occurs under higher doses of LPS. Therefore, CXCR4 
may act as an intrinsic regulator for LPS-induced TLR-4 function. The enhanced down-
regulation of CXCR4 expression, corresponding to an increased CXCR4 internalization, 
could be attributed to the cooperative interaction between LPS-activated TLR4 and 
CXCR4 signaling pathways resulting in increased B cell proliferation.  But it is difficult 
to offer a sensible explanation for the intriguing observation of the enhanced down-
regulation of CXCR4 expression (Figure 4.14 C), accompanied with an increased cell 
proliferation of B cells (Figure 4.12), when these B cells were co-stimulated with rDer p 
2 and LPS.  
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Besides being a functional component of LPS activation cluster, previous studies have 
shown that CXCR4 could promote migration of APCs out of the blood vessels and into 
secondary lymphatic organs (Brandes M et al., 2000; Ding Z et al., 2003). A recent study 
demonstrated that monocyte-derived immature human DCs stimulated with 100ng/mL of 
LPS and birch pollen grains extract enhanced CXCR4 expression on the stimulated DCs. 
The authors suggested that such an increase of CXCR4 expression could enhance the 
migration of the DCs to secondary lymphoid tissues (Mariani V et al., 2007). In the 
current study, B cells stimulated with 10μg/mL of clean rDer p 2 showed up-regulation of 
CXCR4 as compared to that seen in un-stimulated B cells (Figure 4.14 B). Although the 
biological and functional significance of this observation is unclear, it is reasonable to 
speculate that the enhanced CXCR4 expression on B cells may facilitate the migration of 
Der p 2 stimulated B cells to secondary lymphoid organ for antigen presentation and T 
cell priming. Further studies at cellular and molecular levels are necessary to address this 
research question.    
 
It is worth noting that in B cells, RP105 facilitates TLR4 signaling. Both TLR4/MD-2 
and RP105/MD-1 are required for the full activation of B cells. Either RP105 -/-or MD-1-/- 
results in reduced B cell responses to LPS in mouse (Ogata H et al., 2000; Kimoto M et 
al., 2003).  Incidentally, it was proposed that Der p 2 share some structural homology 
with MD 1 and MD2 (Gruber A et al., 2004). Although there is no direct evidence to 
support the notion that Der p 2 can function as a homologue for MD1 and MD2, the 
possibility that Der p 2 exerts a regulatory role in the LPS-mediated activation of B cells 
cannot be ruled out and deserves further studies to shed light in this interesting 
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observation. The modulatory effect of rDer p 2 is unlikely through the interaction with 
LPS, as binding assay demonstrated that the binding ability of rDer p 2 to LPS is much 
weaker as compared with that of MD-2 (Keber MM., 2005).  
As ELISA method may not be sensitive enough to detect the B cells’ cytokine profile 
especially the expression profile of IL-4, I further performed the intracellular staining of 
IL-4 and IL-10 produced by B cells stimulated with LPS alone or in combination with 
rDer p 2. In accordance with cytokine data obtained by ELISA results (Figure 3.6), B 
cells stimulated with LPS doses at 100ng/mL and 1000ng/mL produced  increased levels 
of IL-10 in a dose-dependent manner (between 2- and 3-fold of the background level). 
Interestingly, LPS doses at 100ng/mL and 1000ng/mL could also induce IL-4 production 
by B cells in a dose-dependent manner (between 2- and 3-fold of the background level). 
It is worth noting that IL-4 production by LPS-stimulated B cells was not detectable in 
culture supernatant by ELISA. The result discrepancies could be due to the fact that IL-4 
produced by the stimulated B cells was probably non-secretary. Further studies are 
needed to confirm this proposed observation.    However, stimulation of B cells with rDer 
p 2 alone at 10µg/mL or 100µg/mL did not induce the intracellular IL-4 and IL-10 
production by the stimulated B cells (Figure 4.16, panel B and D).  Interestingly, in the 
presence of 100 µg/mL rDer p 2 with 0.1ng/mL LPS, there was significant increased 
production of intracellular IL-4 and IL-10 by B cells (Figure 4.17 B and D). It is unclear 
whether the IL-4 and IL-10 cytokines were co-produced by the same B subset. However, 
the possible existence of IL-4 or IL-10- producing B cell subset cannot be ruled out.  It 
has been shown that B cells have the capacity to present antigen but fail to secrete IL-12--
a key regulatory cytokine produced by APCs which drives the development of IFN-γ-
                  Chapter 4 Effects of House Dust Mite Allergens on Stimulated B cells 186 
 
producing cells and Th1 polarization. This unique characteristic of B cells may explain 
their propensity to selectively drive Th2 cell development (Guéry JC et al., 1997). In 
addition, study on the induction and regulation of IL-12 produced by mouse DCs has 
clearly demonstrated that both IL-4 and IL-10 are the important factors to down-regulate 
IL-12 production (Koch F et al., 1996). My data show that LPS-stimulated B cells 
produced IL-4 and IL-10 may represent a possible mechanism to down-regulate IL-12 
production by B cells. Furthermore, it was observed that mite allergen Der p 2 could 
significantly increase the IL-4 production by B cells upon stimulation with low dose LPS, 
suggesting some possible underlying mechanisms of the phenomenon of allergenicity of 
Der p 2 allergen .  
 
To further address the combined effect of rDer p 2 plus LPS in modulating T cell 
polarization driven by activated B cells, in vivo functional assay of B cells stimulated 
with either 1ng/mL of LPS alone or in combination with 100ng/mL of rDer p 2 were 
performed using DO11.10 TCR transgenic mice. Figure 4.18 demonstrated the cytokine 
production of splenocytes from DO11.10 mice, which received adoptively- transferred B 
cells stimulated with LPS alone or with B cells stimulated with LPS plus rDer p 2. As 
shown in Figure 4.18, B cells co-stimulated with rDer p 2 and LPS could polarize T cells 
producing higher levels of IL-4 and lower levels of IFN-γ as compared to those seen in T 
cells from mice receiving un-stimulated B cells. However, there were no significant 
increase of IL-4 production in the this group of T cells as compared to its corresponding 
T cells receiving the stimulation of B cells activated by LPS alone, although for the IFN-γ 
production, the splenocytes from mice received LPS and rDer p 2-stimulated B cells 
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produced significantly attenuated levels of IFN-γ than that of the corresponding LPS 
controls. Taking together, the increased production of IL-4 cytokine and the reduced level 
of IFN-γ resembled a typical Th2 phenotype. Very low dose of rDer p 2 protein 
(100ng/mL) and LPS (1ng/mL) still can cooperatively enhance the Th2 polarization 
effects of B cells. However, addition of low dose (100ng/mL) of rDer p 2 protein had no 
significant impact on low dose (1ng/mL) LPS-activated B cell-conferred Th2 
polarization. 
 
In summary, in vitro B cell culture experimental results suggested that both Der p 1 and 
Der p 2 dust mite allergens can work cooperatively with LPS to enhance B cell 
proliferation. Adoptive B cells transfer experiment using wild type BALB/c mice showed 
that B cells could uptake, process and present LPS containing native Der p 1 to prime Der 
p 1 specific T cell responses. The accessory functions of B cells stimulated with 30µg/mL 
of LPS contaminated nDer p 1 or rDer p 2 were assayed by in vitro and in vivo 
experiments using DO11.10 CD4+ T cells.  Results showed that the LPS plus mite 
allergen co-stimulated B cells acquired capability to drive Th2 polarization. Further 
similar studies showed that B cells co-stimulated with very low doses of LPS (1ng/mL) 
and rDer p 2 (100ng/mL) could also drive Th2 polarization. These data further support 
the earlier data that low dose LPS (1-100ng/mL) stimulated B cells preferentially drive 
Th2 polarization. Addition of high (30µg/mL) or low dose (100ng/mL) of Der p 2 
allergen had no significant impact on low doses of LPS activated B cell-conferred Th2 
polarization. Taken together, it seems that by targeting B cells as APCs, low doses of 
LPS could serve as potent Th2 adjuvant to drive Th2 polarization. In this scenario, 
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inhalant indoor environmental allergens such as Der p 1 and Der p 2 alone may not have 
direct impact on B cells per se. However, the combination of low doses of LPS and 
allergen could enhance LPS-induced B cells activation, probably by lowering the 
threshold of B cell activation. However, the enhanced B cell activation may or may not 
be directly responsible for the corresponding increased capability of the activated B cells 
to drive Th2 polarization. The involvement of other unknown underlying mechanisms is 
highly possible and deserves more future studies. An interesting observation in this study 
is that rDer p 2 allergen stimulated B cells showed increased expression of chemokine 
receptor CXCR4, which suggests that the interaction of B cells with Der p 2 may lead to 
increased migration of these B cells to secondary lymphoid tissue to perform APC 
functions. This is an interesting hypothesis that is worth exploring in future studies.  
Taken together, the observations derived from this study may open up new avenues for 
investigating the role of B cells in initiation, enhancement or attenuation of the allergic 
immune responses.   
  
 
Chapter 5  




The prevalence of allergic diseases such as allergic bronchial asthma, allergic rhinitis, 
and atopic dermatitis is increasing worldwide. In the past decade, allergy research has 
been greatly influenced and directed by the much favored “hygiene hypothesis”, 
which proposes that the microbial environment interfaces with the innate immune 
system and modulates antigen specific adaptive immune responses. Elucidation of the 
potential link of environmental exposures in the development of allergic diseases such 
as asthma and rhinitis has focused on its effects on the underlying responses of the 
innate immunity and its subsequent impact on the adaptive immunity. Although the 
precise molecular and cellular mechanisms underlying the hygiene hypothesis remain 
elusive, it is quite clear that the recent increased worldwide prevalence of allergy and 
allergic diseases reflects recent changes in the gene-environment interactions in atopic 
individuals. Over the past decades, studies focusing on the understanding of 
interactions between external environmental factors and host’s genetic factors have 
been actively performed. 
 
Epidemiological studies suggested that nonviable microbial products in the 
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environment such as lipopolysaccharide (LPS) can stimulate immune responses in 
ways to confer protection against allergies (Schaub B et al., 2006). However, the 
immunological mechanisms underlying such protective immunity remain unclear. In 
addition, although it is well established that allergen exposure is a major triggering 
factor associated with the development and persistence of Th2-mediated allergic 
diseases, the mechanisms for the initiation and development of such Th2 responses 
remain ambiguous. Given that LPS is frequently coexisting with the major inhalant 
allergens (Platt-Mills TA et al., 1995), the roles of LPS in initiating/maintaining 
allergen-specific T cell immune responses have been investigated. However, current 
studies mainly focus on the in vivo mechanisms for the LPS-mediated DCs’ effects on 
the development of allergic reactions and most of these studies also focus the global 
effects of LPS on allergic responses (Dabbagh K et al., 2002;  Piggott D et al., 
2005). The crucial missing link in our understanding of the immunomodulatory roles 
of LPS on both innate and adaptive immunity in allergic responses is the elucidation 
of the direct effects of LPS on individual immune-cell populations, particularly 
antigen presenting cells such as DCs, macrophages and B cells. The main objective of 
this proposed study is to address the question from the B cell perspective. 
 
The first specific aim of this project is to investigate the modulatory effects of LPS 
stimulated splenic B cells on differential T cell polarization. The LPS dosage effects 
on B cells’ activation and the subsequent accessory functions of the activated B cells 
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in mediating T cell polarization were assessed by in vivo and in vitro experiments. 
The experimental data showed that low dose of LPS (1-100ng/mL) or high dose of 
LPS (0.1-10μg/mL)-stimulated B cells were capable of polarizing Th2 or Tr1 cells, 
respectively.  These data suggest that B cells activated by varying doses of LPS 
acquired differential modulatory effects on T cell polarization. Such modulatory 
effects of B cells on T cells are dependent on the stimulation with LPS in a dose- 
dependent manner.  
 
The second specific aim of the project is to investigate the effects of major house dust 
mite allergens on LPS stimulated splenic B cells. Systematic in vitro cell culture 
experiments revealed that both the two major dust mite allergens from 
Dermatophagoides pteronyssinus, Der p 1 and Der p 2, could work cooperatively with 
LPS to activate B cells and enhance B cell proliferation. However, clean Der p 2 
alone did not have any significant effect on cell surface molecules expression, 
cytokine production and B cells proliferation. B cell adoptive transfer experiments 
showed that splenic B cells pulsed with native Der p 1 contaminated with about 100 
ng/mL of LPS, could prime Der p 1-specific T cell responses in BALB/c mice. These 
data suggested that such stimulated B cells possessed some capability to uptake, 
process and present native Der p 1 to naïve T cells in vivo, which provided some 
direct evidence to support the notion that activated B cells are functionally competent 
antigen presenting cells. To further investigate the effects of low dose of LPS plus 
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high or low dose of mite allergens on the accessory functions of the stimulated B 
cells, functional assays were conducted using DO11.10 OVA TCR transgenic mice 
assay system. Results showed that B cells co-stimulated with 80-100ng/mL of LPS 
plus high dose (i.e. 30μg/mL) of mite allergens Der p 1 or Der p 2 acquired 
capabilities to drive Th2 polarization. Furthermore, B cells co-stimulated with very 
low doses of LPS (1ng/mL) and Der p 2 (100ng/mL) also resulted in Th2 polarization. 
These data further support the earlier data that low dose of LPS (1-100ng/mL) 
stimulated B cells preferentially drive Th2 polarization. Addition of high (30µg/mL) 
or low dose (100ng/mL) of Der p 2 allergen to the assay systems had no significant 
impact on low doses of LPS activated B cell-conferred Th2 polarization. Taken 
together, it seems that by targeting B cells as APCs, low dose LPS could serve as 
potent Th2 adjuvant to drive Th2 polarization. In this scenario, inhalant indoor 
environmental mite allergens such as Der p 1 and Der p 2 alone may not have direct 
impact on B cells per se. However, the combination of low dose LPS and allergen 
could enhance LPS-induced B cells activation, probably by lowering the threshold of 
B cell activation. Nevertheless, the enhanced B cell activation may or may not be 
directly responsible for the corresponding increased capability of the activated B cells 
to drive Th2 polarization. The involvement of other unknown underlying mechanisms 
is highly possible and deserves more future studies.  
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In summary, this study has generated new information on the understanding of the 
interactions between B cells and environmental factors such as LPS and/or mite 
allergens Der p 1 and Der p 2. Collectively, the data reveal that the LPS dosage is a 
critical determining factor in the immunological events leading to the B cell-mediated 
differential T cell polarization. This study also provides some evidence to show that B 
cells may have a unique role in the induction/initiation of allergic diseases. 
Furthermore, the polarization of T regulatory cells via B cell-based pathway may 
generate novel strategies in the prevention and treatment of allergy and allergic 
diseases. 
 
5.2 Future Prospective 
 
Based on the current study, there are several aspects that require further investigation:  
 
1. In the in vitro experiment using DO11.10 T cells as readouts, my data 
demonstrated that high doses LPS stimulation of B cells, defined as a dose 
ranging from 0.1 to 10µg/mL, favored Tr1 like regulatory polarization. It is 
necessary to evaluate the accessory functions of high dose LPS stimulated B 
cells in vivo to further confirm the in vitro findings. 
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2. My data indicated that low level LPS containing Der p 1 could induce 
allergen-specific T cells in wild type mice. There would be more biological or 
physiological relevant to investigate whether high dose LPS and clean form of 
mite allergens can induce allergen-specific T regulatory cells in wild type 
mice. Thus, it would be interesting to explore whether B cells co-stimulated 
with a mixture of high dose LPS (above 100ng/mL) and clean form of Der p 2 
or Blo t 5 mite allergens can induce allergen-specific T regulatory cells in wild 
type mice.  
 
3. It is essential to identify the splenic B cell subset(s) responsible for priming 
differential T cell polarization following high or low LPS stimulation. On the 
basis of the distinct phenotypic characteristics of the various B subsets, it is 
hypothesized that both B-1 and MZB B cell subsets, which have “innate 
immunity” property, could be the subsets or the dominant cell types of B cells 
that are responsible for conferring the divergent T cell polarization capability. 
Hence, B cells subsets from neonatal and adult mice should be used to perform 
the various in vitro and in vivo functional studies.  
 
4. Following the identification of the targeted B subset(s), the gene microarray 
approach can be adopted to identify novel genes in B cells that are involved in 
the differential response to low or high LPS stimulation. The data gained from 
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this experiment will provide new insight into the understanding of the 
expression patterns and rhythms of genes in respond to high or low dose LPS 
stimulation. In addition, novel signaling related gene(s) might be identified by 
this approach. 
 
5. In recent years, the existence of an immunoregulatory B cell subset possessing 
regulatory functions (Regulatory B cells, designated as Bregs) in inflammatory 
conditions to dampen on-going pathological inflammatory responses has been 
reported in a number of experimental models of chronic inflammation. In this 
study, B cells stimulated with high doses of LPS produce high levels of IL-10 
and these B cells acquired accessory functions to polarize Tr1 phenotypes. It 
would be interesting to explore whether this observation can be exploited as a 
strategy to induce Bregs to modulate established Th2 allergic immune 
responses directly by interacting with pathogenic Th2 cells to attenuate 
harmful immune responses. Alternatively, generation of such Breg may 
represent a B-cell based strategy to induce antigen-specific T-regulatory cells 
(for example Tr1 cells) to modulate pathogenic inflammatory responses in the 
affected target organs in the upper and lower airways as well as inflamed skin.  
 
6. It is demonstrated that the role of RP105/MD-1 in TLR4/MD2 responses 
seems to vary between immune cells. In B cells, RP105/MD-1 facilitates 
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TLR4 signaling—both TLR4/MD-2 and RP105/MD-1 are required for the 
fully activation of B cells. By contrast, in macrophages and DCs, RP105 
negatively regulates LPS induced responses—TLR4/MD-2 and RP105/MD-1 
play a distinct role in mediating LPS initiated signaling. In this study, Der p 2 
enhanced LPS-induced B cell proliferation and CXCR4 activation. Given that 
the specific structural similarities between Der p 2 and LPS 
receptor-associated proteins such as MD-2 and MD-1, the possibility that Der 
p 2 exerts the modulatory effect through RP105 or MD-1 by undefined mode 
of interactions or other unknown mechanisms could not be excluded. Further 
studies to understand the role of RP105/MD1 in B cells’ response to LPS and 
Der p 2 by using RP105-/-or MD-1-/- mice to address the underlying 
mechanism could be worthwhile. 
 
7. Further studies are needed to evaluate the functional significance of the 
CXCR4 up-regulation in B cells stimulated with Der p 2. Firstly, another mite 
allergen Blo t 5 should be used in future studies to address the question 
whether this CXCR4 up-regulation is unique to Der p 2.  Secondly, as it is 
believed that CXCR4 up-regulation promotes migration of B cells to the 
secondary lymphoid organ (Kim CH et al., 1999; Stein JV et al.,  2005), the 
recent study also suggested that LPS and birch pollen grains extract stimulated 
human DCs to enhance CXCR4 expression and further migration of the DCs 
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to secondary lymphoid tissues (Mariani V, et al., 2007), chemotaxis or cell 
migration assays are necessary to test the theory of enhanced mobilization 
corresponding to up-regulation of CXCR4. 
 
8. To study the crosstalk between CXCR4 and TLR4 in B cells. The crosstalk 
between GPCRs such as CXCR4 and non-GPCRs, such as the TLRs has been 
proposed in macrophages (Lattin J et al., 2007). The current study suggested 
the possibility that such crosstalk may occur in B cells, especially in the 
context of the interaction with environmental factors such as LPS and mite 
allergens. This type of mechanistic study may help us to understand the role of 
CXCR4 in mobilization of B lymphocytes to lymphoid environment and the 
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The modulatory effects of lipopolysaccharide-stimulated B cells on
differential T-cell polarization
Introduction
Innate immune recognition relies on germ-line encoded
receptors known as pattern recognition receptors, which
recognize a wide range of molecular structures in groups
of microorganisms, commonly known as pathogen-associ-
ated molecular patterns (PAMPs). A major component of
the environmental microbial products is endotoxin or
lipopolysaccharide (LPS). This represents one of the most
well-studied PAMPs; it is an immunostimulatory product
of Gram-negative bacteria that signals through Toll-like
receptor 4 (TLR-4).1,2 Active research focusing on the
interactions of LPS and its TLRs expressed by the innate
immune response cells such as dendritic cells (DCs),
macrophages and B cells have been driven by the well-
accepted ‘hygiene hypothesis’, which proposes that the
microbial environment interfaces with the innate immune
system and modulates antigen-specific adaptive immune
responses in early life.3 Of these, exposure to LPS is an
attractive candidate in this hypothesis because it may be
the link between microbial exposures and the develop-
ment of allergic diseases such as asthma and rhinitis
through its effects on innate immunity and its subsequent
impact on the adaptive immunity.
Beside DCs and macrophages, B cells are the largest
subset of leucocytes with the capacity to internalize, pro-
cess and present antigen to the responding T cells. There-
fore, B cells also serve as an important link between the
innate and adaptive immune systems. In addition, B cells
constitute a major lymphocyte subset in neonates and
infants, and they are likely to play important roles in
driving the development of the immune system in early
life.4–8 The important contribution of antigen presenta-
tion of B cells to T-cell activation has been demonstrated
both in vitro and in vivo. In vitro studies have shown that
the capacity of activated B cells to activate naive CD4+ T
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Summary
Lipopolysaccharide (LPS) is a major component of environmental micro-
bial products. Studies have defined the LPS dose as a critical determining
factor in driving differential T-cell polarization but the direct effects of
LPS on individual antigen-presenting cells is unknown. Here, we investi-
gated the effects of LPS doses on naive B cells and the subsequent modu-
latory effects of these LPS-activated B cells on T-cell polarization. The
LPS was able to induce a proliferative response starting at a dose of
100 ng/ml and was capable of enhancing antigen internalization at a dose
of 1 lg/ml in naive B cells. Following LPS stimulation, up-regulation of
the surface markers CD40, CD86, I-Ad, immunoglobulin M, CD54 and
interleukin-10 production, accompanied by down-regulation of CD5 and
CD184 (CXCR4) were observed in a LPS dose-dependent manner. Low
doses (< 10 ng/ml) of LPS-activated B cells drove T helper type 2 polari-
zation whereas high doses (> 01 lg/ml) of LPS-activated B cells resulted
in T regulatory type 1 cell polarization. In conclusion, LPS-activated B
cells acquire differential modulatory effects on T-cell polarization. Such
modulatory effects of B cells are dependent on the stimulation with LPS
in a dose-dependent manner. These observations may provide one of the
mechanistic explanations for the influence of environmental microbes on
the development of allergic diseases.
Keywords: accessory function; B cells; lipopolysaccharide; T helper type 2;
T regulatory type 1
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cells is almost as effective as that of DCs.9 In vivo studies
using the absence or depletion of B cells in animal models
have demonstrated a decrease in antigen-induced T-cell
activation, implying that B cells may contribute to the
level of T-cell priming.10–12
Lipopolysaccharide is a potent mitogen of B cells and
the in vitro responses of B cells to LPS are extremely
robust.13,14 Previous studies have shown that like myeloid
and lymphoid tissue-resident DCs, B cells exhibit up-
regulation CD86, CD40, CD54, OX40L, immunoglobulin
M (IgM) and major histocompatibility complex (MHC)
class II molecules, as well as production of interleukin-10
(IL-10) upon stimulation with LPS.15–18 However, unlike
their DC and macrophage counterparts, they do not pro-
duce the T helper type 1 (Th1) signature cytokine,
IL-12.19 This distinct functional feature between B cells
and DC subsets hints that B cells as antigen-presenting
cells might play a part in initiating or maintaining anti-
gen-specific Th2-skewed immunity. Indeed, studies by
Secrist et al. had demonstrated that B-lymphocyte-
enriched populations preferentially induced antigen-
specific CD4+ T cells to produce IL-4.20 Moreover, this
notion is further supported by two independent studies
showing that LPS-activated splenic B cells are able to ini-
tiate antigen-specific Th2-skewed responses in vitro using
specific T-cell receptor (TCR) transgenic CD4+ T
cells.21,22 Based on these parallels, the default hypothesis
for the role of B cells as antigen-presenting cells is pro-
posed in driving Th2-skewed immunity.23
Despite the potential importance of B cells as antigen-
presenting and accessory cells for T-cell differentiation
and polarization, little attention has been paid to B cells
because most of the research work in the field had been
focused on DC subsets, which are regarded as the master
regulators dictating the T-cell responses. The aim of this
study was to elucidate the accessory roles of LPS-stimu-
lated splenic B cells in initiating/modulating T-cell
immune responses. To the best of our knowledge, this
work represents the first systematic study to examine the




Specific pathogen free BALB/cArc mice were purchased
from the Centre for Animal Resources, Singapore and
housed at the Animal Holding Unit, National University
of Singapore. The BALB/cArc colonies were derived from
the Animal Resources Centre, Western Australia. T-cell
receptor transgenic C.Cg-Tg (DO11.10)10Dlo/J mice,
which bear an I-Ad-restricted, TCR recognizing OVA323–339
peptide, were obtained from The Jackson Laboratories
(Bar Harbor, ME) and were bred and maintained under
specific pathogen-free conditions at the Satellite Animal
Holding Unit, National University of Singapore. All mice
used in these experiments were females, aged 6–8 weeks.
Animal experiments were performed according to the
guidelines set by the Institutional Animal Care and Use
Committee, National University of Singapore.
Culture medium, antibodies and LPS
The culture medium used for all in vitro tissue cultures
was RPMI-1640 (HyClone, South Logan, UT) supple-
mented with 1 mM sodium pyruvate, 2 mM L-glutamine,
100 U/ml penicillin, 100 lg/ml streptomycin (HyClone),
55 · 10)2 mM 2-mercaptoethanol (Gibco BRL Life Tech-
nologies, Paisley, UK) and 10% heat-inactivated bovine
calf serum (HyClone). The LPS levels in all the medium
supplements, RPMI-1640, deionized water and bovine calf
serum, were below 009 EU/ml as assayed by Limulus
amoebocyte lysate QCL-1000 (50-648U; Cambrex Bio
Science Walkersville, MD).
Allophycocyanin (APC)-conjugated anti-CD19 (clone
1D3), fluorescein isothiocyanate (FITC)-conjugated anti-
CD40 (clone 3/23), FITC-conjugated anti-CD54 (Clone
3E2), phycoerythrin (PE)-labelled anti-CD86 (clone GL1),
PE-labelled anti-IgM (clone R6-60.2), PE-labelled anti-
CD184 (CXCR4) (clone 2B11/CXCR4), peridinin chloro-
phyll protein (PerCP) labelled anti-CD5 (clone 53-7.3),
PerCP-labelled anti-I-Ad (clone AMS-32.1), rat anti-
mouse IL-4 (clone BVD4-1D11), rat anti-mouse
interferon-c (IFN-c; clone R4-6A2), biotinylated rat anti-
mouse-IL-4 (clone BVD6-24G2) and biotinylated rat anti-
mouse IFN-c (clone XMG1.2) antibodies were purchased
from PharMingen (San Diego, CA). An FITC-conjugated
anti-CD80 (clone 1G10) monoclonal antibody was
obtained from Southern Biotech (Birmingham, AL). Rat
anti-mouse tumour necrosis factor-a (TNF-a; clone
AF-410-NA), rat anti-mouse IL-10 (clone JES052A5), bio-
tinylated rat anti-mouse TNF-a (clone BAF410) and bio-
tinylated rat anti-mouse IL-10 (clone BAF417) were
purchased from R&D Systems (Minneapolis, MN).
Lipopolysaccharide (Escherichia coli serotype 0111:B4;
Sigma-Aldrich, St Louis, MO) was supplied as lyophilized
c-irradiated powder, reconstituted in culture, and further
diluted with culture medium to working concentrations.
Splenic B-cell purification
Splenic B cells from naive BALB/cArc mice were purified
by magnetic separation according to the manufacturer’s
protocol. Briefly, 1 · 107 splenocytes were resuspended in
90 ll running buffer [phosphate-buffered saline (PBS)
containing 05% bovine serum albumin (Sigma Aldrich)
and 2 mM ethylenediaminetetraacetic acid, followed by
the addition of 10 ll anti-CD19 MicroBeads (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) and
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incubated for 15–20 min at 4. After washing twice with
running buffer, the cells underwent magnetic separation
using AutoMACS (Miltenyi Biotec GmbH). The puri-
fied splenic B cells (> 95%, as assessed by flow cyto-
metry analysis) were resuspended in culture medium for
all in vitro cultures.
CFDA-SE labelling of splenocytes
Splenocytes were resuspended at 4 · 107/ml in flow
cytometry staining buffer (PBS containing 01% bovine
serum albumin). A 5 mM stock solution of 5-(and-6)-
carboxyfluorescein diacetate succinimidyl ester (CFDA-SE;
Molecular Probes, Eugene, OR) in dimethylsulphoxide
was added to a final concentration of 5 lM and incubated
at 37 for 10 min. At the end of the incubation period,
the cells were immediately washed three times with cold
flow cytometry staining buffer. The cells were then resus-
pended in culture medium for in vitro cultures and LPS-
stimulated cell proliferation was examined at 24 and
48 hr by flow cytometry analyses using the FACSCalibur
flow cytometer with CELLQUEST software (Becton Dickin-
son, Franklin Lakes, NJ).
B-cell surface molecule analyses by flow cytometry
Splenocytes (2 · 106) were cultured in 1 ml/well in
24-well plate (Nalge Nunc International, Rochester, NY)
in the presence or absence of varying concentrations of
LPS (01–10 000 ng/ml) at 37 in 5% humidified CO2 for
24 hr. Subsequently, the splenocytes were stained with
APC-conjugated anti-CD19 in combination with either
FITC-conjugated anti-CD40, FITC-conjugated anti-CD80,
FITC-conjugated anti-CD54, PE-labelled anti-CD86,
PE-labelled anti-IgM, PE-labelled anti-CD184 (CXCR4),
PerCP-labelled anti-CD5 or PerCP-labelled anti-I-Ad
monoclonal antibodies for 30 min at 4. After extensive
washing with flow cytometry staining buffer, cells were
spun down and resuspended in 05–1 ml fixing buffer
(1% paraformaldehyde in PBS) for flow cytometry
analyses.
Cytokine sandwich enzyme-linked immunosorbent assay
The concentrations of IL-4, IFN-c, TNF-a and IL-10 in
the culture supernatants were measured by specific solid-
phase sandwich enzyme-linked immunosorbent assay
(ELISA). Mouse recombinant IL-4, IFN-c, TNF-a and
IL-10 purchased from Pharmingen were used to generate
the standard curves in the assays. The detection limits for
IFN-c and TNF-a were 20 pg/ml whereas those for IL-4
and IL-10 were 10 and 40 pg/ml, respectively. The cyto-
kine concentrations of each sample were calculated by
converting the raw reading of optical density at 405 nm
using the standard curves.
Antigen internalization assay
Purified splenic B cells (2 · 106) were cultured in 1 ml/
well in 24-well plates in the presence or absence of LPS
(1 lg/ml) at 37 in 5% humidified CO2 for 12, 24, 48 or
72 hr. After extensive washing, the B cells were resus-
pended in culture medium and, 5 · 105 B cells in 01 ml
culture medium were incubated with 25 lg/ml of FITC-
dextrans (Molecular Probes) or 1 mg/ml lucifer yellow
(Molecular Probes) at 37 for 1 hr. Subsequently the B
cells were washed with flow cytometry staining buffer and
fluorescence intensity was measured using flow cytometry
analyses.
Determination of naive CD4+ DO.11.10 T-cell
polarization by LPS-treated splenic B cells
Purified splenic B cells (2 · 106) were cultured in 1 ml/
well in 24-well plates in the presence or absence of vary-
ing concentrations of LPS (01–10 000 ng/ml) at 37 in a
5% humidified CO2 incubator. After 24 hr, splenic B cells
were harvested and washed thoroughly with PBS and
resuspended in culture medium. The naive CD4+ T cells
(95–98% purity as assessed by flow cytometry) from
DO11.10 TCR transgenic mice were purified by positive
sorting using anti-CD4 MicroBeads (Miltenyi Biotec) and
AutoMACS. The coculture system was modified from the
method of Hosken et al. study.21 Briefly, 1 · 105 naive
CD4+ DO11.10 T cells in the presence or absence of
1 · 105 LPS-treated splenic B cells were coincubated in
02 ml/well in 96-well, U-bottom plates in the presence or
absence of 02 lM OVA323–339 peptide (AnaSpec, Inc., San
Jose, CA) at 37 in a 5% humidified CO2 incubator. In
another set of experiments, the B cells were treated with
50 lg/ml mitomycin C (Roche Diagnostics GmbH,
Mannheim, Germany) at 37 for 20 min followed by
three washes with PBS before use in the B/T-cell co-
culture experiment. After 48 hr, culture supernatants were
collected for cytokine determination by ELISA.
Results
Proliferative profile of splenic B cells stimulated with
various doses of LPS
LPS can stimulate polyclonal mouse B-cell proliferation
and is regarded as a mitogen for mouse B cells. To estab-
lish the dose–response and proliferative kinetics of LPS-
stimulated polyclonal B-cell activation, purified splenic B
cells were labelled with CFDA-SE and stimulated with
various LPS doses (0–10 000 ng/ml). The B-cell prolifera-
tion was analysed by flow cytometry. At 24 hr after stim-
ulation LPS-stimulated B-cell proliferation was not
observed. At doses of 01–10 ng/ml, LPS-triggered B-cell
proliferation was not obvious at 48 hr. However, LPS
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promoted prominent B-cell proliferation at doses above
100 ng/ml and the B-cell proliferative responses increased
in a dose-dependent manner at 48 hr (Fig. 1).
Dose-dependent up-regulation of MHC II molecule,
CD86, CD40, IgM and CD54 but down-regulation of
CD5 and CD184 (CXCR4) expression on B cells by LPS
Lipopolysaccharide is known to provoke differentiation
and maturation of subsets of immature DC with charac-
teristics of high level expression of surface MHC II mole-
cules, CD86, CD80 and CD40 molecules.24,25 Recent
in vitro and in vivo studies have shown that the surface
density of MHC II and CD86 molecules on DCs may play
a key role in regulating the Th1/Th2 polarization.26,27 We
analysed the surface expression profiles of MHC class II
molecule I-Ad, CD86, CD80, CD40, CD5, CD184
(CXCR4), CD54 and membrane-bound IgM on in vitro
LPS-stimulated CD19+ splenic B cells by flow cytometry.
As shown in Fig. 2, 24 hr after LPS stimulation, there was
marked, dose-dependent, up-regulation of surface expres-
sion of CD40, CD86, I-Ad, CD54 and membrane-bound
IgM; whereas LPS could dose-dependently down-regulate
CD5 and CD184 (CXCR4) expression. Detailed analysis
revealed that CD5, CD184 (CXCR4) and membrane-
bound IgM were more sensitive to LPS stimulation;
expression levels began to change at a dose of 01 ng/ml
LPS. Elevation of surface expression of CD86, I-Ad
and CD54 was observed only at a higher dose of LPS
(1 ng/ml) and LPS doses of 10 ng/ml or more were
required to up-regulate the surface expression of CD40.
The expression levels of CD80 remained unaltered on B
cells stimulated with various doses of LPS (data not
shown).
Dose-dependent effect of LPS on triggering B-cell
IL-10 production
Besides the overall signal strength delivered by the MHC/
TCR cognate interaction and the binding of costimulatory
molecules/ligands of APCs and the responding T cells,
cytokines such as IL-12, IFN-c, IL-4 and IL-6 produced
by the activated antigen-presenting cells, natural killer
cells, natural killer T cells, basophils, eosinophils, mast
cells or cd T lymphocytes also play an essential role in
modulating Th1/Th2 polarization.28–31 We therefore
investigated the effects of a variety of LPS doses, ranging
from 100 pg/ml to 10 lg/ml, on the splenic B-cell profile
of cytokine production. After stimulation with LPS, the
B-cell supernatants were analysed for TNF-a, IL-10, IL-6,
IL-4, IFN-c and IL-12 using ELISA. Among these cyto-
kines, only IL-10 was consistently produced by B cells fol-
lowing LPS stimulation. As shown in Fig. 3, B cells
stimulated with LPS doses between 100 pg/ml and
10 ng/ml secreted low levels of IL-10 (threefold above the
background level), while LPS doses of 100 ng/ml or above
were able to stimulate B cells to produce enormous levels
of IL-10 in a dose-dependent manner (between 10- and
30-fold the background level). The secretion of TNF-a by
B cells following stimulation with low doses of LPS was
detected inconsistently (data not shown). Cytokines
IFN-c, IL-12, IL-6 and IL-4 were consistently undetect-
able in all the B-cell culture supernatants tested.
LPS stimulation enhances mannose-receptor-mediated
endocytosis and pinocytosis in B cells
To investigate the effect of LPS on augmenting the anti-
gen internalization ability of splenic B cells, uptake of
lucifer yellow and FITC-labelled dextrans was employed
to monitor the kinetics over a period of 72 hr after stim-
ulation with 1 lg/ml LPS. Twelve hours after LPS stimu-
lation, splenic B cells began to exhibit incremental uptake
of lucifer yellow with a mean fluorescence intensity (MFI)
of 124 compared with the background value of 107 in
non-stimulated splenic B cells. The endocytosis capability
on lucifer yellow uptake reached a maximum 48 hr
(MFI = 394) after LPS stimulation (Fig. 4a), then
decreased to an MFI of 292 at 72 hr. Moreover, uptake
of FITC-dextrans showed similar kinetics, which was
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Figure 1. Proliferative response of splenic B cells to lipopolysaccharide (LPS) stimulation. Purified splenic B cells from naive BALB/cArc were
labelled with 5 lm 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) for 10 min, washed thoroughly and resuspended in cul-
ture medium. The cells (2 · 106 cells) were then cultured in the absence or presence of varying concentrations of LPS (01–10 000 ng/ml) for 24
and 48 hr and assayed for CFDA-SE levels by flow cytometry analyses. The numbers indicate the percentage of cells in the quadrants. These data
are representative of two independent experiments.
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Figure 3. Cytokine production of B cells stimulated with lipopoly-
saccharide (LPS). Purified splenic B cells (2 · 106 cells) from BALB/
cArc mice were cultured in the absence or presence of varying con-
centrations of LPS (01–10 000 ng/ml) for 48 hr and the culture
supernatants were collected for IL-10 detection by enzyme-linked
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Figure 2. Expression profiles of costimulatory and accessory molecules on lipopolysaccharide (LPS) -stimulated splenic B cells. Splenocytes from
naive BALB/cArc were cultured in the absence or presence of varying concentrations of LPS (01–10 000 ng/ml) for 24 hr. Surface expression
levels of CD40, CD86, I-Ad, CD54, IgM, CD184 (CXCR4) and CD5 molecules on CD19+ cells were analysed by flow cytometry. The numbers
inserted in the CD40, CD86, I-Ad, CD54, IgM and CD184 (CXCR4), histogram plots represent the mean fluorescence intensity (MFI) of that
surface molecule. The numbers inserted in the CD5 histogram plots represent the percentages of B cells expressing surface CD5. Filled areas
represent the respective isotype controls. These data are representative of three independent experiments.






















Figure 4. Effect of lipopolysaccharide (LPS) stimulation on splenic
B-cell antigen internalization. Purified splenic B cells (2 · 106) from
BALB/cArc mice were cultured in the presence or absence of 1 lg/ml
LPS for 12, 24, 48 or 72 hr. The cells were then incubated with
(a) lucifer yellow or (b) fluorescein isothiocyanate (FITC)-dextrans
at 37 for 1 hr. Filled area represents the non-stimulated B cells
whereas the bold lines represent the LPS-stimulated B cells. The
numbers inserted in the histogram plots are the mean fluorescence
intensity (MFI) of LPS-stimulated B cells and the numbers shown on
the top of the histogram plots are the MFI of unstimulated B cells.
These data are representative of four independent experiments.
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detectable at 12 hr after LPS stimulation; and reached a
plateau 48 hr after LPS stimulation (MFI = 106)
(Fig. 4b).
Dose-dependent effect of LPS in conferring
differential T-cell polarizing capability on B cells
The level of LPS exposure is known to modulate antigen-
specific T-cell polarization via the TLR-4 signalling path-
way in vivo and has been presumed to be mediated by
DCs.32–37 To investigate whether splenic B cells, like DCs,
would acquire similar Th-type polarizing capability after
receiving a varied strength of LPS stimulus, an in vitro
antigen-presenting cell/T-cell coculture system for assess-
ing the T-cell phenotype profile was employed.21 Splenic
B cells activated by increasing doses of LPS, ranging from
01 ng/ml to 10 lg/ml, were cocultured with naive CD4+
T cells from DO.11.10 TCR transgenic mice in the pres-
ence of 02 lM OVA323–339 peptide for 48 hr. Similar B/
T-cell cocultures without peptide were included as con-
trols. As shown in Fig. 5, splenic B cells activated by 01–
10 ng/ml LPS induced IL-4 production; however, when B
cells received LPS stimuli of increasing strength
(> 100 ng/ml) an inverse relationship in IL-4 production
was observed (Fig. 5a, closed bar). On the other hand,
both IFN-c (Fig. 5b, closed bar) and IL-10 (Fig. 5c,
closed bar) steadily increased with increasing doses of
LPS. In the absence of OVA323–339 peptide, the levels of
IL-10 produced were remarkably attenuated (Fig. 5c, open
bar). These results suggested that both peptide-activated
T cells and the B cells activated with high-dose LPS were
capable of producing IL-10 in an LPS-dose-dependent
manner. CD4+ DO11.10 T cells alone produced very low
levels of IL-4, IFN-c and IL-10 in the presence of
OVA323–339 peptide.
To address the question of whether the lower levels of
IL-4 in the B/T-cell cocultures could be the result of con-
sumption of IL-4 by the proliferative B cells upon LPS
stimulation, we used mitomycin C-treated B cells to per-
form the B/T-cell coculture experiments. The profile of
cytokine production analysed by ELISA showed that in
the absence of proliferative B cells, the levels of IL-4 pro-
duced by T cells cocultured with high-dose LPS-activated,
mitomycin-C-treated B cells remained low, indicating that
the low level of IL-4 production was not the result of the
consumption of IL-4 by the proliferative B cells (Fig. 5d).
The B/T-cell coculture experiments performed with LPS-
activated B cells with or without mytomycin C treatment
produced similar cytokine profiles, but the levels of cyto-
kine produced were lower when mytocycin-C-treated B
cells were used in the coculture experiments (Fig. 5d–f).
Discussion
This study examined the accessory roles of LPS-activated










































































































Figure 5. Cytokine production of B-cell and
CD4+ DO.11.10 T-cell cocultures. Purified
splenic B cells were cultured in the absence or
presence of varying doses of lipopolysaccharide
(LPS; 01–10 000 ng/ml) for 24 hr. The B cells
were thoroughly washed and cocultured with
naive CD4+ DO.11.10 T cells in the presence
(closed bar) or absence (open bar) of 02 lm
OVA323–339 peptide for 48 hr (a,–c). In another
set of experiments, the LPS-stimulated B cells
were treated with mitomycin C before co-
culture with naive CD4+ DO.11.10 T cells in
the presence of 02 lm OVA323–339 peptide for
48 hr (d–f). The culture supernatants were
measured for the levels of interleukin-4 (IL-4;
a and d), interferon-c (IFN-c; b and e) and
IL-10 (c and f) by enzyme-linked immuno-
sorbent assay. T cells alone represent T cells
cultured with OVA323–339 peptide without B
cells. These data are the representative results
of three independent experiments.
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immune responses. Our results showed that LPS induced
up-regulation of CD40, CD86, MHC II, CD54 and IgM
as well as down-regulation of CD5 and CD184 (CXCR4)
in B cells in a dose-dependent manner (Fig. 2). B cells
stimulated with 100–10 000 ng/ml LPS produced signifi-
cant levels of IL-10, but the B cells stimulated with low-
dose LPS (01–10 ng/ml) produced IL-10 at basal levels
(Fig. 3). Other cytokines, such as IL-12 and IL-6, were
not detected. Importantly, the functional assays revealed
that LPS-activated B cells acquired differential modulatory
effects on the polarization of T cells. Such modulatory
effects of B cells on T cells are dependent on the dose of
LPS used for stimulation. Low-dose LPS-stimulated B
cells (01–10 ng/ml) were capable of driving Th2 polariza-
tion, as demonstrated by the production of high levels of
IL-4, accompanied by low levels of IFN-c, by DO11.10
TCR transgenic CD4+ T cells. In contrast, high-dose LPS-
stimulated B cells (1–10 lg/ml) polarized T cells produc-
ing high levels of IFN-c and IL-10 (Fig. 5), resembling
the T regulatory type 1 (Tr1) phenotype.38
The surface antigen expression profiles of the LPS-acti-
vated B cells revealed down-regulation of CD5 and
CD184 (CXCR4) in B cells that was dependent on the
LPS dose (Fig. 2). CD5, a 67 000 Da molecular weight
transmembrane glycoprotein, has been defined as an
inhibitory receptor of B cells.39 CD5 negatively regulated
the activation of B1a subsets of B cells. In addition, CD5
is a necessary molecule that maintains tolerance in aner-
gic B cells.40 In this study, the dose-dependent down-reg-
ulation of CD5 expression after LPS stimulation may
signal the activation of B cells. CD184 (CXCR4), a
chemokine receptor, is found on a variety of B-cell sub-
sets including the B-1, B-2 and pro-B cells.41,42 It has
been shown that this receptor, mediated via CCL12, plays
a role in promoting the migration of B cells to the sec-
ondary lymphoid organs.42,43 However, the recent discov-
ery of CD184 (CXCR4) as a member of the putative LPS
activation clusters, which include heat-shock protein 70,
heat-shock protein 90 and growth differentiation factor 5
in monocytes/epithelial cells, argues for an additional role
of CD184 (CXCR4) in operating the TLR-4/LPS signalling
pathway.44 To our knowledge, even though studies of
monocytes and macrophages have been well illustrated
both in vitro and in vivo;45,46 the down-regulation of
CD184 (CXCR4) expression in B cells following LPS
stimulation has not been reported. Recently Kishore et al.
showed that CD184 (CXCR4) can exert local regulatory
control over the TLR-4 signalling pathway, implying that
there is cross-talk between TLR-4 and CD184 (CXCR4).47
Molecular signalling studies will be required to determine
whether such cross-talk between G-protein-coupled recep-
tor-mediated and TLR-mediated pathways exist to core-
gulate the activation and mediate the bimodal effects of
the LPS-stimulated B cells on T cells as seen in our
study.48
Interleukin-10 is a pleiotropic cytokine that modulates
the interaction between innate and adaptive immune
responses, but its role on T-cell responses remain ambig-
uous as reflected by conflicting findings of several stud-
ies.49 Indeed, the roles of IL-10 produced by DCs in
innate immunity remain unclear despite extensive studies.
Langenkamp et al. demonstrated that LPS-stimulated
human monocyte-derived DCs produced IL-10 from 6 hr
post-stimulation and this production was sustained at
least up to 24 hr.50 This IL-10 production preceded IL-12
production. Animal studies showed that IL-10 secreted by
DCs has been associated with Th2 T cells.51,52 However,
IL-10-secreting DCs were shown to be associated with the
T regulatory phenotype in studies using a Bordetella per-
tussis infection model. The filamentous haemagglutinin of
B. pertussis inhibited IL-12 production and stimulated
IL-10 production by DCs, and then induced polarization
of IL-10-producing T regulatory cells.53 Furthermore, it
has been reported that signalling through TLR4 in
response to B. pertussis activates IL-10 production by DCs
and macrophages, which promotes IL-10-producing T
cells.54 However, a recent study demonstrated that DC-
derived IL-10 is not required for the induction of Th1 or
Th2 in vivo, but IL-10 could regulate the outcomes of a
DC-driven immune response.55
In the B-cell scenario, the notion that antigen presenta-
tion by B cells preferentially drives the development of
Th2 cells has been suggested by several studies.20,56 It was
further suggested that the production of IL-10, but not of
IL-12, by B cells is the critical determining factor for Th2
induction and polarization. Both CD5+ and CD5) naive
murine B cells have been shown to have the capacity to
produce IL-10 in response to LPS stimulation.15,18 How-
ever, the effects of LPS dose on these naive B cells and
the subsequent modulatory effects of the LPS-induced
activated B cells on T-cell polarization have not been fully
elucidated. Our data derived from the LPS dosage studies
showed that B cells stimulated with low-dose LPS
(01–10 ng/ml) produced only basal levels of IL-10
(Fig. 3) and these LPS-stimulated B cells were shown to
drive Th2 polarization (Fig. 5). Whereas B cells stimu-
lated with high-dose LPS (1–10 lg/ml) polarized T cells
to produce high levels of IFN-c and IL-10 (Fig. 5), resem-
bling the Tr1 phenotype.38 In previous studies on the role
of B cells in regulating T helper cell differentiation,21,22
splenic B cells stimulated by high doses of LPS were used
for coculture experiments with naive transgenic CD4+ T
cells bearing TCRs specific for OVA323–339 or C5 peptide.
Interestingly, both groups were able to demonstrate the
differentiation of naive CD4+ T cells to Th2 cells by pro-
ducing high levels of IL-4, the Th2 signature cytokine. In
contrast, our data showed the acquisition of Th1-like T
regulatory phenotype polarizing capacity by B cells fol-
lowing stimulation with high doses of LPS, which there-
fore challenged their hypothesis that a default pathway
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was operated by B cells as antigen-presenting cells to ini-
tiate Th2 polarization.23 Our results suggested that LPS
can exert a dose-dependent bimodal effect on splenic B
cells, in which B cells stimulated with low-dose LPS were
capable of driving Th2-skewed T-cell polarization whereas
high-dose LPS-stimulated B cells drove Th1-like T regula-
tory cell polarization.
Interferon-c-producing and IL-10-producing Th1-like
T regulatory cells have been observed in a T-cell line spe-
cific for Borrelia burgdorferi57 and in animals infected
with Toxoplasma gondii.58 Stock et al.59 reported that
antigen-specific IFN-c- and IL-10-producing Th1-like reg-
ulatory cells induced by CD8a+ DCs could potently in-
hibit the development of airway hypersensitivity. More
recently, Anderson et al.60 reported that the immune sup-
pression seen in chronic cutaneous leishmaniasis was
mediated by IL-10 produced by CD4+ CD25) Foxp3)
Th1 cells. The roles of IL-10 produced by the Th1-like
cells have been extensively reviewed by O’Garra and Vie-
ira,61 but the molecular mechanisms that regulate the
production of IL-10 by these Th1-like cells remain
unclear. For example, Gerosa et al.62 reported that IL-12
could prime human T-cell clones to produce high levels
of both IL-10 and IFN-c; but data derived from a T. gon-
dii infection model demonstrated that production of IL-
10 by Th1 cells was independent of IL-12.58 Our unique
finding that high-dose LPS-activated B cells were capable
of polarizing IL-10- and IFN-c-producing Th1-like cells
in the absence of IL-12 is interesting, but the cellular sig-
nals and molecular mechanisms involved remain to be
elucidated. It is unlikely that such observations were the
result of trace contamination by splenic residual DCs dur-
ing B-cell sorting leading to the production of IL-12 in
the B/T-cell coculture because the B cells used in this
study were positively isolated by anti-CD19 MicroBeads
with purity greater than 95%. It is also unlikely that con-
tamination by CD4+ CD8) splenic DCs during positive
isolation of DO11.10 CD4+ T cells contributed to such
observations, because CD4+ CD8) splenic DCs are poor
producers of IL-12.63 This notion is further supported by
the evidence that only background levels of IFN-c or IL-4
were produced by CD4+ DO11.10 T cells in the presence
of OVA323–339 peptide. In addition, although we cannot
rule out the possible trace contamination of CD19+ DCs
during B-cell sorting, these CD19+ DCs do not express
TLR-4 and hence are unable to respond to LPS stimula-
tion.64,65 It is highly possible that additional signal(s)
delivered by unknown cytokine(s) or accessory molecules
from high-dose LPS-activated B cells might play an
instrumental role in orchestrating the polarization of Tr1
cells. Nevertheless, like the current scenario seen in DCs,
the cellular signals and molecular mechanisms that
induced Tr1 cells by LPS-activated B cells, as observed in
our study, remain to be elucidated. Future study will
also include blocking experiments using anti-IL-10
neutralization antibody to determine whether the differ-
ential modulatory effects on T-cell polarization are medi-
ated solely by the relative amounts of IL-10 produced by
the LPS-stimulated B cells.
The results from the current study may have some
significant implications in physiological settings. In the
context of systemic infection, the activation of antigen-
presenting cells by pathogens is an essential step towards
the generation of effective immune responses to ensure
rapid clearance of pathogens by the host. As a counter-
regulatory mechanism to prevent the detrimental effects
of an excessive inflammatory response linked to potent
immune activation, the production of anti-inflammatory
cytokines, such as IL-10, by antigen-presenting cells and
T cells is essential.66 In this regard, the Th1-like Tr1 cells
driven by B cells stimulated with high-dose LPS may play
a significant role in maintaining a balance between pro-
tective immunity and detrimental immunopathology. The
amount of LPS encountered by systemically infected indi-
viduals is difficult to quantify and, to the best of our
knowledge, there is no such report has been published. It
is also noteworthy that exposure to microbes can occur
in the absence of infection. For example, endotoxin (LPS)
is one of most commonly found non-viable microbial
products in the living environment and is likely to play
an important role in modulating immune responses to
environmental allergens.67 Additionally, it is also well
established that LPS frequently coexists with the major
inhalant allergens.68 Allergen exposure is a major trigger-
ing factor associated with the development and persis-
tence of Th2-mediated allergic diseases; however, the
mechanisms for the initiation and development of such
Th2 responses remain ambiguous. Animal and human
studies have been carried out to elucidate the role(s) of
LPS in initiating/maintaining allergen-specific T-cell
immune responses. A study using a mouse model of aller-
gic sensitization showed that low-dose endotoxin pro-
motes Th2 responses to allergen.32 Furthermore, Alexis
et al.69 reported that airways challenged with low doses of
endotoxin resulted in a Th2-skewed airway inflammatory
response in humans. Additionally, epidemiological studies
have shown that the levels of exposure to LPS are inver-
sely correlated to atopy and related allergic diseases.
High-level exposure to environmental endotoxin in early
life might protect against the development of atopy and
allergic diseases,70 but the underlying mechanisms for
such protective immunity against atopy remain unclear.
Taken together, these studies imply that in the context of
allergen sensitization and development of allergic diseases,
the effect of LPS on the immune response depends on the
level of exposure (low levels directing Th2 responses and
high levels dampening these responses). The mechanism
of this paradox of differential adjuvant activities associ-
ated with high- and low-dose LPS has yet to be fully
resolved. We would like to propose that our observation
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that B cells activated by low doses of LPS drive T helper
type 2 (Th2) polarization, while those activated by high
doses of LPS result in Tr1 cell polarization, may offer a
possible mechanistic explanation for the opposing influ-
ences of low and high levels of environmental LPS on the
development of allergic diseases. This notion is further
supported by the observation that B cells represent a
dominant population of antigen-presenting cells coexis-
ting with DCs in the respiratory tract71 and that these
respiratory tract antigen-presenting cells play an impor-
tant immunomodulatory role in controlling the balance
between tolerance and immunity in response to environ-
mental antigens, such as pathogens or allergens, in the
respiratory tract.
In conclusion, our data demonstrate that LPS-activated
B cells acquire differential modulatory effects on T-cell
polarization. Such modulatory effects of B cells on T cells
are dependent on the stimulation with LPS in a dose-
dependent manner. Low-dose LPS (< 10 ng/ml)
stimulation of B cells results in Th2 polarization whereas
high-dose LPS (> 01 lg/ml) stimulation of B cells results
in Tr1 polarization. Further studies are necessary to eval-
uate the cellular and molecular mechanisms of this phe-
nomenon. Knowledge gained from such studies will shed
new light on our understanding of the effects of LPS on
the underlying responses of innate and adaptive immu-
nity driving and modulating the development of the
Th2-mediated allergic responses. Understanding of the
signalling pathways involved in the interaction between B
cells and LPS can potentially provide useful information
for developing novel strategies to prevent allergy onset or
to treat allergic diseases by therapeutic manipulation of
the innate immune system.
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